https://aibio.space/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-10-31hourly1.0 https://aibio.space/news/pelthos-amends-horizon-venture-loan-funds-loans-e-h-adds-loans/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-10-30weekly0.7 https://aibio.space/news/repligen-announces-1-0-billion-private-convertible-notes-transaction/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-10-30weekly0.7 https://aibio.space/news/ptc-reports-third-quarter-2026-revenue-358-million-raises-product/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-10-29weekly0.7 https://aibio.space/news/processa-clears-vt-7208-csu-ind-names-new-executive-chair/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-10-29weekly0.7 https://aibio.space/news/kiora-licenses-late-stage-kio-401-retinal-artery-occlusion/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-10-29weekly0.7 https://aibio.space/news/azitra-expands-atr-04-trial-rash-kras-mek-inhibitors/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-29weekly0.7 https://aibio.space/news/foxo-buy-ludwig-enterprises-preferred-stock-majority-voting-power/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-10-29weekly0.7 https://aibio.space/news/dermata-enrolls-first-participant-tome-clearing-treatment-trial/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-10-29weekly0.7 https://aibio.space/news/alnylam-details-texas-patent-suit-two-cipla-patent-cases-u-s-attorney/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-10-29weekly0.7 https://aibio.space/news/viking-ligand-dispute-vk2809-license-termination-san-diego-court/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-10-29weekly0.7 https://aibio.space/news/vikings-itc-trade-secret-ruling-against-ascletis-appeal-federal/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-10-29weekly0.7 https://aibio.space/news/court-rules-teva-apotex-vandas-hetlioz-patent-suits/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-10-29weekly0.7 https://aibio.space/news/indivior-discloses-suboxone-dental-injury-mdl-about-22-098-plaintiffs/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-10-29weekly0.7 https://aibio.space/news/altimmune-draws-10-0-million-third-tranche-hercules-loan-facility/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-10-29weekly0.7 https://aibio.space/news/european-patent-court-rules-enanta-patent-invalid-paxlovid-suit/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-10-29weekly0.7 https://aibio.space/news/inmune-bio-raises-4-50-million-registered-direct-offering-warrants/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-10-29weekly0.7 https://aibio.space/news/lexeo-therapeutics-files-300-million-shelf-registration/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-10-29weekly0.7 https://aibio.space/news/mineralys-takes-ownership-lorundrostat-patents-but-keeps-tanabe/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-10-29weekly0.7 https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-10-29weekly0.7 https://aibio.space/news/prokidney-files-650-million-shelf-200-million-jefferies-sales-program/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-10-29weekly0.7 https://aibio.space/news/bristol-myers-squibb-drops-prothenas-prx019-ending-up-617-5-million/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-10-29weekly0.7 https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-10-29weekly0.7 https://aibio.space/news/metavia-present-phase-1-da-1726-data-precision-liver-symposium/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-10-28weekly0.7 https://aibio.space/news/jaguar-health-adds-six-fold-stock-plan-increase-ahead-november-vote/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-10-28weekly0.7 https://aibio.space/news/genprex-present-tusc2-aging-research-gsa-2026-meeting/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-10-28weekly0.7 https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-10-28weekly0.7 https://aibio.space/news/sanuwave-gets-jpmorgan-waiver-fixed-charge-ratio-tightens-limits/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-10-28weekly0.7 https://aibio.space/news/skye-bioscience-faces-nimacimab-securities-class-action-two-derivative/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-10-28weekly0.7 https://aibio.space/news/skye-bioscience-faces-october-2026-retrial-cunning-whistleblower-suit/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-10-28weekly0.7 https://aibio.space/news/amarin-settles-hikma-patent-antitrust-cases-generic-vascepa/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-10-28weekly0.7 https://aibio.space/news/replimune-10-q-lists-two-massachusetts-securities-class-actions/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-10-28weekly0.7 https://aibio.space/news/actuate-therapeutics-prices-11-0-million-offering-shares-warrants/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-10-28weekly0.7 https://aibio.space/news/adial-pharmaceuticals-renames-itself-azora-therapeutics-after/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-10-28weekly0.7 https://aibio.space/news/lenz-therapeutics-reorganizes-cut-2027-operating-expenses-more-50/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-10-28weekly0.7 https://aibio.space/news/milestone-pharmaceuticals-falls-below-nasdaqs-1-00-minimum-bid-rule/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-10-28weekly0.7 https://aibio.space/news/nasdaq-panel-delists-osr-health-1-00-bid-price-rule/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-10-28weekly0.7 https://aibio.space/news/silexion-files-register-resale-up-8-813-531-shares/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-10-28weekly0.7 https://aibio.space/news/lifeward-names-ronen-tsimerman-chief-financial-officer/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-10-27weekly0.7 https://aibio.space/news/60-degrees-reports-pcr-negative-results-five-babesiosis-patients/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-10-27weekly0.7 https://aibio.space/news/volitionrx-prepays-500-000-lind-note-defers-two-monthly-payments/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-10-27weekly0.7 https://aibio.space/news/beta-bionics-discloses-securities-class-action-ilet-statements/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-10-27weekly0.7 https://aibio.space/news/aclaris-therapeutics-prices-49-999-934-stock-pre-funded-warrant/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-10-27weekly0.7 https://aibio.space/news/artiva-drops-allonk-cuts-about-94-percent-staff-weighs-strategic/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-10-27weekly0.7 https://aibio.space/news/atyr-pharma-sets-1-40-reverse-split-shares-trade-adjusted-october-29/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-10-27weekly0.7 https://aibio.space/news/cdt-equity-seeks-votes-reverse-splits-up-1-1-000-astor-note-shares/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-10-27weekly0.7 https://aibio.space/news/endovia-health-sciences-raises-equity-line-ceiling-135-million/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-10-27weekly0.7 https://aibio.space/news/enlivex-gets-nasdaq-delisting-notice-plans-appeal-1-16-reverse-split/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-10-27weekly0.7 https://aibio.space/news/geovax-signs-1-000-000-credit-line-five-directors-make-way-lender/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-10-27weekly0.7 https://aibio.space/news/geovax-stockholders-approve-reverse-split-up-1-25-warrant-share/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-10-27weekly0.7 https://aibio.space/news/imunon-files-share-offering-350-percent-warrant-coverage-four-tranches/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-10-27weekly0.7 https://aibio.space/news/inmed-sets-november-5-record-date-cvrs-tied-mentari-merger/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-10-27weekly0.7 https://aibio.space/news/pulmatrix-stockholders-approve-eos-senolytix-merger-reverse-split/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-10-27weekly0.7 https://aibio.space/news/rapport-therapeutics-launches-stock-offering-convertible-notes-due/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-10-27weekly0.7 https://aibio.space/news/sangamo-ends-july-chapter-11-16-906-955-cash/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-10-27weekly0.7 https://aibio.space/news/valion-bio-sells-preferred-stock-mostly-settle-overdue-series/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-10-27weekly0.7 https://aibio.space/news/aptevo-says-ten-frontline-aml-patients-mipletamig-reached-stem-cell/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-10-26weekly0.7 https://aibio.space/news/rallybio-declares-estimated-82-7-million-cash-distribution-tied-avenzo/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-10-26weekly0.7 https://aibio.space/news/west-pharmaceutical-enters-750-million-revolver-200-million-term-loan/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-10-26weekly0.7 https://aibio.space/news/acumen-pharmaceuticals-files-500-000-000-shelf-registration/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-10-26weekly0.7 https://aibio.space/news/aeon-biopharma-seeks-approval-reverse-split-up-1-100/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-10-26weekly0.7 https://aibio.space/news/first-eq504-dosing-unlocks-20-million-private-placement-tranche/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-10-26weekly0.7 https://aibio.space/news/onconetix-sets-1-10-reverse-stock-split-november-6/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-10-26weekly0.7 https://aibio.space/news/skye-bioscience-files-preliminary-proxy-redx-pharma-acquisition/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-10-26weekly0.7 https://aibio.space/news/silexion-shareholders-back-1-24-reverse-split-more-authorized-shares/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-10-26weekly0.7 https://aibio.space/news/supernus-ends-ubs-credit-line-ahead-indivior-merger/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-10-26weekly0.7 https://aibio.space/news/tscan-therapeutics-asks-stockholders-approve-reverse-split-up-one/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-10-26weekly0.7 https://aibio.space/news/neuphoria-extends-rights-agreement-october-27-2027/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-10-23weekly0.7 https://aibio.space/news/aquabountys-preferred-stock-converts-8-077-043-common-shares/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-10-23weekly0.7 https://aibio.space/news/china-resources-pharmaceutical-issues-rmb800-million-third-tranche/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-10-23weekly0.7 https://aibio.space/news/integra-lifesciences-details-new-jersey-class-action-two-derivative/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-10-23weekly0.7 https://aibio.space/news/akebia-therapeutics-gets-nasdaq-bid-price-notice-has-until-april-19/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-10-23weekly0.7 https://aibio.space/news/bolt-biotherapeutics-buys-prana-therapies-raises-120-million/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-10-23weekly0.7 https://aibio.space/news/citius-oncology-gets-nasdaq-extension-april-19-2027-bid-price/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-10-23weekly0.7 https://aibio.space/news/lunai-bioworks-gets-nasdaq-delisting-notice-plans-leave-exchange/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-10-23weekly0.7 https://aibio.space/news/medicus-pharma-regains-nasdaq-1-00-bid-price-compliance-days-after/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-10-23weekly0.7 https://aibio.space/news/traws-pharma-signs-50-000-000-stock-purchase-agreement-roth-principal/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-10-23weekly0.7 https://aibio.space/news/fractyl-cuts-about-45-percent-staff-drops-rejuva-gene-therapy-fund/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-10-22weekly0.7 https://aibio.space/news/united-therapeutics-authorizes-another-2-billion-share-repurchase/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-10-22weekly0.7 https://aibio.space/news/csl-faces-shareholder-class-action-fy26-guidance-disclosure/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-10-22weekly0.7 https://aibio.space/news/nuwellis-sets-one-nine-reverse-stock-split-effective-october-26/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-10-22weekly0.7 https://aibio.space/news/azitra-carry-out-1-10-reverse-stock-split-october-26/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-10-22weekly0.7 https://aibio.space/news/glucotrack-sells-secured-convertible-notes-warrants-dawson-james/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-10-22weekly0.7 https://aibio.space/news/medpace-discloses-plaintiff-dropped-ohio-securities-class-action-book/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-10-22weekly0.7 https://aibio.space/news/enlivex-announces-1-16-reverse-share-split-effective-october-27-2026/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-10-22weekly0.7 https://aibio.space/news/sagimet-expects-cash-115-million-offering-fund-operations-mid-2029/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-10-22weekly0.7 https://aibio.space/news/biotech-reverse-mergers-reach-highest-count-since-2021-pipes-return/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-10-21weekly0.7 https://aibio.space/news/arcus-raises-250-million-17-50-share-day-after-kidney-cancer-data/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-10-21weekly0.7 https://aibio.space/news/genprex-reports-mouse-research-linking-tusc2-healthy-brain-aging/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-10-21weekly0.7 https://aibio.space/news/somalogic-stockholder-suit-heads-2027-trial-without-standard-biotools/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-10-21weekly0.7 https://aibio.space/news/china-sxt-ends-purchasers-right-buy-up-12-million-more-shares/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-10-21weekly0.7 https://aibio.space/news/alaunos-therapeutics-says-350-0-million-financing-restores-nasdaq/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-10-21weekly0.7 https://aibio.space/news/disc-medicine-raises-450-million-75-share-after-phase-3-win/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-10-20weekly0.7 https://aibio.space/news/quoin-publishes-peer-reviewed-paper-qrx003-netherton-syndrome/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-10-20weekly0.7 https://aibio.space/news/premier-air-charters-chief-financial-officer-resigns-ceo-named-interim/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-10-20weekly0.7 https://aibio.space/news/surrozen-closes-second-tranche-march-2025-private-placement-about-95-1/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-10-20weekly0.7 https://aibio.space/news/lifecore-reports-july-hearing-securities-class-action-settlement/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-10-20weekly0.7 https://aibio.space/news/fifth-circuit-vacates-class-certification-filana-securities-class/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-10-20weekly0.7 https://aibio.space/news/bioatla-signs-40-0-million-standby-equity-deal-yorkville/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-10-20weekly0.7 https://aibio.space/news/indaptus-therapeutics-closes-24-0-million-private-placement-20-338-974/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-10-20weekly0.7 https://aibio.space/news/surrozen-closes-95-1-million-second-tranche-march-2025-private/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-10-20weekly0.7 https://aibio.space/news/alpha-teknova-launches-stock-offering-then-prices-8-000-000-shares-5/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-10-20weekly0.7 https://aibio.space/news/merck-kgaa-agrees-buy-silence-therapeutics-20-ads-get-pv-drug/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-10-19weekly0.7 https://aibio.space/news/eyepoint-cuts-about-half-staff-after-second-duravyu-wet-amd-phase-3/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-10-19weekly0.7 https://aibio.space/news/cosmos-health-expects-fourth-quarter-u-s-revenue-about-15-million/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-10-19weekly0.7 https://aibio.space/news/two-polomar-health-directors-resign-leaving-three-board/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-10-19weekly0.7 https://aibio.space/news/silexion-adjourns-vote-500-million-new-shares-reverse-split-october-26/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-10-19weekly0.7 https://aibio.space/news/integra-lifesciences-sells-450-million-9-500-percent-senior-secured/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-10-19weekly0.7 https://aibio.space/news/curanex-discloses-two-new-york-class-actions-tied-august-2025-ipo/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-10-19weekly0.7 https://aibio.space/news/collegium-settles-grunenthal-patent-suit-nucynta-er-generic-17-000-000/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-10-19weekly0.7 https://aibio.space/news/ultragenyx-baylor-settle-dojolvi-patent-litigation-navinta-generic/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-10-19weekly0.7 https://aibio.space/news/collegium-pays-grunenthal-17-000-000-settle-nucynta-suit-end-license/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-10-19weekly0.7 https://aibio.space/news/curis-agrees-sell-stock-warrants-about-8-5-million-gross-proceeds/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-10-19weekly0.7 https://aibio.space/news/dogwood-therapeutics-agrees-sell-5-million-stock-top-holder-ck-life/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-10-19weekly0.7 https://aibio.space/news/os-therapies-gets-7-2-million-gross-initial-warrant-inducement-closing/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-10-19weekly0.7 https://aibio.space/news/city-therapeutics-raises-200-million-upsized-ipo-priced-18/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-10-16weekly0.7 https://aibio.space/news/fractyl-shares-fall-48-percent-even-revita-meets-six-month-remain-1/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-10-16weekly0.7 https://aibio.space/news/vivosim-amends-organovo-lease-giving-up-part-san-diego-office/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-10-16weekly0.7 https://aibio.space/news/tenon-medical-obtains-investor-waiver-increase-market-sales/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-10-16weekly0.7 https://aibio.space/news/china-resources-pharmaceutical-unit-issues-rmb900-million-corporate/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-10-16weekly0.7 https://aibio.space/news/mimedx-sanara-medtech-receive-ftc-second-request-merger/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-10-16weekly0.7 https://aibio.space/news/alector-prices-75-030-000-stock-offering-2-05-above-prior-close/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-10-16weekly0.7 https://aibio.space/news/clearmind-medicine-sell-2-000-000-convertible-notes-1-800-000-cash/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-10-16weekly0.7 https://aibio.space/news/maze-therapeutics-swaps-2-776-007-frazier-held-shares-pre-funded/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-10-16weekly0.7 https://aibio.space/news/mimedx-sanara-receive-ftc-second-request-proposed-merger/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-10-16weekly0.7 https://aibio.space/news/recursion-raises-200-million-3-25-share-sanofi-options-first-candidate/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-10-15weekly0.7 https://aibio.space/news/adial-adjourns-annual-meeting-again-nasdaq-approval-pending/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-10-15weekly0.7 https://aibio.space/news/velocity-bioworks-completes-nmr-feasibility-test-larmorbio/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-10-15weekly0.7 https://aibio.space/news/profusa-issues-769-230-77-secured-convertible-note-ascent-partners/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-10-15weekly0.7 https://aibio.space/news/osr-health-amends-vxm01-license-allow-up-15-000-000-convertible-notes/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-10-15weekly0.7 https://aibio.space/news/rallybio-holders-own-2-8-percent-combined-company-avenzo-reverse/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-10-15weekly0.7 https://aibio.space/news/supernus-inherits-sage-securities-class-action-derivative-suits-sec/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-10-15weekly0.7 https://aibio.space/news/actinium-securities-class-action-dismissed-prejudice-plaintiffs-file/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-10-15weekly0.7 https://aibio.space/news/jasper-therapeutics-faced-oct-15-hearing-motion-dismiss-briquilimab/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-10-15weekly0.7 https://aibio.space/news/sangamos-nasdaq-delisting-becomes-final-chapter-11-case-continues/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-10-15weekly0.7 https://aibio.space/news/aditxt-unit-ignite-proteomics-copley-acquisition-corp-end-spac-merger/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-10-15weekly0.7 https://aibio.space/news/alx-oncology-swaps-13-353-384-shares-pre-funded-warrants-investors/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-10-15weekly0.7 https://aibio.space/news/evofem-biosciences-pushes-adjuvant-note-maturity-december-1-2026/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-10-15weekly0.7 https://aibio.space/news/iambic-therapeutics-prices-ipo-9-375-000-shares-16-00/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-10-15weekly0.7 https://aibio.space/news/mustang-bio-gets-second-180-day-nasdaq-grace-period-fix-bid-price/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-10-15weekly0.7 https://aibio.space/news/first-tracks-biotherapeutics-agrees-sell-6-106-870-shares-32-75-about/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-10-15weekly0.7 https://aibio.space/news/ultragenyx-agrees-transfer-two-priority-review-vouchers-413-million/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-10-14weekly0.7 https://aibio.space/news/aibotics-completes-purchase-playjamaica-robotics-drone-assets/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-10-14weekly0.7 https://aibio.space/news/ema-grants-orphan-drug-designation-qrx003-peeling-skin-syndrome/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-10-14weekly0.7 https://aibio.space/news/aptevo-present-cd40-multispecific-platform-data-sitc-2026/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-10-14weekly0.7 https://aibio.space/news/mannatech-says-regained-nasdaq-stockholders-equity-compliance/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-10-14weekly0.7 https://aibio.space/news/interpace-biosciences-expects-third-quarter-revenue-10-1-million-10-4/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-10-14weekly0.7 https://aibio.space/news/liquidia-settles-all-patent-trade-secret-litigation-united/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-10-14weekly0.7 https://aibio.space/news/xeris-sues-torrent-rising-others-new-jersey-generic-keveyis-patent/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-10-14weekly0.7 https://aibio.space/news/eton-pharmaceuticals-pays-10-0-million-upfront-us-rights-aquestives/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-10-14weekly0.7 https://aibio.space/news/immutep-ltd-regains-nasdaq-bid-price-compliance-after-ads-ratio-change/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-10-14weekly0.7 https://aibio.space/news/liquidia-pay-net-175-million-global-settlement-united-therapeutics/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-10-14weekly0.7 https://aibio.space/news/silo-pharma-issues-150-000-shares-buy-software-intellectual-property/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-10-14weekly0.7 https://aibio.space/news/vir-biotechnology-agrees-sell-gilead-1-765-486-shares-about-25-million/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-10-14weekly0.7 https://aibio.space/news/metavia-appoints-sarah-browne-chief-medical-officer/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-10-13weekly0.7 https://aibio.space/news/bluejay-completes-toray-manufacturing-site-ahead-deadline/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-10-13weekly0.7 https://aibio.space/news/logicmark-completes-merger-holders-receive-1-31-share-cash/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-10-13weekly0.7 https://aibio.space/news/phio-completes-first-commercial-scale-cgmp-batch-ph-762-drug-substance/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-10-13weekly0.7 https://aibio.space/news/scienture-expects-preliminary-third-quarter-revenue-about-1-22-million/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-10-13weekly0.7 https://aibio.space/news/weird-science-demands-10-million-end-delaware-chancery-suit-other/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-10-13weekly0.7 https://aibio.space/news/adc-therapeutics-agrees-86-6-million-pipe-plans-loan-cut-50-0-million/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-10-13weekly0.7 https://aibio.space/news/cdt-equity-gets-3-000-000-first-tranche-6-750-000-convertible-note/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-10-13weekly0.7 https://aibio.space/news/cytomed-therapeutics-gets-nasdaq-bid-price-notice-has-until-april-5/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-10-13weekly0.7 https://aibio.space/news/pulmatrix-stockholders-vote-october-26-2026-eos-senolytix-merger/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-10-13weekly0.7 https://aibio.space/news/senti-biosciences-adjourns-annual-meeting-seek-more-votes-merger/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-10-13weekly0.7 https://aibio.space/news/alaunos-therapeutics-acquires-velaris-closes-350-million-private/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-10-13weekly0.7 https://aibio.space/news/vaxcyte-raises-about-1-1-billion-stock-convertible-notes-after-phase-3/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-10-09weekly0.7 https://aibio.space/news/integra-lifesciences-prices-450-000-000-senior-secured-notes/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-10-09weekly0.7 https://aibio.space/news/tuhura-biosciences-draws-650-000-more-parkview-credit-line-2/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-10-09weekly0.7 https://aibio.space/news/ss-innovations-issues-21-025-000-00-secured-convertible-note/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-10-09weekly0.7 https://aibio.space/news/co-diagnostics-issues-senior-secured-convertible-note-j-j-astor/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-10-09weekly0.7 https://aibio.space/news/co-diagnostics-takes-up-3-1-million-secured-convertible-loans/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-10-09weekly0.7 https://aibio.space/news/passage-bio-holders-would-keep-about-6-percent-remix-reverse-merger/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-10-09weekly0.7 https://aibio.space/news/alaunos-therapeutics-gets-nasdaq-delisting-notice-under-2-500-000/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-10-09weekly0.7 https://aibio.space/news/lunai-bioworks-cites-delaware-suit-against-seven-points-capital-nasdaq/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-10-09weekly0.7 https://aibio.space/news/artelo-biosciences-flags-exposure-nasdaqs-new-5-000-000-market-value/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-10-09weekly0.7 https://aibio.space/news/retension-pharmaceuticals-prices-ipo-3-750-000-shares-12-00/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-10-09weekly0.7 https://aibio.space/news/trex-bio-prices-ipo-8-333-334-shares-14-00-each/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-10-09weekly0.7 https://aibio.space/news/revolution-medicines-borrows-250-0-million-under-royalty-pharma-loan/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-10-08weekly0.7 https://aibio.space/news/x4-pharmaceuticals-replaces-loan-up-150-million-k2-facility/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-10-08weekly0.7 https://aibio.space/news/aquabounty-convert-all-preferred-stock-8-077-043-common-shares/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-10-08weekly0.7 https://aibio.space/news/biodexa-changes-ads-ratio-400-ordinary-shares-one-eight-reverse-ads/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-10-08weekly0.7 https://aibio.space/news/boundless-bio-files-s-4-serapha-merger-partner-later-reports-early/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-10-08weekly0.7 https://aibio.space/news/viatris-agrees-acquire-pacira-biosciences-36-50-share-cash/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-10-08weekly0.7 https://aibio.space/news/atrium-therapeutics-agrees-private-placement-about-50-million-7-93/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-10-08weekly0.7 https://aibio.space/news/valion-bio-files-100-000-000-shelf-5-000-000-market-program/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-10-08weekly0.7 https://aibio.space/news/x4-pharmaceuticals-signs-up-150-million-senior-loan-k2-healthventures/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-10-08weekly0.7 https://aibio.space/news/cero-agrees-sell-operating-unit-srx-global/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-10-07weekly0.7 https://aibio.space/news/biorestorative-appoints-donald-j-currie-board/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-10-07weekly0.7 https://aibio.space/news/bionexus-signs-exclusive-malaysian-healthcare-licence-cogniai/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-10-07weekly0.7 https://aibio.space/news/cosmos-health-reports-preliminary-nine-month-revenue-54-3-million/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-10-07weekly0.7 https://aibio.space/news/nexgel-sets-1-20-reverse-stock-split-effective-october-12-2026/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-10-07weekly0.7 https://aibio.space/news/fibrobiologics-sells-1-200-000-convertible-debenture-peak-one/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-10-07weekly0.7 https://aibio.space/news/envoy-medical-ends-atlas-spac-redemption-suit-delaware-no-payment/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-10-07weekly0.7 https://aibio.space/news/neogen-discloses-appeal-dismissed-michigan-securities-suit-two-related/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-10-07weekly0.7 https://aibio.space/news/nasdaq-files-remove-aditxt-common-stock-listing/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-10-07weekly0.7 https://aibio.space/news/jasper-therapeutics-offers-0-324-warrant-buy-back-up-12-345-707/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-10-07weekly0.7 https://aibio.space/news/redhill-biopharma-gets-180-more-days-nasdaq-bid-price-april-5-2027/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-10-07weekly0.7 https://aibio.space/news/nasdaq-files-sec-notice-remove-sangamo-therapeutics-stock-listing/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-10-07weekly0.7 https://aibio.space/news/vivosim-labs-stockholders-elect-two-directors-approve-split-range/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-06weekly0.7 https://aibio.space/news/60-degrees-outlines-next-steps-after-babesiosis-hospital-study-interim/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-10-06weekly0.7 https://aibio.space/news/bluejay-reports-symon-ii-baseline-patient-characteristics/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-10-06weekly0.7 https://aibio.space/news/global-innovative-platforms-appoints-david-r-wells-fractional-chief/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-10-06weekly0.7 https://aibio.space/news/kairos-pharma-reports-positive-interim-phase-2-data-env-105-prostate/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-10-06weekly0.7 https://aibio.space/news/nomad-launches-26-stop-mobile-power-demonstration-tour/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-10-06weekly0.7 https://aibio.space/news/hepion-acquires-gravitas-life-sciences-related-party-deal/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-10-06weekly0.7 https://aibio.space/news/adia-med-agrees-sell-30-percent-adia-labs-qcm-biologics-1-500-000/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-10-06weekly0.7 https://aibio.space/news/sonoma-pharmaceuticals-adopts-new-section-382-rights-agreement/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-10-06weekly0.7 https://aibio.space/news/premier-air-charter-says-lessors-terminated-cj3-aircraft-leases/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-10-06weekly0.7 https://aibio.space/news/vaxcyte-offers-500-000-000-1-50-percent-convertible-notes-due-2032/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-10-06weekly0.7 https://aibio.space/news/nuo-therapeutics-receives-325-000-second-funding-under-loan/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-10-06weekly0.7 https://aibio.space/news/rocket-pharmaceuticals-secures-credit-facility-up-150-million-hercules/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-10-06weekly0.7 https://aibio.space/news/caribou-explores-strategic-alternatives-ends-allogeneic-car-t-programs/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-10-06weekly0.7 https://aibio.space/news/beyondspring-completes-sale-subsidiary-holding-china-unit-bulin-non/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-10-06weekly0.7 https://aibio.space/news/inovio-faces-securities-class-action-five-derivative-suits-ino-3107/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-10-06weekly0.7 https://aibio.space/news/beyondspring-sells-beyondspring-ltd-trial-data-rights-instead-cash/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-10-06weekly0.7 https://aibio.space/news/kyntra-bio-gets-nasdaq-delisting-determination-requests-hearing/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-10-06weekly0.7 https://aibio.space/news/rocket-pharmaceuticals-secures-credit-facility-up-150-million-hercules/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-10-06weekly0.7 https://aibio.space/news/range-impact-issues-654-434-shares-each-mrr-wicks-end-option-deals/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-10-06weekly0.7 https://aibio.space/news/telomir-pharmaceuticals-sells-about-5-6-million-common-stock-pipe/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-10-06weekly0.7 https://aibio.space/news/universe-pharmaceuticals-holders-approve-conditional-10-1-share/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-10-06weekly0.7 https://aibio.space/news/seastar-medical-collects-about-3-3-million-warrant-exercises/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-10-05weekly0.7 https://aibio.space/news/immunome-pays-bristol-myers-squibb-20-0-million-4-425-487-shares-end/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-10-05weekly0.7 https://aibio.space/news/apimeds-unit-mindwave-signs-assurechain-deal-blockassure/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-10-04weekly0.7 https://aibio.space/news/profusa-amends-ascent-partners-convertible-note-terms/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-10-04weekly0.7 https://aibio.space/news/aibotics-agrees-acquire-empulser-series-c-preferred-stock/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-10-02weekly0.7 https://aibio.space/news/silo-pharma-buys-norsight-software-assets-warrant/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-10-02weekly0.7 https://aibio.space/news/tonix-gets-paragraph-iv-patent-notice-dr-reddys-generic-tonmya/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-10-02weekly0.7 https://aibio.space/news/lantheus-discloses-three-stockholder-suits-curium-merger-16-demand/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-10-02weekly0.7 https://aibio.space/news/beyondspring-gets-nasdaq-notice-after-market-value-falls-below-35/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-10-02weekly0.7 https://aibio.space/news/dare-bioscience-gets-nasdaq-notice-stock-below-1-00/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-10-02weekly0.7 https://aibio.space/news/sunshine-biopharma-files-7-000-000-unit-offering-later-priced-0-55/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-10-02weekly0.7 https://aibio.space/news/surrozen-ind-clearance-sets-up-expected-95-1-million-second-private/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-10-02weekly0.7 https://aibio.space/news/adagio-medical-converts-776-111-notes-4-978-869-shares/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-10-01weekly0.7 https://aibio.space/news/endra-amends-merger-agreement-asp-isotopes-renergen/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-10-01weekly0.7 https://aibio.space/news/azitra-advances-atr-04-trial-cohort-2-after-safety-review/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-10-01weekly0.7 https://aibio.space/news/scientific-industries-signs-cfo-agreement-extends-two-others/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-10-01weekly0.7 https://aibio.space/news/aethlon-stockholders-approve-200-000-000-authorized-common-shares/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-10-01weekly0.7 https://aibio.space/news/spyglass-buys-lens-maker-advanced-vision-science-santen-about-13/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-10-01weekly0.7 https://aibio.space/news/lantern-pharma-gets-nasdaq-notice-35-000-000-market-value-rule/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-10-01weekly0.7 https://aibio.space/news/mangoceuticals-unit-mangorx-ip-gets-2-5-million-commitment-receives-1/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-10-01weekly0.7 https://aibio.space/news/q32-bio-reports-week-36-signal-aa-part-b-results-bempikibart/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-09-30weekly0.7 https://aibio.space/news/apimeds-names-eric-sherb-chief-financial-officer/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-09-30weekly0.7 https://aibio.space/news/osr-health-chief-scientific-officer-resigns-effective-immediately/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-09-30weekly0.7 https://aibio.space/news/nomad-issues-6-57-million-secured-note-9-percent-rate/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-09-30weekly0.7 https://aibio.space/news/valion-skl-complete-oral-mucosal-entolimod-formulation/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-09-30weekly0.7 https://aibio.space/news/aeon-says-fda-feedback-may-support-streamlined-abp-450-development/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-09-30weekly0.7 https://aibio.space/news/itonic-holdings-extends-maturity-bank-loan-march-2027/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-09-30weekly0.7 https://aibio.space/news/positron-issues-three-promissory-notes-20-percent-interest-warrants/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-09-30weekly0.7 https://aibio.space/news/nasdaq-files-removal-notice-nutriband-public-warrants-expire/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-09-30weekly0.7 https://aibio.space/news/lantern-pharma-closes-registered-direct-offering-about-4-0-million/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-09-30weekly0.7 https://aibio.space/news/nasdaq-files-remove-abpro-holdings-stock-warrants-listing/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-09-30weekly0.7 https://aibio.space/news/biostem-technologies-prices-3-million-private-placement-4-08-share/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-09-30weekly0.7 https://aibio.space/news/calcimedica-files-sell-up-25-000-000-stock-through-market-program/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-09-30weekly0.7 https://aibio.space/news/chemomab-amends-domestication-merger-terms-ahead-scipher-medicine-deal/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-09-30weekly0.7 https://aibio.space/news/clearmind-medicine-effect-1-8-reverse-share-split-trading-october-5/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-09-30weekly0.7 https://aibio.space/news/evogene-gets-extra-180-days-nasdaq-fix-bid-price-march-29-2027/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-09-30weekly0.7 https://aibio.space/news/petros-pharmaceuticals-assigns-all-assets-creditors-halts-operations/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-09-30weekly0.7 https://aibio.space/news/scisparc-reports-4-436-thousand-cash-6-051-thousand-loss-first-half/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-09-30weekly0.7 https://aibio.space/news/tevogen-regains-compliance-nasdaq-global-market-listing-rules/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-09-30weekly0.7 https://aibio.space/news/alzamend-neuro-presents-lithium-brain-imaging-results-phase-1-2a-trial/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-09-29weekly0.7 https://aibio.space/news/moleculin-completes-enrollment-part-miracle-trial/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-09-29weekly0.7 https://aibio.space/news/pelthos-stockholders-approve-2026-equity-plan-elect-eight-directors/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-09-29weekly0.7 https://aibio.space/news/odyssey-health-extends-two-note-maturities-january-2027/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-09-29weekly0.7 https://aibio.space/news/beyondspring-sets-up-market-program-up-11-942-800-shares/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-09-29weekly0.7 https://aibio.space/news/cuprina-closes-allotment-648-373-shares-1-15-raising-offering-about-5/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-09-29weekly0.7 https://aibio.space/news/immix-biopharma-prices-125-million-stock-offering-11-00-share/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-09-29weekly0.7 https://aibio.space/news/imunon-agrees-swap-1-200-000-streeterville-note-series-b-preferred/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-09-29weekly0.7 https://aibio.space/news/lakewood-amedex-holders-approve-share-increase-reverse-split-authority/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-09-29weekly0.7 https://aibio.space/news/liminatus-pharma-regains-nasdaq-compliance-after-1-50-reverse-split/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-09-29weekly0.7 https://aibio.space/news/lunai-bioworks-delays-annual-report-expects-net-loss-about-3-2-million/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-09-29weekly0.7 https://aibio.space/news/lexeo-completes-mantle-therapeutics-deal-5-300-000-cash-plus-3-000-000/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-09-29weekly0.7 https://aibio.space/news/pyxis-oncology-prices-109-998-133-stock-warrant-offering-2-90/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-09-29weekly0.7 https://aibio.space/news/tela-bio-gets-lender-consent-pause-revenue-covenant-test/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-09-28weekly0.7 https://aibio.space/news/glucotrack-amends-terms-senior-secured-convertible-note/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-09-28weekly0.7 https://aibio.space/news/silexion-cuts-warrant-price-0-2603-raise-about-0-84-million/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-09-28weekly0.7 https://aibio.space/news/unicycive-discloses-another-securities-class-action-olc-application/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-09-28weekly0.7 https://aibio.space/news/adarx-pharmaceuticals-closes-ipo-26-250-000-shares-17-00-each/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-09-28weekly0.7 https://aibio.space/news/advanced-biomed-files-late-notice-annual-report-audit-not-complete/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-09-28weekly0.7 https://aibio.space/news/celularity-sells-11-01-million-secured-convertible-notes-deal-up-25-0/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-09-28weekly0.7 https://aibio.space/news/gossamer-bio-regains-nasdaq-minimum-bid-price-compliance/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-09-28weekly0.7 https://aibio.space/news/jaguar-health-issues-481-584-shares-cut-streeterville-note-3-400-000/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-09-28weekly0.7 https://aibio.space/news/lifecore-biomedical-agrees-6-28-share-cash-sale-webster-equity/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-09-28weekly0.7 https://aibio.space/news/polyrizon-reports-8-410-thousand-cash-june-30-2026/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-09-28weekly0.7 https://aibio.space/news/zeo-scientifix-says-cannot-file-eight-month-transition-report-time/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-09-28weekly0.7 https://aibio.space/news/cdt-equity-do-1-25-reverse-stock-split-nasdaq/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-09-25weekly0.7 https://aibio.space/news/calidi-biotherapeutics-receives-nyse-american-equity-deficiency-notice/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-09-25weekly0.7 https://aibio.space/news/matinas-biopharma-effects-one-fifteen-reverse-stock-split/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-09-25weekly0.7 https://aibio.space/news/silexion-adds-bid-price-deficiency-pending-nasdaq-panel-review/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-09-25weekly0.7 https://aibio.space/news/jury-awards-nektar-90-million-lilly-contract-case-securities-class/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-09-25weekly0.7 https://aibio.space/news/outlook-therapeutics-gets-nasdaq-bid-price-notice-weeks-after-drugs/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-09-25weekly0.7 https://aibio.space/news/america-great-health-says-cannot-file-annual-report-september-30-2026/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-09-25weekly0.7 https://aibio.space/news/viking-raises-575-million-stock-convertible-notes-after-maintenance/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-09-24weekly0.7 https://aibio.space/news/aptevo-advances-trispecific-candidates-toward-scalable-manufacturing/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-09-24weekly0.7 https://aibio.space/news/bgm-group-announces-30-1-share-consolidation-trading-october-1-2026/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-09-24weekly0.7 https://aibio.space/news/nanobiotix-reports-110-9-million-cash-after-86-million-follow-runway/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-09-24weekly0.7 https://aibio.space/news/adagio-medical-starts-strategic-review-cuts-workforce/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-09-23weekly0.7 https://aibio.space/news/moleculin-sells-888-400-shares-through-market-program-september/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-09-23weekly0.7 https://aibio.space/news/glucotrack-ceo-outlines-lokahi-priorities-lt-100-ai2-platform/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-09-23weekly0.7 https://aibio.space/news/evofem-adds-second-manufacturer-phexx/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-09-23weekly0.7 https://aibio.space/news/valion-names-dean-zikria-interim-ceo-changes-board-chair/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-09-23weekly0.7 https://aibio.space/news/jazz-pharmaceuticals-extends-term-loan-2033-adds-273-310-355-18/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-09-23weekly0.7 https://aibio.space/news/iqvia-issues-2-000-000-000-6-375-percent-senior-notes-due-2034/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-09-23weekly0.7 https://aibio.space/news/viking-therapeutics-sells-225-000-000-2-00-percent-convertible-notes/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-09-23weekly0.7 https://aibio.space/news/procept-biorobotics-amends-canadian-imperial-bank-term-loan-maturity/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-09-23weekly0.7 https://aibio.space/news/quidelortho-amends-credit-agreement-resets-covenant-levels-2029/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-09-23weekly0.7 https://aibio.space/news/bayer-places-2-billion-euros-hybrid-bonds/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-09-23weekly0.7 https://aibio.space/news/maplight-resale-registration-13-2-million-private-placement-shares/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-09-23weekly0.7 https://aibio.space/news/zymeworks-completes-theravance-biopharma-acquisition-350-million/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-09-23weekly0.7 https://aibio.space/news/sarepta-faces-securities-class-action-five-derivative-suits-elevidys/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-09-23weekly0.7 https://aibio.space/news/xenetic-files-investor-presentation-proposed-transaction-santersus/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-09-23weekly0.7 https://aibio.space/news/fda-grants-fast-track-designation-qrx003-peeling-skin-syndrome/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-09-22weekly0.7 https://aibio.space/news/leonabio-series-warrants-become-exercisable-6-35-share/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-09-22weekly0.7 https://aibio.space/news/halozyme-therapeutics-sells-1-500-0-million-1-50-percent-convertible/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-09-22weekly0.7 https://aibio.space/news/aytu-biopharmas-adzenys-patent-suit-against-granules-heads-january/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-09-22weekly0.7 https://aibio.space/news/enlivex-terminates-private-placement-66-666-667-shares-payable-rain/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-09-22weekly0.7 https://aibio.space/news/ptc-completes-acquisition-st-920-fabry-gene-therapy-sangamo/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-09-21weekly0.7 https://aibio.space/news/jaguar-health-completes-1-15-reverse-split-removes-old-preferred/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-09-21weekly0.7 https://aibio.space/news/insulet-amends-credit-agreement-refinancing-475-million-term-loans/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-09-21weekly0.7 https://aibio.space/news/tuhura-biosciences-draws-another-650-000-parkview-credit-line/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-09-21weekly0.7 https://aibio.space/news/anaptysbio-awaits-post-trial-argument-delaware-suit-against-gsk-tesaro/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-09-21weekly0.7 https://aibio.space/news/iambic-therapeutics-files-ipo-plans-nasdaq-listing-iam/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-09-21weekly0.7 https://aibio.space/news/scinai-immunotherapeutics-regains-nasdaq-bid-price-compliance/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-09-21weekly0.7 https://aibio.space/news/xenon-pauses-depression-trial-enrollment-after-psychosis-reports/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-09-18weekly0.7 https://aibio.space/news/alaunos-sells-1-120-000-stock-warrants-registered-direct-offering/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-09-18weekly0.7 https://aibio.space/news/inmed-receives-nasdaq-notice-minimum-shareholders-equity/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-09-18weekly0.7 https://aibio.space/news/trafalgar-international-names-carlos-septien-chief-executive-officer/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-09-18weekly0.7 https://aibio.space/news/endovia-closes-510-000-secured-convertible-note-c-m-capital/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-09-18weekly0.7 https://aibio.space/news/moleculin-biotech-gets-nasdaq-staff-determination-bid-price-plans/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-09-18weekly0.7 https://aibio.space/news/beyondspring-gets-nasdaq-minimum-bid-price-notice-has-until-march-16/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-09-18weekly0.7 https://aibio.space/news/biostem-technologies-signs-committed-equity-facility-sell-up-40-000/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-09-18weekly0.7 https://aibio.space/news/electra-therapeutics-prices-ipo-23-333-334-shares-15-00-about-350/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-09-18weekly0.7 https://aibio.space/news/filana-therapeutics-gets-nasdaq-bid-price-notice-has-until-march-16/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-09-18weekly0.7 https://aibio.space/news/nasus-pharma-sets-up-market-program-btig-up-8-500-000-shares/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-09-18weekly0.7 https://aibio.space/news/retension-pharmaceuticals-files-ipo-seeks-nasdaq-listing-rtsn/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-09-18weekly0.7 https://aibio.space/news/trex-bio-files-ipo-eli-lilly-signals-interest-buying-shares/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-09-18weekly0.7 https://aibio.space/news/halozyme-prices-upsized-1-3-billion-convertible-offering-retires-older/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-09-17weekly0.7 https://aibio.space/news/soligenix-stockholders-approve-reverse-split-authority-share-increase/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-09-17weekly0.7 https://aibio.space/news/adial-stockholders-approve-equity-plans-larger-share-authorization/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-09-17weekly0.7 https://aibio.space/news/nasdaq-delist-aditxt-common-stock-after-june-suspension/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-09-17weekly0.7 https://aibio.space/news/impact-biomedical-reports-zoar-f-4-filing-business-combination/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-09-17weekly0.7 https://aibio.space/news/aethlon-merge-north-immunology-all-stock-deal/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-09-17weekly0.7 https://aibio.space/news/aquestive-faces-securities-class-action-derivative-suit-anaphylm-nda/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-09-17weekly0.7 https://aibio.space/news/quantum-biopharma-closes-fourth-debenture-tranche-100-000-cancels/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-09-17weekly0.7 https://aibio.space/news/alaunos-lowers-stockholder-meeting-quorum-one-third-voting-power/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-09-16weekly0.7 https://aibio.space/news/pasithea-warrants-expire-september-17-2026/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-09-16weekly0.7 https://aibio.space/news/co-diagnostics-readygo-evaluate-blood-testing-ebola/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-09-16weekly0.7 https://aibio.space/news/matinas-biopharma-sets-one-fifteen-reverse-stock-split/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-09-16weekly0.7 https://aibio.space/news/halozyme-plans-1-05-billion-convertible-notes-offering/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-09-16weekly0.7 https://aibio.space/news/profusa-sells-senior-secured-convertible-note-ascent-partners-fund/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-09-16weekly0.7 https://aibio.space/news/bone-biologics-gets-nasdaq-minimum-bid-price-notice-has-until-march-9/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-09-16weekly0.7 https://aibio.space/news/xenetic-biosciences-agrees-acquire-santersus-ag-all-stock-share/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-09-16weekly0.7 https://aibio.space/news/jaguar-health-swaps-note-preferred-shares-common-stock/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-09-15weekly0.7 https://aibio.space/news/beta-bionics-discloses-securities-class-action-filed-september-4-2026/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-09-15weekly0.7 https://aibio.space/news/tyra-biosciences-prices-400-million-offering-shares-pre-funded/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-09-15weekly0.7 https://aibio.space/news/ascendis-takes-back-obesity-rights-novo-nordisk-authorizes-400-million/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-09-14weekly0.7 https://aibio.space/news/q32-bio-appoints-jose-trevejo-chief-medical-officer-ellie-hershberger/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-09-14weekly0.7 https://aibio.space/news/onconetix-provides-2-5-million-bridge-advance-realbotix-before/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-09-14weekly0.7 https://aibio.space/news/phio-reports-ph-762-fda-submission-planned-phase-2b-study/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-09-14weekly0.7 https://aibio.space/news/biofrontera-gets-fda-approval-ameluz-superficial-basal-cell-carcinoma/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-09-14weekly0.7 https://aibio.space/news/glucotrack-director-resigns-citing-possible-conflict-merger-terms/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-09-14weekly0.7 https://aibio.space/news/mindwalk-signs-binding-30-million-credit-facility-term-sheet/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-09-14weekly0.7 https://aibio.space/news/tuhura-biosciences-makes-650-000-draw-parkview-credit-line/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-09-14weekly0.7 https://aibio.space/news/cdt-equity-issues-2-126-250-secured-convertible-note-j-j-astor-co/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-09-14weekly0.7 https://aibio.space/news/cardiff-oncology-settles-onvansertib-license-lawsuit-nerviano-medical/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-09-14weekly0.7 https://aibio.space/news/sionna-therapeutics-cuts-about-46-percent-workforce-sees-cash-second/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-09-14weekly0.7 https://aibio.space/news/60-degrees-seeks-fda-priority-voucher-tafenoquine-babesiosis/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-09-12weekly0.7 https://aibio.space/news/tenon-medical-announces-warrant-inducement-2-872-338-58-gross/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-09-11weekly0.7 https://aibio.space/news/biovie-enters-sales-agreement-up-6-464-341-common-stock/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-09-11weekly0.7 https://aibio.space/news/glucotrack-issues-secured-convertible-notes-warrants-private-placement/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-09-11weekly0.7 https://aibio.space/news/acadia-derivative-settlement-gets-preliminary-approval-securities/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-09-11weekly0.7 https://aibio.space/news/regentis-reports-9-0-million-cash-after-6-5-million-june-private/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-09-11weekly0.7 https://aibio.space/news/apimeds-pharmaceuticals-adds-sungjoon-chae-board/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-09-10weekly0.7 https://aibio.space/news/cerenome-gets-up-20-million-royalty-based-facility-3i-lp/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-09-10weekly0.7 https://aibio.space/news/karyopharm-gets-forbearance-after-missed-loan-note-payments/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-09-10weekly0.7 https://aibio.space/news/tarsus-pharmaceuticals-completes-alkeus-acquisition-270-000-000-cash/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-09-10weekly0.7 https://aibio.space/news/metavia-reports-da-1726-tissue-distribution-data-preclinical-study/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-09-09weekly0.7 https://aibio.space/news/rallybio-cfo-jonathan-lieber-moves-part-time-employment/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-09-09weekly0.7 https://aibio.space/news/tenon-medical-repays-convertible-notes-ahead-september-11-maturity/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-09-09weekly0.7 https://aibio.space/news/cocrystal-doses-last-subject-cdi-988-norovirus-challenge-study/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-09-09weekly0.7 https://aibio.space/news/lexaria-agrees-warrant-inducement-approximately-5-9-million-gross/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-09-09weekly0.7 https://aibio.space/news/lexaria-agrees-warrant-exercise-reduced-12-92-price-about-5-9-million/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-09-09weekly0.7 https://aibio.space/news/protagonist-authorizes-300-million-share-buyback-after-two-drug/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-09-08weekly0.7 https://aibio.space/news/fda-grants-rare-pediatric-disease-designation-qrx003-peeling-skin/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-09-08weekly0.7 https://aibio.space/news/lifeward-investor-deck-lays-out-pipeline-reimbursement-oramed-platform/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-09-08weekly0.7 https://aibio.space/news/60-degrees-presents-july-financing-cash-runway-investors/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-09-08weekly0.7 https://aibio.space/news/bluejay-signs-federal-distribution-partnership-lovell-government/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-09-08weekly0.7 https://aibio.space/news/ispecimen-gets-until-november-25-2026-meet-nasdaq-equity-rule/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-09-08weekly0.7 https://aibio.space/news/kiora-appoints-keith-lane-executive-vice-president-clinical/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-09-08weekly0.7 https://aibio.space/news/stimcell-hires-stonegate-capital-markets-non-exclusive-advisor/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-09-08weekly0.7 https://aibio.space/news/gri-bio-presents-new-phase-2a-data-gri-0621-ipf/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-09-08weekly0.7 https://aibio.space/news/evommune-drops-evo756-atopic-dermatitis-after-phase-2b-misses-all/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-09-08weekly0.7 https://aibio.space/news/can-fite-details-1-3-000-reverse-split-ads-ratio-change-6/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-09-08weekly0.7 https://aibio.space/news/keros-therapeutics-authorizes-5-million-share-buyback-after-20-million/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-09-08weekly0.7 https://aibio.space/news/ispecimen-agrees-buy-foldlab-ai-software-assets-4-500-000/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-09-04weekly0.7 https://aibio.space/news/biorestoratives-r-d-vice-president-resigns-claims-severance/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-09-04weekly0.7 https://aibio.space/news/matinas-biopharma-receives-nyse-american-stockholders-equity-notice/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-09-04weekly0.7 https://aibio.space/news/intellia-therapeutics-gets-up-400-million-term-loan-orbimed/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-09-04weekly0.7 https://aibio.space/news/nutriband-reports-3-42-million-cash-says-operations-will-fund-next/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-09-04weekly0.7 https://aibio.space/news/nutriband-says-lawsuit-ended-offering-engagement-remains-discovery/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-09-04weekly0.7 https://aibio.space/news/quince-therapeutics-now-irulya-therapeutics-gets-nasdaq-stockholders/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-09-04weekly0.7 https://aibio.space/news/adarx-pharmaceuticals-files-ipo-plans-nasdaq-listing-adrx/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-09-04weekly0.7 https://aibio.space/news/clearmind-medicine-agrees-buy-51-percent-charging-robotics-2-5-million/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-09-04weekly0.7 https://aibio.space/news/polyrizon-closes-4-0-million-registered-direct-offering-private/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-09-04weekly0.7 https://aibio.space/news/xortx-therapeutics-files-2-500-000-paid-promotion-agreement-ir-agency/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-09-04weekly0.7 https://aibio.space/news/aptevo-reports-93-percent-clinical-benefit-rate-mipletamig-tp53/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-09-03weekly0.7 https://aibio.space/news/hepion-pharmaceuticals-issues-500-000-secured-convertible-note/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-09-03weekly0.7 https://aibio.space/news/senti-biosciences-unit-sells-2-0-million-convertible-notes-nsg/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-09-03weekly0.7 https://aibio.space/news/prf-technologies-reports-8-526-thousand-cash-june-30-2026/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-09-03weekly0.7 https://aibio.space/news/tuhura-biosciences-borrows-1-500-000-under-parkview-revolving-facility/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-09-02weekly0.7 https://aibio.space/news/volitionrx-gets-lind-waiver-atm-sales-above-10-million/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-09-02weekly0.7 https://aibio.space/news/tscan-cuts-75-percent-staff-pauses-phase-3-trial-lack-capital/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-09-02weekly0.7 https://aibio.space/news/biorestorative-gets-nasdaq-late-filing-notice-then-does-1-20-reverse/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-09-02weekly0.7 https://aibio.space/news/anavex-regains-nasdaq-compliance-after-filing-overdue-10-qs-august-28/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-09-02weekly0.7 https://aibio.space/news/immuteps-fy2026-loss-widens-29-1-percent-after-tacti-004-lung-cancer/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-09-02weekly0.7 https://aibio.space/news/quantum-biopharma-applies-delist-class-b-shares-cse/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-09-02weekly0.7 https://aibio.space/news/intelligent-bio-solutions-places-up-15-million-one-investor/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-09-01weekly0.7 https://aibio.space/news/international-stem-cell-completes-sale-lifeline-cell-technology-atcc/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-09-01weekly0.7 https://aibio.space/news/profusa-sells-another-senior-secured-convertible-note-ascent/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-09-01weekly0.7 https://aibio.space/news/kpc-gets-registration-rmb1-billion-medium-term-notes/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-09-01weekly0.7 https://aibio.space/news/earth-science-tech-holders-approve-reverse-split-authority-uplisting/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-09-01weekly0.7 https://aibio.space/news/lifeward-chief-executive-mark-grant-departs-josh-hexter-named-interim/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-08-31weekly0.7 https://aibio.space/news/aim-immunotech-satisfies-streeterville-note-full-through-share/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-08-31weekly0.7 https://aibio.space/news/pds-biotechnology-amends-6-000-000-promissory-note/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-08-31weekly0.7 https://aibio.space/news/kyntra-bio-cuts-royalty-financing-cap-65-million/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-08-31weekly0.7 https://aibio.space/news/cdt-equity-issues-541-620-senior-secured-convertible-note-j-j-astor/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-08-31weekly0.7 https://aibio.space/news/moderna-sells-3-0-billion-zero-coupon-convertible-notes-after-upsized/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-08-28weekly0.7 https://aibio.space/news/teva-bids-57-5-million-upfront-bioxcels-agitation-drug-bankruptcy-sale/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-08-28weekly0.7 https://aibio.space/news/aprea-therapeutics-reports-expanded-patent-portfolio-wee1-atr-programs/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-08-28weekly0.7 https://aibio.space/news/vyome-names-jerry-leonard-chief-financial-officer/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-08-28weekly0.7 https://aibio.space/news/tenon-medical-prices-3-0-million-private-placement-warrants/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-08-28weekly0.7 https://aibio.space/news/oragenics-receives-nyse-american-deficiency-letter-equity/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-08-28weekly0.7 https://aibio.space/news/glucotrack-effects-1-15-reverse-stock-split/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-08-28weekly0.7 https://aibio.space/news/envue-medical-announces-1-12-reverse-stock-split-effective-september-1/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-08-28weekly0.7 https://aibio.space/news/insilico-medicine-plans-us-305-million-convertible-bond-sale/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-08-28weekly0.7 https://aibio.space/news/biolinerx-raises-3-75m-2-78-ads-1-5x-warrant-coverage/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-08-28weekly0.7 https://aibio.space/news/quoin-pharmaceuticals-agrees-private-placement-about-30-8-million/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-08-28weekly0.7 https://aibio.space/news/shuttle-pharmaceuticals-gets-nasdaq-deficiency-notice-late-form-10/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-08-28weekly0.7 https://aibio.space/news/can-fite-files-100-000-000-shelf-market-program-up-1-065-000/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-08-28weekly0.7 https://aibio.space/news/electra-therapeutics-files-ipo-plans-nasdaq-listing-etra/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-08-28weekly0.7 https://aibio.space/news/china-sxt-cuts-pre-paid-share-purchase-floor-price-back-0-20-16-00/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-08-28weekly0.7 https://aibio.space/news/jazz-prices-1-1-billion-exchangeable-notes-repurchases-225-million/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-08-27weekly0.7 https://aibio.space/news/osr-health-hearing-before-nasdaq-panel-set-september-29/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-08-27weekly0.7 https://aibio.space/news/artelo-biosciences-sets-1-9-reverse-split-trading-august-31-2026/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-08-27weekly0.7 https://aibio.space/news/valion-sets-1-25-reverse-stock-split-regain-nasdaq-compliance/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-08-27weekly0.7 https://aibio.space/news/moderna-plans-2-0-billion-convertible-notes-private-placement/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-08-27weekly0.7 https://aibio.space/news/cero-therapeutics-consolidates-older-notes-secured-srx-global-loan/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-08-27weekly0.7 https://aibio.space/news/pharmaron-agrees-issue-rmb2-180-million-convertible-bonds/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-08-27weekly0.7 https://aibio.space/news/bioxcel-files-chapter-11-teva-57-5-million-stalking-horse-bidder/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-08-27weekly0.7 https://aibio.space/news/cyclerion-now-korsana-biosciences-shareholders-approve-merger-issuance/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-08-27weekly0.7 https://aibio.space/news/senti-biosciences-gets-two-nasdaq-notices-bid-price-3-4m-equity/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-08-27weekly0.7 https://aibio.space/news/optimi-health-sets-up-equity-line-sell-up-us-100-million-shares-seven/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-08-27weekly0.7 https://aibio.space/news/nuwellis-investor-presentation-cites-20-percent-first-half-revenue/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-08-26weekly0.7 https://aibio.space/news/leonabio-enrolls-500th-subject-phase-3-elaine-3-trial/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-08-26weekly0.7 https://aibio.space/news/interpace-biosciences-sets-1-5-reverse-stock-split-support-nasdaq-bid/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-08-26weekly0.7 https://aibio.space/news/jazz-plans-1-0-billion-exchangeable-notes-offering-share-buyback/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-08-26weekly0.7 https://aibio.space/news/turn-sells-1-35-million-stock-existing-investors-10-00-share/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-08-26weekly0.7 https://aibio.space/news/immatics-agrees-sell-shares-warrants-8-69-150-million-offering/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-08-26weekly0.7 https://aibio.space/news/ptc-agrees-buy-sangamos-fabry-gene-therapy-st-920-bankruptcy/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-08-25weekly0.7 https://aibio.space/news/miles-suk-steps-down-abpro-holdings-chairman-but-stays-board/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-08-25weekly0.7 https://aibio.space/news/ensysce-gets-nasdaq-bid-price-extension-february-2027/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-08-25weekly0.7 https://aibio.space/news/hepion-sells-8-000-000-shares-warrants-400-000-private-placement/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-08-25weekly0.7 https://aibio.space/news/pds-biotechnology-cut-about-36-percent-workforce-removes-chief/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-08-25weekly0.7 https://aibio.space/news/bioxcel-takes-1-250-000-additional-term-loans-lenders/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-08-24weekly0.7 https://aibio.space/news/longeveron-does-1-10-reverse-split-meet-nasdaqs-1-bid-minimum/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-08-24weekly0.7 https://aibio.space/news/arbutus-biopharma-starts-tender-offer-up-us-230-million-shares/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-08-24weekly0.7 https://aibio.space/news/skye-bioscience-signs-equity-line-redmile-affiliate-up-22-000-000/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-08-24weekly0.7 https://aibio.space/news/vivosim-labs-receives-nasdaq-bid-price-notice-february-2027-deadline/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-08-21weekly0.7 https://aibio.space/news/pasithea-receives-nasdaq-extension-regain-bid-price-compliance/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-08-21weekly0.7 https://aibio.space/news/azitra-regains-nyse-american-continued-listing-compliance/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-08-21weekly0.7 https://aibio.space/news/kairos-pharma-sets-1-7-reverse-stock-split-effective-september-1-2026/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-08-21weekly0.7 https://aibio.space/news/nexgel-names-brian-kieser-interim-ceo-forms-strategic-review-committee/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-08-21weekly0.7 https://aibio.space/news/nexalin-issues-1-170-000-00-promissory-note-streeterville-capital/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-08-21weekly0.7 https://aibio.space/news/bcal-diagnostics-details-convertible-note-draws-under-10-million/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-08-21weekly0.7 https://aibio.space/news/imugene-amends-cvi-convertible-notes-issues-new-warrants/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-08-21weekly0.7 https://aibio.space/news/moleculin-lifts-atm-19-7m-weeks-after-9-3m-deal-3x-warrants/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-08-21weekly0.7 https://aibio.space/news/veradermics-ceo-technical-chief-two-large-holders-sell-shares-august/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-08-21weekly0.7 https://aibio.space/news/estrella-immunopharma-gets-nasdaq-minimum-bid-price-notice-has-until/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-08-21weekly0.7 https://aibio.space/news/elutia-completes-simpliderm-business-sale-cellution-biologics-receives/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-08-21weekly0.7 https://aibio.space/news/adial-pharmaceuticals-gets-nasdaq-stockholders-equity-notice-plan-due/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-08-21weekly0.7 https://aibio.space/news/gossamer-bio-private-placement-has-150-million-committed-25-0-million/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-08-21weekly0.7 https://aibio.space/news/arbutus-plans-us-230-million-dutch-auction-tender-offer-shares/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-08-21weekly0.7 https://aibio.space/news/citius-pharmaceuticals-gets-nasdaq-extension-february-8-2027-bid-price/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-08-21weekly0.7 https://aibio.space/news/oruka-therapeutics-files-1-000-000-000-shelf-500-000-000-sales-program/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-08-21weekly0.7 https://aibio.space/news/profusa-reports-q2-2026-results-progress-g3-option/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-08-20weekly0.7 https://aibio.space/news/adaptin-bio-opens-enrollment-phase-1-trial-aptn-101-glioblastoma/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-08-20weekly0.7 https://aibio.space/news/protagenic-reports-fda-pre-ind-feedback-pt00114-generalized-anxiety/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-08-20weekly0.7 https://aibio.space/news/curanex-regains-nasdaq-bid-price-compliance-after-1-20-reverse-split/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-08-20weekly0.7 https://aibio.space/news/abbott-agrees-settle-gill-case-preterm-formula-nec-claims/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-08-20weekly0.7 https://aibio.space/news/urogen-signs-option-deal-intragel-agrees-invest-up-7-000-000/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-08-20weekly0.7 https://aibio.space/news/jaguar-health-reports-second-quarter-2026-net-loss-12-7-million/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-08-19weekly0.7 https://aibio.space/news/osr-health-receives-nasdaq-delisting-determination-will-request/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-08-19weekly0.7 https://aibio.space/news/apimeds-pharmaceuticals-takes-assignment-apitox-rights/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-08-19weekly0.7 https://aibio.space/news/kiora-licenses-kio-301-rights-south-korea-chong-kun-dang/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-08-19weekly0.7 https://aibio.space/news/cosmos-health-reports-second-quarter-2026-revenue-18-99-million/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-08-19weekly0.7 https://aibio.space/news/intelligent-bio-solutions-reports-fiscal-2026-revenue-4-215-175/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-08-19weekly0.7 https://aibio.space/news/hepion-appoints-james-liddy-director/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-08-19weekly0.7 https://aibio.space/news/tuhura-biosciences-inc-stockholders-approve-1-878-287-loan-fee-shares/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-08-19weekly0.7 https://aibio.space/news/mereo-biopharma-faces-securities-class-action-naming-ceo-chief/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-08-19weekly0.7 https://aibio.space/news/innate-pharma-files-subscription-agreement-new-shares-1-70-each/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-08-19weekly0.7 https://aibio.space/news/mereo-biopharma-gets-second-nasdaq-bid-price-period-february-16-2027/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-08-19weekly0.7 https://aibio.space/news/skye-bioscience-gets-nasdaq-notice-stockholders-equity-was-497-307/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-08-19weekly0.7 https://aibio.space/news/silo-pharma-issues-165-000-shares-software-domain-names/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-08-18weekly0.7 https://aibio.space/news/genprex-signs-cdmo-deal-scale-up-diabetes-gene-therapy-manufacturing/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-08-18weekly0.7 https://aibio.space/news/cocrystal-appoints-carol-l-brosgart-board-directors/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-08-18weekly0.7 https://aibio.space/news/bullfrog-ai-granted-nasdaq-second-compliance-period-bid-price/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-08-18weekly0.7 https://aibio.space/news/icon-plc-issues-2-15-billion-senior-unsecured-notes/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-08-18weekly0.7 https://aibio.space/news/baxter-raises-note-tender-offer-cap-600-million-after-early-results/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-08-18weekly0.7 https://aibio.space/news/liminatus-pharma-sets-1-50-reverse-stock-split-meet-nasdaq-minimum-bid/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-08-18weekly0.7 https://aibio.space/news/outlook-therapeutics-faces-securities-class-action-stayed-derivative/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-08-18weekly0.7 https://aibio.space/news/amylyx-pharmaceuticals-launches-350-000-000-common-stock-offering/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-08-18weekly0.7 https://aibio.space/news/scisparc-unit-neurothera-labs-completes-c-5-4-million-private/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-08-18weekly0.7 https://aibio.space/news/revelation-grants-ceo-cfo-restricted-stock-tied-market-value/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-08-17weekly0.7 https://aibio.space/news/endra-reports-second-quarter-2026-results-merger-progress/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-08-17weekly0.7 https://aibio.space/news/dermata-agrees-3-4-million-private-placement-warrants/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-08-17weekly0.7 https://aibio.space/news/coherus-oncology-takes-55-000-000-senior-secured-term-loan-refinance/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-08-17weekly0.7 https://aibio.space/news/outlook-therapeutics-files-nt-10-q-june-quarter-cites-finance-staff/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-08-17weekly0.7 https://aibio.space/news/bright-minds-biosciences-reports-c-307-828-515-cash-after-public/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-08-17weekly0.7 https://aibio.space/news/fulcrum-therapeutics-agrees-all-stock-merger-slate-medicines/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-08-17weekly0.7 https://aibio.space/news/lexaria-bioscience-regains-nasdaq-bid-price-compliance-hearing/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-08-17weekly0.7 https://aibio.space/news/xortx-reports-994-045-cash-going-concern-note-first-half-2026/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-08-17weekly0.7 https://aibio.space/news/bioforce-nanosciences-names-interim-ceo-adds-general-counsel-advisers/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-08-14weekly0.7 https://aibio.space/news/quoin-reports-second-quarter-2026-results-qrx003-progress/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-08-14weekly0.7 https://aibio.space/news/traws-pharma-reports-q2-2026-results-updated-mhra-timeline/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-08-14weekly0.7 https://aibio.space/news/adagio-medical-receives-nasdaq-notice-stockholders-equity/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-08-14weekly0.7 https://aibio.space/news/retractable-technologies-reports-second-quarter-net-sales-7-2-million/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-08-14weekly0.7 https://aibio.space/news/lifeward-reports-second-quarter-2026-revenue-up-16-percent-6-6-million/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-08-14weekly0.7 https://aibio.space/news/leonabio-reports-second-quarter-2026-results-elaine-3-update/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-08-14weekly0.7 https://aibio.space/news/pavmed-reports-second-quarter-2026-results-lucid-coverage-policy/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-08-14weekly0.7 https://aibio.space/news/vycor-medical-reports-second-quarter-2026-results/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-08-14weekly0.7 https://aibio.space/news/enveric-reports-second-quarter-2026-net-loss-3-0-million/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-08-14weekly0.7 https://aibio.space/news/scienture-reports-second-quarter-2026-revenue-343-639/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-08-14weekly0.7 https://aibio.space/news/trinity-biotech-amends-perceptive-term-loan-adding-about-2-5-million/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-08-14weekly0.7 https://aibio.space/news/senti-biosciences-unit-sells-4-0-million-convertible-notes-celadon/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-08-14weekly0.7 https://aibio.space/news/dare-prices-6-0m-registered-direct-warrants-twice-shares/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-08-14weekly0.7 https://aibio.space/news/curanex-flags-going-concern-doubt-2-94-million-cash-june-30/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-08-14weekly0.7 https://aibio.space/news/silexion-had-2-2-million-cash-june-30-flags-going-concern-doubt/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-08-14weekly0.7 https://aibio.space/news/exicures-class-action-derivative-suits-end-court-approved-settlements/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-08-14weekly0.7 https://aibio.space/news/neumora-ipo-class-action-navacaprant-disclosures-awaits-ruling/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-08-14weekly0.7 https://aibio.space/news/gt-biopharma-sued-four-convertible-note-holders-undelivered-conversion/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-08-14weekly0.7 https://aibio.space/news/vistagen-faces-securities-class-action-two-derivative-suits-palisade-3/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-08-14weekly0.7 https://aibio.space/news/hcw-biologics-faces-december-jury-trial-florida-mechanics-lien/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-08-14weekly0.7 https://aibio.space/news/scilex-loses-ztlido-patent-appeal-federal-circuit-affirms-non/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-08-14weekly0.7 https://aibio.space/news/scilex-semnur-named-sorrento-equity-holders-suit-now-stayed-california/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-08-14weekly0.7 https://aibio.space/news/capricor-discloses-new-securities-class-action-derivative-suit-fda/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-08-14weekly0.7 https://aibio.space/news/adlai-nortye-reports-us-231-9-million-cash-after-two-2026-private/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-08-14weekly0.7 https://aibio.space/news/casi-pharmaceuticals-reports-3-8-million-cash-details-nasdaq-delisting/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-08-14weekly0.7 https://aibio.space/news/inflarx-registers-up-65-000-000-more-shares-sales-program/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-08-14weekly0.7 https://aibio.space/news/nutra-pharma-files-late-filing-notice-june-30-2026-quarterly-report/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-08-14weekly0.7 https://aibio.space/news/protokinetix-files-late-filing-notice-june-30-2026-quarterly-report/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-08-14weekly0.7 https://aibio.space/news/skye-bioscience-outlines-redx-pharma-deal-august-14-2026-investor-deck/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-08-14weekly0.7 https://aibio.space/news/lifeloc-reports-second-quarter-2026-revenue-up-10-percent/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-08-13weekly0.7 https://aibio.space/news/dogwood-reports-second-quarter-2026-results-halneuron-update/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-08-13weekly0.7 https://aibio.space/news/nuwellis-reports-14-percent-second-quarter-revenue-growth-76-percent/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-08-13weekly0.7 https://aibio.space/news/mink-reports-second-quarter-2026-results-early-trial-observations/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-08-13weekly0.7 https://aibio.space/news/equillium-expects-eq504-phase-1-start-q4-2026-cash-2029/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-08-13weekly0.7 https://aibio.space/news/bluejay-reports-q2-2026-results-9-6-million-cash/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-08-13weekly0.7 https://aibio.space/news/tenon-medical-reports-second-quarter-2026-revenue-1-3-million/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-08-13weekly0.7 https://aibio.space/news/biofrontera-reports-second-quarter-2026-net-product-revenue-12-0/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-08-13weekly0.7 https://aibio.space/news/co-diagnostics-reports-second-quarter-2026-results-flu-rsv-test/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-08-13weekly0.7 https://aibio.space/news/ensysce-completes-cy-biopharma-acquisition-38-6-million-placements/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-08-13weekly0.7 https://aibio.space/news/aethlon-reports-first-quarter-fiscal-2027-results-third-cohort-dosing/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-08-13weekly0.7 https://aibio.space/news/opko-issues-125-000-000-additional-senior-secured-notes/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-08-13weekly0.7 https://aibio.space/news/positron-arranges-2-000-000-line-credit-12-percent-investor-george/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-08-13weekly0.7 https://aibio.space/news/sangamo-bankruptcy-auction-brings-163-55-million-ptc-lilly/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-08-13weekly0.7 https://aibio.space/news/maplight-agrees-150-million-private-placement-shares-pre-funded/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-08-13weekly0.7 https://aibio.space/news/maplight-reports-351-3-million-cash-investments-sees-funding-through/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-08-13weekly0.7 https://aibio.space/news/polaryx-reports-11-5-million-cash-funding-early-2027-going-concern/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-08-13weekly0.7 https://aibio.space/news/silexion-raises-2-5-million-public-offering-shares-warrants-0-65/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-08-13weekly0.7 https://aibio.space/news/turn-issues-579-664-shares-gem-exercises-warrant-cashless-basis/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-08-13weekly0.7 https://aibio.space/news/pelthos-therapeutics-says-first-quarter-2026-financials-can-no-longer/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-08-13weekly0.7 https://aibio.space/news/cytokinetics-sues-bristol-myers-squibb-myokardia-delaware-patent-suit/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-08-13weekly0.7 https://aibio.space/news/aptevo-therapeutics-closes-warrant-inducement-private-placement-about/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-08-13weekly0.7 https://aibio.space/news/kyntra-bio-accrues-7-0-million-indemnity-tied-sec-case-against-ex-cmo/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-08-13weekly0.7 https://aibio.space/news/calidi-faces-suits-two-former-finance-staff-investors-securities-fraud/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-08-13weekly0.7 https://aibio.space/news/cormedix-faces-defencath-securities-class-action-derivative-settlement/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-08-13weekly0.7 https://aibio.space/news/alumis-carries-acelyrin-securities-class-action-izokibep-trial/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-08-13weekly0.7 https://aibio.space/news/ars-pharmaceuticals-details-aptar-trade-secret-suit-own-antitrust/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-08-13weekly0.7 https://aibio.space/news/ars-pharmaceuticals-faces-securities-class-action-neffy-insurance/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-08-13weekly0.7 https://aibio.space/news/fate-therapeutics-faces-securities-class-action-three-derivative-suits/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-08-13weekly0.7 https://aibio.space/news/biovie-securities-class-certified-nevada-three-derivative-suits-stayed/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-08-13weekly0.7 https://aibio.space/news/gossamer-bio-faces-securities-class-action-lead-plaintiff-named/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-08-13weekly0.7 https://aibio.space/news/satellos-reports-47-251-thousand-net-equity-proceeds-first-half-2026/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-08-13weekly0.7 https://aibio.space/news/nervgen-reports-c-86-789-698-cash-after-may-2026-public-offering/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-08-13weekly0.7 https://aibio.space/news/proqr-reports-59-2-million-june-financing-117-1-million-cash/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-08-13weekly0.7 https://aibio.space/news/regen-biopharma-files-late-filing-notice-june-30-2026-quarterly-report/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-08-13weekly0.7 https://aibio.space/news/aprea-reports-second-quarter-2026-results-41-2-million-cash/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-08-12weekly0.7 https://aibio.space/news/ptc-named-winning-bidder-sangamos-fabry-gene-therapy-st-920/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-08-12weekly0.7 https://aibio.space/news/ispecimen-signs-2-000-000-investor-relations-consulting-agreement/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-08-12weekly0.7 https://aibio.space/news/aditxt-completes-sale-pearsanta-mdna-holdings/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-08-12weekly0.7 https://aibio.space/news/mannatech-reports-second-quarter-2026-net-income-1-0-million/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-08-12weekly0.7 https://aibio.space/news/envue-medical-agrees-50-million-committed-equity-facility/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-08-12weekly0.7 https://aibio.space/news/bio-green-med-reports-second-quarter-results-updates-future-nrg-deal/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-08-12weekly0.7 https://aibio.space/news/aeon-reports-second-quarter-2026-results-15-3-million-financing/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-08-12weekly0.7 https://aibio.space/news/alkermes-amends-term-loan-credit-agreement-cutting-interest-spreads/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-08-12weekly0.7 https://aibio.space/news/agenus-extends-ocean-1181-loan-maturity-november-2029/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-08-12weekly0.7 https://aibio.space/news/profusa-issues-714-285-72-senior-secured-convertible-note/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-08-12weekly0.7 https://aibio.space/news/turn-therapeutics-ends-june-10-3-million-going-concern-warning/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-08-12weekly0.7 https://aibio.space/news/alto-neuroscience-ipo-securities-class-action-dismissed-leave-amend/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-08-12weekly0.7 https://aibio.space/news/inovios-supply-contract-suit-against-vgxi-geneone-set-trial-october/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-08-12weekly0.7 https://aibio.space/news/spero-says-sec-closed-investigation-without-action-against-two-ex/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-08-12weekly0.7 https://aibio.space/news/humacyte-securities-suit-symvess-safety-enters-discovery-four/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-08-12weekly0.7 https://aibio.space/news/atara-biotherapeutics-faces-securities-class-action-tab-cel-allele/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-08-12weekly0.7 https://aibio.space/news/lakefront-biotherapeutics-reports-241-904-shares-bought-back-under-eur/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-08-12weekly0.7 https://aibio.space/news/pharvaris-reports-318-million-cash-after-132-3-million-offering/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-08-12weekly0.7 https://aibio.space/news/vogenx-prices-ipo-6-250-000-shares-13-00-nasdaq/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-08-12weekly0.7 https://aibio.space/news/absci-cash-rises-201-million-after-june-raise-lilly-invests-40-million/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-08-11weekly0.7 https://aibio.space/news/silence-therapeutics-raises-175-million-after-divesiran-phase-2-win/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-08-11weekly0.7 https://aibio.space/news/theriva-biologics-doses-first-virage2-patients-reports-cash-q1-2027/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-08-11weekly0.7 https://aibio.space/news/bolt-biotherapeutics-reports-second-quarter-results-cash-2027/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-08-11weekly0.7 https://aibio.space/news/eloxx-reports-second-quarter-results-after-66-0-million-offering/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-08-11weekly0.7 https://aibio.space/news/dermata-reports-second-quarter-2026-results-4-4-million-cash/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-08-11weekly0.7 https://aibio.space/news/intensity-therapeutics-reports-q2-2026-results-trial-updates/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-08-11weekly0.7 https://aibio.space/news/enlivex-amends-21-0-million-lind-note-resets-conversion-price/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-08-11weekly0.7 https://aibio.space/news/veradermics-reports-819-9-million-cash-securities-sees-funding-2030/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-08-11weekly0.7 https://aibio.space/news/kyverna-faces-ipo-securities-class-action-consolidated-derivative-suit/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-08-11weekly0.7 https://aibio.space/news/taysha-derivative-suit-2023-private-placement-faces-termination-motion/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-08-11weekly0.7 https://aibio.space/news/therapeuticsmds-mayne-pharma-suit-stayed-imvexxy-patent-cases-against/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-08-11weekly0.7 https://aibio.space/news/erasca-faces-securities-class-action-eras-0015-derivative-suit/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-08-11weekly0.7 https://aibio.space/news/bicara-biocon-face-y-trap-inventorship-suit-ficerafusp-alfa-patents/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-08-11weekly0.7 https://aibio.space/news/gain-therapeutics-ceo-gene-mack-sued-delaware-warrant-exercise-price/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-08-11weekly0.7 https://aibio.space/news/abcellera-launches-200-000-000-share-offering-then-prices-9-75/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-08-11weekly0.7 https://aibio.space/news/aura-biosciences-cuts-about-20-percent-workforce-expects-cash-runway/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-08-11weekly0.7 https://aibio.space/news/tango-therapeutics-files-up-400-000-000-market-stock-program/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-08-11weekly0.7 https://aibio.space/news/adial-expects-ceo-cfo-leave-after-september-annual-meeting/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-08-10weekly0.7 https://aibio.space/news/palisade-bio-reports-second-quarter-2026-results-phase-2-plans-pali/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-08-10weekly0.7 https://aibio.space/news/bionano-reports-second-quarter-2026-revenue-8-2-million/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-08-10weekly0.7 https://aibio.space/news/interpace-biosciences-reports-second-quarter-revenue-9-1-million/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-08-10weekly0.7 https://aibio.space/news/bioxcel-amends-oaktree-credit-agreement-sets-august-21-deadline/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-08-10weekly0.7 https://aibio.space/news/os-therapies-sells-up-10-000-000-senior-secured-convertible-notes/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-08-10weekly0.7 https://aibio.space/news/aspire-closes-30-0-million-cash-acquisition-enters-22-5-million/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-08-10weekly0.7 https://aibio.space/news/anavex-life-sciences-files-nt-10-q-says-june-quarter-report-late-amid/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-08-10weekly0.7 https://aibio.space/news/veru-faces-securities-class-action-five-derivative-suits-sabizabulin/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-08-10weekly0.7 https://aibio.space/news/veru-faces-fraud-warranty-suit-buyer-fc2-business/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-08-10weekly0.7 https://aibio.space/news/sana-biotechnology-securities-class-action-stayed-after-second-amended/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-08-10weekly0.7 https://aibio.space/news/rocket-pharmaceuticals-faces-securities-class-action-derivative-suit/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-08-10weekly0.7 https://aibio.space/news/metagenomis-ipo-class-action-moderna-collaboration-disclosures-moves/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-08-10weekly0.7 https://aibio.space/news/axsome-derivative-suit-dismissed-delaware-new-york-case-awaits-ruling/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-08-10weekly0.7 https://aibio.space/news/axsome-resolves-all-sunosi-patent-suits-symbravo-case-against-apotex/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-08-10weekly0.7 https://aibio.space/news/moonlake-faces-securities-class-action-sonelokimab-motion-dismiss/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-08-10weekly0.7 https://aibio.space/news/anavex-life-sciences-says-cannot-file-june-quarter-report-time/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-08-10weekly0.7 https://aibio.space/news/cogent-biosciences-files-up-400-000-000-market-stock-sales/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-08-10weekly0.7 https://aibio.space/news/lakewood-amedex-biotherapeutics-sets-vote-share-increase-100-000-000/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-08-10weekly0.7 https://aibio.space/news/wave-life-sciences-ltd-now-wave-life-sciences-inc-files-form-15-end/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-08-10weekly0.7 https://aibio.space/news/minerva-neurosciences-reports-second-quarter-2026-results-c19-trial/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-08-07weekly0.7 https://aibio.space/news/osr-health-says-nasdaq-did-not-endorse-loyalty-cvr-program/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-08-07weekly0.7 https://aibio.space/news/kiora-reports-second-quarter-2026-results-cash-runway-late-2028/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-08-07weekly0.7 https://aibio.space/news/glucotrack-amends-white-lion-equity-line-commitment-shares/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-08-07weekly0.7 https://aibio.space/news/biorestorative-suspends-orders-shipments-two-biocosmeceutical-lines/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-08-07weekly0.7 https://aibio.space/news/tuhura-biosciences-draws-650-000-more-parkview-credit-line/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-08-07weekly0.7 https://aibio.space/news/cervomed-discloses-ex-ceos-2014-suit-narrowed-march-trial-set-october/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-08-07weekly0.7 https://aibio.space/news/natera-appeals-guardant-false-advertising-judgment-after-292-5-million/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-08-07weekly0.7 https://aibio.space/news/agenus-securities-class-action-dismissed-plaintiff-appeals-sec-closes/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-08-07weekly0.7 https://aibio.space/news/ani-loses-post-trial-motions-cg-oncology-royalty-case-defends-acella/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-08-07weekly0.7 https://aibio.space/news/ani-novitium-face-two-generic-drug-patent-suits-antitrust/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-08-07weekly0.7 https://aibio.space/news/merck-faces-securities-class-action-gardasil-demand-china-derivative/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-08-07weekly0.7 https://aibio.space/news/atyr-pharma-moves-dismiss-amended-class-action-efzofitimod-statements/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-08-07weekly0.7 https://aibio.space/news/blossomhill-prices-ipo-9-375-000-shares-16-00-150-000-000-total/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-08-07weekly0.7 https://aibio.space/news/corbus-pharmaceuticals-sets-up-sales-program-up-127-500-000/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-08-07weekly0.7 https://aibio.space/news/latigo-biotherapeutics-prices-ipo-19-200-000-shares-18-00/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-08-07weekly0.7 https://aibio.space/news/aptorum-group-now-niki-biosolutions-regains-nasdaq-bid-price/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-08-07weekly0.7 https://aibio.space/news/roivant-posts-290-6m-quarterly-loss-3-9b-cash-keeps-buying-back-stock/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-08-06weekly0.7 https://aibio.space/news/scholar-rock-files-new-200-million-market-stock-program/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-08-06weekly0.7 https://aibio.space/news/celldex-holds-717-6-million-before-phase-3-readout-cfo-sam-martin/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-08-06weekly0.7 https://aibio.space/news/theriva-doses-first-patient-virage2-pancreatic-cancer-trial/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-08-06weekly0.7 https://aibio.space/news/metavia-reports-second-quarter-2026-net-loss-5-3-million/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-08-06weekly0.7 https://aibio.space/news/vivosim-labs-reports-regained-equity-compliance-after-july-cash-events/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-08-06weekly0.7 https://aibio.space/news/in8bio-reports-second-quarter-2026-results-glioblastoma-survival-data/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-08-06weekly0.7 https://aibio.space/news/revelation-reports-second-quarter-2026-results-cash-early-2027/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-08-06weekly0.7 https://aibio.space/news/ispecimen-prices-5-million-public-offering-1-30-share/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-08-06weekly0.7 https://aibio.space/news/biovie-reports-topline-results-phase-2-sunrise-pd-trial-parkinsons/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-08-06weekly0.7 https://aibio.space/news/aquabounty-widens-ohio-strategic-review-power-infrastructure/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-08-06weekly0.7 https://aibio.space/news/icon-plc-subsidiary-prices-senior-notes-repay-bridge-term-loans/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-08-06weekly0.7 https://aibio.space/news/spyglass-ends-june-234-2-million-says-cash-lasts-through-2028/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-08-06weekly0.7 https://aibio.space/news/tarsus-agrees-buy-alkeus-270-000-000-cash-180-000-000-stock/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-08-06weekly0.7 https://aibio.space/news/ensysce-biosciences-buys-cy-biopharma-agrees-two-tranche-private/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-08-06weekly0.7 https://aibio.space/news/ardelyx-securities-suit-xphozah-ends-after-appeal-withdrawn/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-08-06weekly0.7 https://aibio.space/news/gilead-hiv-antitrust-appeal-awaits-ruling-after-october-2025-argument/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-08-06weekly0.7 https://aibio.space/news/gilead-cites-august-2026-ruling-hiv-drug-injury-suits-about-23-000/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-08-06weekly0.7 https://aibio.space/news/iovance-faces-securities-class-action-three-derivative-suits-2025/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-08-06weekly0.7 https://aibio.space/news/iovance-defends-two-delaware-derivative-suits-director-pay-2024-stock/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-08-06weekly0.7 https://aibio.space/news/intellia-says-court-dismissed-securities-class-action-director-pay/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-08-06weekly0.7 https://aibio.space/news/viatris-faces-indore-plant-securities-class-action-derivative-suits/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-08-06weekly0.7 https://aibio.space/news/relay-therapeutics-nominal-defendant-delaware-derivative-suit-2021/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-08-06weekly0.7 https://aibio.space/news/federal-circuit-affirms-invalidity-puma-licensed-patents-tagrisso-suit/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-08-06weekly0.7 https://aibio.space/news/pumas-malpractice-suit-against-former-law-firm-waits-north-carolina/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-08-06weekly0.7 https://aibio.space/news/ocugen-awaits-third-circuit-ruling-dismissed-securities-suit/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-08-06weekly0.7 https://aibio.space/news/arcturus-sues-abbvie-capstan-trade-secrets-capstan-counterclaims/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-08-06weekly0.7 https://aibio.space/news/pepgen-reports-securities-class-action-shareholder-demand/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-08-06weekly0.7 https://aibio.space/news/verrica-agrees-principle-settle-2022-securities-class-action-ycanth/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-08-06weekly0.7 https://aibio.space/news/agomab-therapeutics-nv-reports-252-0-million-cash-after-208-million/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-08-06weekly0.7 https://aibio.space/news/artiva-biotherapeutics-files-400-000-000-shelf-100-000-000-atm-program/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-08-06weekly0.7 https://aibio.space/news/braveheart-bio-prices-ipo-21-250-000-shares-18-00/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-08-06weekly0.7 https://aibio.space/news/gh-research-reports-111-2-million-net-proceeds-april-2026-share/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-08-06weekly0.7 https://aibio.space/news/oculis-reports-chf-47-775-thousand-market-share-sales-first-half/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-08-06weekly0.7 https://aibio.space/news/relay-therapeutics-adds-212-978-049-market-stock-program/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-08-06weekly0.7 https://aibio.space/news/solid-biosciences-adds-sales-program-up-200-000-000-jefferies/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-08-06weekly0.7 https://aibio.space/news/zhengye-biotechnology-regains-nasdaq-bid-price-compliance/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-08-06weekly0.7 https://aibio.space/news/arcus-ends-last-tigit-phase-3-gilead-gives-up-three-board-seats/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-08-05weekly0.7 https://aibio.space/news/q32-bio-reports-q2-2026-net-loss-8-9-million-106-3-million-cash/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-08-05weekly0.7 https://aibio.space/news/genprex-regains-nasdaq-bid-price-compliance-panel-oversight-runs/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-08-05weekly0.7 https://aibio.space/news/dermata-sets-august-25-2026-sale-date-tome-foundational-treatment/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-08-05weekly0.7 https://aibio.space/news/eton-pharmaceuticals-licenses-asn-001-auson-3-0-million-upfront/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-08-05weekly0.7 https://aibio.space/news/vistagen-gets-180-day-nasdaq-extension-until-february-1-2027-minimum/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-08-05weekly0.7 https://aibio.space/news/perrigo-faces-new-york-securities-class-action-infant-formula/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-08-05weekly0.7 https://aibio.space/news/bioage-faces-ninth-circuit-appeal-dismissed-ipo-securities-class/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-08-05weekly0.7 https://aibio.space/news/geron-faces-rytelo-securities-class-action-four-derivative-suits/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-08-05weekly0.7 https://aibio.space/news/revolution-medicines-reports-final-judgment-delaware-suit-eqrx-merger/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-08-05weekly0.7 https://aibio.space/news/context-therapeutics-closes-delaware-suit-three-year-director-terms/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-08-05weekly0.7 https://aibio.space/news/amgen-agrees-settle-roofers-securities-class-action-irs-tax/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-08-05weekly0.7 https://aibio.space/news/amgens-chemocentryx-securities-class-action-settlement-gets/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-08-05weekly0.7 https://aibio.space/news/biocryst-sues-annora-hetero-camber-delaware-generic-orladeyo/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-08-05weekly0.7 https://aibio.space/news/recursion-lab-landlord-remain-utah-court-lease-construction-claims/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-08-05weekly0.7 https://aibio.space/news/acadia-awaits-federal-circuit-ruling-nuplazid-patent-suits-zydus-trial/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-08-05weekly0.7 https://aibio.space/news/mirum-sues-sandoz-hetero-biophore-zydus-delaware-generic-livmarli/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-08-05weekly0.7 https://aibio.space/news/attovia-therapeutics-prices-ipo-17-000-000-shares-17-00/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-08-05weekly0.7 https://aibio.space/news/aura-biosciences-holders-approve-raising-authorized-shares-500-000-000/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-08-05weekly0.7 https://aibio.space/news/emergent-biosolutions-posts-180-2-million-q2-loss-cuts-about-90-roles/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-08-05weekly0.7 https://aibio.space/news/faeth-therapeutics-reports-186-4-million-cash-securities-after-sensei/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-08-04weekly0.7 https://aibio.space/news/glucotrack-adds-3-500-000-secured-convertible-bridge-financing/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-08-04weekly0.7 https://aibio.space/news/60-degrees-pharmaceuticals-closes-private-placement-about-1-0-million/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-08-04weekly0.7 https://aibio.space/news/bio-rad-starts-restructuring-plan-80-90-million-pre-tax-charges/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-08-04weekly0.7 https://aibio.space/news/camp4-completes-second-closing-private-placement-50-1-million-gross/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-08-04weekly0.7 https://aibio.space/news/niagen-bioscience-details-consumer-class-actions-thorne-suit-elysium/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-08-04weekly0.7 https://aibio.space/news/arrowhead-still-defending-ionis-patent-suit-plozasiran-after-delaware/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-08-04weekly0.7 https://aibio.space/news/onkure-says-plaintiffs-have-not-pursued-two-new-york-suits-reneo/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-08-04weekly0.7 https://aibio.space/news/onkure-files-100-000-000-market-stock-sale-supplement/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-08-04weekly0.7 https://aibio.space/news/tyra-biosciences-sold-full-150-000-000-under-sales-program-raises/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-08-04weekly0.7 https://aibio.space/news/logicmark-agrees-1-31-share-cash-merger-langham-project/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-08-03weekly0.7 https://aibio.space/news/alzamend-neuro-sells-7-5-million-series-d-preferred-affiliate-ault/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-08-03weekly0.7 https://aibio.space/news/cocrystal-sells-5-million-stock-opko-health/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-08-03weekly0.7 https://aibio.space/news/qhslab-reports-second-quarter-2026-revenue-up-40-1-percent/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-08-03weekly0.7 https://aibio.space/news/aeon-regains-nyse-american-compliance-after-july-offering/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-08-03weekly0.7 https://aibio.space/news/supernus-indivior-plan-merger-backed-650-million-citibank-loan/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-08-03weekly0.7 https://aibio.space/news/amneal-reprices-2-039-billion-term-loan-adds-45-2-million/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-08-03weekly0.7 https://aibio.space/news/autolus-issues-first-75-million-under-up-250-million-perceptive/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-08-03weekly0.7 https://aibio.space/news/lisata-cuts-72-percent-staff-after-failed-kuva-buyout-then-merges/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-08-03weekly0.7 https://aibio.space/news/krystal-biotech-reports-doj-subpoenas-vyjuvek-testing-program-director/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-08-03weekly0.7 https://aibio.space/news/krystal-biotech-sued-delaware-inventorship-two-kb407-cystic-fibrosis/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-08-03weekly0.7 https://aibio.space/news/supernus-faces-january-2027-apokyn-antitrust-trial-related-insurance/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-08-03weekly0.7 https://aibio.space/news/ocular-therapeutix-faces-eyepoint-defamation-suit-injunction-ruling/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-08-03weekly0.7 https://aibio.space/news/autolus-issues-75-0-million-notes-under-up-250-0-million-perceptive/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-08-03weekly0.7 https://aibio.space/news/stoke-therapeutics-files-new-200-000-000-market-stock-program/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-08-03weekly0.7 https://aibio.space/news/nuwellis-prices-3-4-million-registered-direct-offering-2-59-share/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-07-31weekly0.7 https://aibio.space/news/nasdaq-tells-osr-health-loyalty-cvr-program-will-not-adjust-price/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-07-31weekly0.7 https://aibio.space/news/co-diagnostics-warrant-inducement-expected-raise-about-2-67-million/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-07-31weekly0.7 https://aibio.space/news/hepion-closes-3-055-000-private-placement-matching-warrants/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-07-31weekly0.7 https://aibio.space/news/aethlon-effects-1-5-reverse-stock-split-effective-july-31/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-07-31weekly0.7 https://aibio.space/news/bioxcel-amends-oaktree-credit-agreement-defers-payment/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-07-31weekly0.7 https://aibio.space/news/cdt-equity-raises-j-j-astor-note-2-266-650-19-percent-interest/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-07-31weekly0.7 https://aibio.space/news/prophase-labs-issues-2-085-000-senior-secured-convertible-note/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-07-31weekly0.7 https://aibio.space/news/aiforia-signs-eur-20-million-venture-debt-eib/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-07-31weekly0.7 https://aibio.space/news/mira-pharmaceuticals-gets-nasdaq-bid-price-deficiency-notice-deadline/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-07-31weekly0.7 https://aibio.space/news/pds-biotechnology-gets-nasdaq-minimum-bid-price-deficiency-letter-has/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-07-31weekly0.7 https://aibio.space/news/organon-faces-securities-class-action-dividend-statements-merger-proxy/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-07-31weekly0.7 https://aibio.space/news/apnimed-prices-ipo-12-000-000-shares-16-00/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-07-31weekly0.7 https://aibio.space/news/evogene-calls-september-4-meeting-director-slates-share-capital/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-07-31weekly0.7 https://aibio.space/news/northwest-biotherapeutics-registers-40-325-000-shares-tied-4-9-million/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-07-31weekly0.7 https://aibio.space/news/ptc-raises-2026-product-revenue-guidance-after-second-quarter/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-07-30weekly0.7 https://aibio.space/news/nasdaq-panel-grants-genprex-exception-1-00-bid-price-rule/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-07-30weekly0.7 https://aibio.space/news/annexon-secures-credit-facility-up-200-million-oxford-finance/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-07-30weekly0.7 https://aibio.space/news/novo-holdings-cuts-maplight-stake-below-5-percent-after-july-30-share/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-07-30weekly0.7 https://aibio.space/news/bristol-myers-squibb-details-texas-plavix-suit-arkansas-340b-complaint/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-07-30weekly0.7 https://aibio.space/news/bristol-myers-squibb-sues-seven-generic-drugmakers-delaware-camzyos/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-07-30weekly0.7 https://aibio.space/news/baxter-faces-two-securities-class-actions-derivative-suit-novum-lvp/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-07-30weekly0.7 https://aibio.space/news/baxters-hillrom-unit-faces-linet-antitrust-suit-bed-buyer-appeal-two/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-07-30weekly0.7 https://aibio.space/news/alterity-reports-37-3-million-cash-after-1-50-share-consolidation/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-07-30weekly0.7 https://aibio.space/news/lexaria-sets-1-15-reverse-split-august-3-2026-meet-nasdaq-bid-rule/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-07-30weekly0.7 https://aibio.space/news/dyne-therapeutics-has-898-5-million-cash-runway-2028-after-july/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-07-29weekly0.7 https://aibio.space/news/traws-pharma-receives-nasdaq-notice-1-00-minimum-bid-price/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-07-29weekly0.7 https://aibio.space/news/synlogic-merge-caldera-therapeutics-all-stock-deal/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-07-29weekly0.7 https://aibio.space/news/processa-acquires-vidya-therapeutics-200-million-placement/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-07-29weekly0.7 https://aibio.space/news/vector-biosource-agrees-buy-four-blood-collection-centers/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-07-29weekly0.7 https://aibio.space/news/hcw-biologics-prices-1-6-million-private-placement-insiders/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-07-29weekly0.7 https://aibio.space/news/glucotrack-unit-advances-lt-100-toward-single-injection-dosing/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-07-29weekly0.7 https://aibio.space/news/trafalgar-adds-three-new-officers-three-incoming-directors/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-07-29weekly0.7 https://aibio.space/news/accuray-gets-lender-waiver-defaults-under-financing-agreement/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-07-29weekly0.7 https://aibio.space/news/china-resources-pharmaceutical-issues-rmb1-billion-second-tranche/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-07-29weekly0.7 https://aibio.space/news/celularity-gets-nasdaq-minimum-bid-price-deficiency-notice-has-until/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-07-29weekly0.7 https://aibio.space/news/ra-capital-exchanges-18-030-000-inhibikase-therapeutics-shares-pre/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-07-29weekly0.7 https://aibio.space/news/earth-science-tech-ask-holders-advisory-vote-reverse-split-uplisting/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-07-29weekly0.7 https://aibio.space/news/inventiva-says-cash-covers-operations-end-q2-2027-after-june/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-07-29weekly0.7 https://aibio.space/news/lb-pharmaceuticals-agrees-150-million-private-placement-34-94-share/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-07-29weekly0.7 https://aibio.space/news/onconetix-sells-30-249-600-series-f-preferred-pipe-financing/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-07-28weekly0.7 https://aibio.space/news/american-shared-hospital-services-signs-forbearance-fifth-third-bank/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-07-28weekly0.7 https://aibio.space/news/bionexus-advances-vitaguard-rollout-southeast-asia/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-07-28weekly0.7 https://aibio.space/news/grifols-refinances-all-2027-maturities-about-3-billion-term-loan/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-07-28weekly0.7 https://aibio.space/news/tuhura-biosciences-draws-1-500-000-parkview-revolving-credit-facility/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-07-28weekly0.7 https://aibio.space/news/alkermes-sues-teva-apotex-msn-proposed-generic-lybalvi/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-07-28weekly0.7 https://aibio.space/news/alkermes-faces-direct-purchaser-antitrust-class-action-vivitrol-patent/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-07-28weekly0.7 https://aibio.space/news/bgm-group-regains-nasdaq-compliance-after-filing-late-20/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-07-28weekly0.7 https://aibio.space/news/entera-bio-closes-275-0-million-private-placement-2-04-share/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-07-28weekly0.7 https://aibio.space/news/aptevo-files-patent-application-nectin-4-x-pd-l1-dual-targeting/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-07-27weekly0.7 https://aibio.space/news/calidi-biotherapeutics-effects-1-16-reverse-stock-split/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-07-27weekly0.7 https://aibio.space/news/profusa-expects-about-7-million-convertible-note-alongside-diagnostics/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-07-27weekly0.7 https://aibio.space/news/biomx-extends-1-250-000-note-november-1-2026/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-07-27weekly0.7 https://aibio.space/news/scribe-therapeutics-prices-ipo-8-580-000-shares-15-00/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-07-27weekly0.7 https://aibio.space/news/vivosim-labs-gets-nasdaq-equity-notice-cites-july-warrant-exercises/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-07-24weekly0.7 https://aibio.space/news/apimeds-pharmaceuticals-reverse-stock-split-took-effect-july-24/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-07-24weekly0.7 https://aibio.space/news/btig-terminates-matinas-market-sales-agreement/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-07-24weekly0.7 https://aibio.space/news/mannkind-closes-50-0-million-private-placement-led-frazier-life/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-07-24weekly0.7 https://aibio.space/news/standard-biotools-gets-nasdaq-minimum-bid-price-notice-has-until/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-07-24weekly0.7 https://aibio.space/news/oncolytics-biotech-gets-nasdaq-minimum-bid-price-deficiency-notice-has/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-07-24weekly0.7 https://aibio.space/news/fibrobiologics-gets-nasdaq-delisting-determination-1-00-minimum-bid/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-07-24weekly0.7 https://aibio.space/news/summit-files-380-million-stock-program-10-q-flags-going-concern-doubt/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-07-23weekly0.7 https://aibio.space/news/neuphoria-scancell-agree-all-share-merger-up-89-million-financing/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-07-23weekly0.7 https://aibio.space/news/bone-biologics-completes-3-0-million-private-placement-warrants/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-07-23weekly0.7 https://aibio.space/news/nexgel-signs-new-employment-agreement-ceo-adam-levy/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-07-23weekly0.7 https://aibio.space/news/aeon-reports-partial-allotment-exercise-july-offering/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-07-23weekly0.7 https://aibio.space/news/summit-therapeutics-derivative-suit-520-million-duggan-notes-ends/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-07-23weekly0.7 https://aibio.space/news/radiopharm-theranostics-sets-9-300-000-atm-limit-prices-4-050-001-36/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-07-23weekly0.7 https://aibio.space/news/china-pharma-prices-5-million-registered-direct-offering/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-07-22weekly0.7 https://aibio.space/news/kairos-pharma-announces-bayer-collaboration-test-env-105-xofigo/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-07-22weekly0.7 https://aibio.space/news/first-choice-healthcare-amends-deal-florida-pharmacy-companies/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-07-22weekly0.7 https://aibio.space/news/china-resources-pharmaceutical-issues-rmb1-billion-medium-term-notes/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-07-22weekly0.7 https://aibio.space/news/bluejay-completes-symon-ii-enrollment-750-patients-ahead-plan/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-07-21weekly0.7 https://aibio.space/news/phio-adds-dermatologist-r-todd-plott-board/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-07-21weekly0.7 https://aibio.space/news/xtl-biopharmaceuticals-regains-nasdaq-compliance-faces-one-year-panel/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-07-21weekly0.7 https://aibio.space/news/60-degrees-describes-babesiosis-plan-2028-profitability-target/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-07-20weekly0.7 https://aibio.space/news/sunshine-biopharma-sets-up-4-000-000-market-stock-sale-aegis-capital/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-07-20weekly0.7 https://aibio.space/news/okyo-pharma-files-annual-report-cites-22-million-offering-20-6-million/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-07-20weekly0.7 https://aibio.space/news/rockwell-medical-regains-nasdaq-bid-price-compliance-matter-closed/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-07-20weekly0.7 https://aibio.space/news/healthy-extracts-issues-258-750-promissory-note-labrys-fund-ii/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-07-17weekly0.7 https://aibio.space/news/damora-completes-move-delaware-cayman-islands/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-07-17weekly0.7 https://aibio.space/news/dare-bioscience-gets-nasdaq-notice-stockholders-equity-plans-hearing/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-07-17weekly0.7 https://aibio.space/news/blossomhill-therapeutics-files-ipo-plans-nasdaq-listing-blsm/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-07-17weekly0.7 https://aibio.space/news/latigo-biotherapeutics-files-ipo-plans-nasdaq-listing-ltgo/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-07-17weekly0.7 https://aibio.space/news/xeris-completes-note-exchange-conversion-no-2028-convertible-notes/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-07-17weekly0.7 https://aibio.space/news/vivosim-labs-prices-4-0-million-private-placement-0-85-warrants/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-07-16weekly0.7 https://aibio.space/news/raphael-pharmaceutical-chairman-cfo-resign-uri-tadelis-named-cfo/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-07-16weekly0.7 https://aibio.space/news/cdt-equity-do-1-10-reverse-stock-split-effective-july-17/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-07-16weekly0.7 https://aibio.space/news/bio-path-sells-small-regulation-lots-hires-strategic-advisor/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-07-16weekly0.7 https://aibio.space/news/aditxt-amends-secured-note-purchase-deal-ignite-proteomics/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-07-16weekly0.7 https://aibio.space/news/inhibrx-expands-oxford-finance-facility-500-0-million/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-07-16weekly0.7 https://aibio.space/news/arbutus-expects-return-up-approximately-230m-shareholders/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-07-16weekly0.7 https://aibio.space/news/helus-pharma-cybin-inc-closes-us-50-million-share-offering-us-4-85/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-07-16weekly0.7 https://aibio.space/news/inhibrx-expands-oxford-finance-credit-facility-up-500-0-million/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-07-16weekly0.7 https://aibio.space/news/regenxbio-prices-100-million-stock-offering-9-00-share/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-07-16weekly0.7 https://aibio.space/news/kairos-pharma-reports-interim-phase-1-safety-data-env-105-lung-cancer/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-07-15weekly0.7 https://aibio.space/news/azitra-reports-ex-vivo-skin-data-filaggrin-cosmetic-ingredient/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-07-15weekly0.7 https://aibio.space/news/ensysce-chief-operating-officer-jeffrey-millard-resigns/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-07-15weekly0.7 https://aibio.space/news/polomar-health-names-douglas-beck-chief-financial-officer/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-07-15weekly0.7 https://aibio.space/news/prestige-brands-sells-400-0-million-6-250-percent-senior-notes-due/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-07-15weekly0.7 https://aibio.space/news/bayer-places-5-billion-u-s-dollars-bonds-five-tranches/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-07-15weekly0.7 https://aibio.space/news/medincell-secures-28-million-non-dilutive-loans/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-07-15weekly0.7 https://aibio.space/news/neurotech-secures-3-15-million-secured-loan/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-07-15weekly0.7 https://aibio.space/news/senti-biosciences-signs-merger-agreement-celadon-affiliate-cvrs-tied/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-07-15weekly0.7 https://aibio.space/news/braveheart-bio-files-ipo-plans-nasdaq-global-market-listing-brve/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-07-15weekly0.7 https://aibio.space/news/proqr-registers-resale-up-3-030-303-shares-selling-shareholder/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-07-15weekly0.7 https://aibio.space/news/vogenx-files-ipo-plans-nasdaq-capital-market-listing-vogx/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-07-15weekly0.7 https://aibio.space/news/q32-bio-enters-underwriting-agreement-public-offering-18-25-share/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-07-14weekly0.7 https://aibio.space/news/genprex-plans-1-22-reverse-stock-split-effective-july-16/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-07-14weekly0.7 https://aibio.space/news/cero-therapeutics-expands-srx-global-convertible-note-2-085-200/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-07-14weekly0.7 https://aibio.space/news/nextcure-signs-merger-agreement-avere-therapeutics-alongside-320/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-07-14weekly0.7 https://aibio.space/news/apollomics-regains-nasdaq-compliance-35-million-market-value-rule/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-07-14weekly0.7 https://aibio.space/news/attovia-therapeutics-files-ipo-plans-nasdaq-listing-atto/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-07-14weekly0.7 https://aibio.space/news/apimeds-pharmaceuticals-sets-reverse-split-date-july-24/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-07-13weekly0.7 https://aibio.space/news/matinas-plans-gh-power-combination-sells-mat2203-azurity/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-07-13weekly0.7 https://aibio.space/news/aeon-prices-upsized-13-75-million-offering-milestone-warrants/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-07-13weekly0.7 https://aibio.space/news/cumberland-pharmaceuticals-declares-1-50-special-dividend-authorizes-5/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-07-13weekly0.7 https://aibio.space/news/erasca-launches-500-000-000-stock-offering-then-prices-31-428-572/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-07-13weekly0.7 https://aibio.space/news/traws-pharma-sets-5-575-709-market-sales-limit-citizens-jmp/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-07-10weekly0.7 https://aibio.space/news/revelation-adopts-stockholder-rights-plan-10-percent-trigger/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-07-10weekly0.7 https://aibio.space/news/silo-prices-up-11-7-million-private-placement/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-07-10weekly0.7 https://aibio.space/news/nomad-power-solutions-raises-voyager-energy-storage-up-56-percent/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-07-10weekly0.7 https://aibio.space/news/calidi-biotherapeutics-signs-new-san-diego-lease/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-07-10weekly0.7 https://aibio.space/news/international-stem-cell-agrees-sell-lifeline-cell-technology-25-0/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-07-10weekly0.7 https://aibio.space/news/anika-therapeutics-amends-50-0-million-bank-america-revolving-credit/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-07-10weekly0.7 https://aibio.space/news/kestra-medical-draws-75-0-million-up-200-0-million-term-loan/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-07-10weekly0.7 https://aibio.space/news/cue-biopharma-agrees-50-0-million-private-placement-led-cormorant/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-07-10weekly0.7 https://aibio.space/news/apnimed-files-ipo-plans-nasdaq-global-market-listing-apmd/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-07-10weekly0.7 https://aibio.space/news/cue-biopharma-agrees-50-0-million-private-placement-33-21-share/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-07-10weekly0.7 https://aibio.space/news/niagen-bioscience-sets-up-50-000-000-share-sales-program/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-07-10weekly0.7 https://aibio.space/news/metavia-completes-dose-titration-phase-1-part-3-study-da-1726/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-07-09weekly0.7 https://aibio.space/news/endra-regains-nasdaq-stockholders-equity-compliance/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-07-09weekly0.7 https://aibio.space/news/bone-biologics-closes-private-placement-pre-funded-warrants-about-2-7/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-07-09weekly0.7 https://aibio.space/news/zyversa-director-resigns-company-explores-cost-cuts/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-07-08weekly0.7 https://aibio.space/news/biorestoratives-ceo-cfo-resign-claim-severance-new-ceo-named/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-07-08weekly0.7 https://aibio.space/news/aquabountys-board-declines-reverse-stock-split-now/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-07-08weekly0.7 https://aibio.space/news/kyverna-amends-150-million-oxford-finance-loan-facility/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-07-08weekly0.7 https://aibio.space/news/evofem-biosciences-issues-706-304-subordinated-note-hub-cyber-security/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-07-08weekly0.7 https://aibio.space/news/evommune-cfo-agrees-return-10-160-short-swing-profit-after-july-share/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-07-08weekly0.7 https://aibio.space/news/theriva-receives-spanish-authorization-virage2-trial/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-07-07weekly0.7 https://aibio.space/news/semnur-signs-binding-term-sheet-100-million-investment-iholding/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-07-07weekly0.7 https://aibio.space/news/macrogenics-completes-sale-cdmo-manufacturing-business-bora-122-5/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-07-07weekly0.7 https://aibio.space/news/macrogenics-completes-sale-manufacturing-operations-bora-122-5-million/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-07-07weekly0.7 https://aibio.space/news/meiragtx-agrees-up-400-million-oberland-capital-investment-135-million/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-07-07weekly0.7 https://aibio.space/news/bioxcel-amends-credit-agreement-forms-strategic-process-committee/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-07-06weekly0.7 https://aibio.space/news/oragenics-names-john-spencer-cfo-reports-annual-meeting-votes/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-07-06weekly0.7 https://aibio.space/news/foxo-ceo-gives-mid-year-2026-update-says-uplisting-under-consideration/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-07-06weekly0.7 https://aibio.space/news/polomar-health-reconstitutes-board-amends-equity-plan/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-07-06weekly0.7 https://aibio.space/news/aethlon-prices-4-0-million-follow-offering-0-7101-share/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-07-06weekly0.7 https://aibio.space/news/aspira-womens-health-takes-1-050-000-secured-subordinated-loan/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-07-06weekly0.7 https://aibio.space/news/cynata-takes-600-000-loan-secured-against-r-d-ti-rebate/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-07-06weekly0.7 https://aibio.space/news/prestige-consumer-healthcare-draws-95-0-million-term-loan-fund/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-07-06weekly0.7 https://aibio.space/news/nuvation-bio-issues-37-5-million-more-convertible-notes-offering/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-07-06weekly0.7 https://aibio.space/news/cosciens-biopharma-files-form-15-end-sec-reporting-duties/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-07-06weekly0.7 https://aibio.space/news/gelteq-closes-second-debt-tranche-receiving-2-5-million-net-discount/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-07-06weekly0.7 https://aibio.space/news/mindwalk-added-russell-3000e-index-then-files-250-000-000-shelf/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-07-06weekly0.7 https://aibio.space/news/igc-pharma-issues-shares-two-officers-0-27-settle-1-154-210-owed-them/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-07-06weekly0.7 https://aibio.space/news/nuvation-bios-convertible-notes-offering-reaches-287-5-million-after/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-07-06weekly0.7 https://aibio.space/news/metavia-files-prospectus-supplement-up-4-000-000-share-sales/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-07-02weekly0.7 https://aibio.space/news/lixte-completes-merger-nomad-transportable-power-systems/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-07-02weekly0.7 https://aibio.space/news/cns-pharmaceuticals-lays-out-oncology-neurology-asset-search/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-07-02weekly0.7 https://aibio.space/news/omeros-expects-close-16-0-million-note-repurchase-agrees-14-5-million/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-07-02weekly0.7 https://aibio.space/news/ardelyx-draws-50-0-million-term-f-loan-under-slr-investment-corp-loan/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-07-02weekly0.7 https://aibio.space/news/creative-medical-technology-gets-4-5-million-warrant-exercise-reduced/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-07-02weekly0.7 https://aibio.space/news/pyxis-oncology-agrees-sell-about-50-million-stock-warrants-private/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-07-02weekly0.7 https://aibio.space/news/enanta-pharmaceuticals-files-up-75-000-000-market-stock-sales/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-07-02weekly0.7 https://aibio.space/news/integrated-biopharma-extends-pnc-revolving-credit-line-april-14-2027/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-07-02weekly0.7 https://aibio.space/news/scribe-therapeutics-files-ipo-plans-nasdaq-listing-sctx/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-07-02weekly0.7 https://aibio.space/news/bridgebio-raises-up-1-billion-convertible-preferred-sixth-street-kkr/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-07-01weekly0.7 https://aibio.space/news/bioforce-nanosciences-receives-nevada-oil-gas-lease-assignment-pending/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-07-01weekly0.7 https://aibio.space/news/foxo-completes-1-3-000-reverse-stock-split/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-07-01weekly0.7 https://aibio.space/news/hepion-adds-two-directors-including-son-interim-ceo/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-07-01weekly0.7 https://aibio.space/news/viatris-closes-40-000-000-000-unsecured-term-loan-mizuho-bank/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-07-01weekly0.7 https://aibio.space/news/alvotech-secures-75-million-term-loan-goldentree-funds/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-07-01weekly0.7 https://aibio.space/news/fresenius-issues-1-billion-dual-tranche-bonds/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-07-01weekly0.7 https://aibio.space/news/cadrenal-therapeutics-raises-3-0-million-private-placement-priced/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-07-01weekly0.7 https://aibio.space/news/cumberland-pharmaceuticals-closes-100-million-asset-sale-apotex/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-07-01weekly0.7 https://aibio.space/news/cumberland-pharmaceuticals-closes-100-million-branded-product-deal/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-07-01weekly0.7 https://aibio.space/news/lifeward-amends-senior-secured-convertible-notes-tied-oramed/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-06-30weekly0.7 https://aibio.space/news/aptevo-receives-1-5-million-grant-advance-apvo451/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-06-30weekly0.7 https://aibio.space/news/tenon-medical-prices-4-2-million-public-offering-warrants/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-06-30weekly0.7 https://aibio.space/news/bespoke-extracts-extends-senior-secured-notes-august-14-2026/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-06-30weekly0.7 https://aibio.space/news/moleculin-calls-first-45-patient-miracle-results-positive-but-gives-no/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-06-30weekly0.7 https://aibio.space/news/cosmos-health-authorizes-share-repurchase-up-5-million/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-06-30weekly0.7 https://aibio.space/news/tuhura-biosciences-borrows-1-900-000-more-under-parkview-credit-line/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-06-30weekly0.7 https://aibio.space/news/os-therapies-signs-10-million-secured-convertible-note-leonite-fund/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-06-30weekly0.7 https://aibio.space/news/cdt-equity-closes-second-tranche-1-460-000-convertible-loan/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-06-30weekly0.7 https://aibio.space/news/hcw-biologics-regains-nasdaq-bid-price-compliance-faces-monitor-until/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-06-30weekly0.7 https://aibio.space/news/abivax-launches-600-000-000-offering-american-depositary-shares/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-06-30weekly0.7 https://aibio.space/news/biocryst-close-birmingham-discovery-center-cuts-2026-spending-outlook/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-06-29weekly0.7 https://aibio.space/news/alaunos-reports-body-fat-adjusted-liver-weight-analysis-aln1003/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-06-29weekly0.7 https://aibio.space/news/trafalgar-asset-management-gains-voting-control-cancels-company-debt/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-06-29weekly0.7 https://aibio.space/news/agenus-extends-maturity-5-09-million-notes/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-06-29weekly0.7 https://aibio.space/news/celularity-takes-1-000-000-secured-loan-barach-family-trust/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-06-29weekly0.7 https://aibio.space/news/ardelyx-draws-50-0-million-term-loan-slr-investment-corp/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-06-29weekly0.7 https://aibio.space/news/rockwell-medical-sets-1-10-reverse-stock-split-july-1-2026/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-06-29weekly0.7 https://aibio.space/news/zymeworks-agrees-buy-theravance-biopharma-17-share-about-929-million/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-06-29weekly0.7 https://aibio.space/news/soligenix-adds-2-500-000-market-sales-agreement/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-06-26weekly0.7 https://aibio.space/news/matinas-biopharma-receives-nyse-american-equity-notice-plan-accepted/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-06-26weekly0.7 https://aibio.space/news/shoulder-innovations-takes-15-0-million-stifel-term-loan-repays/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-06-26weekly0.7 https://aibio.space/news/china-resources-pharmaceutical-unit-issues-rmb2-billion-corporate/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-06-26weekly0.7 https://aibio.space/news/aquabounty-sells-2-250-000-series-b-preferred-stock/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-06-25weekly0.7 https://aibio.space/news/alx-oncology-closes-up-50-000-000-hsbc-term-loan-facility/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-06-25weekly0.7 https://aibio.space/news/disc-medicine-draws-30-000-000-extends-hercules-loan-draw-periods/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-06-25weekly0.7 https://aibio.space/news/nuvation-bio-proposes-200-0-million-convertible-notes-offering/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-06-25weekly0.7 https://aibio.space/news/ligand-pharmaceuticals-completes-700-0-million-0-00-percent/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-06-25weekly0.7 https://aibio.space/news/cellectis-shareholders-approve-share-issuance-authorizations-including/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-06-25weekly0.7 https://aibio.space/news/absci-raises-100-million-7-41-share-eli-lilly-among-buyers/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-06-24weekly0.7 https://aibio.space/news/revelation-amends-ceo-cfo-employment-agreements-bylaws/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-06-24weekly0.7 https://aibio.space/news/4d-molecular-therapeutics-signs-up-200-0-million-hercules-loan/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-06-24weekly0.7 https://aibio.space/news/calcimedica-agrees-private-placement-expected-upfront-gross-proceeds/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-06-24weekly0.7 https://aibio.space/news/fda-conditionally-accepts-qyleki-brand-name-qrx003/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-06-23weekly0.7 https://aibio.space/news/nuwellis-effect-one-thirty-five-reverse-stock-split-june-25/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-06-23weekly0.7 https://aibio.space/news/calidi-biotherapeutics-appoints-corsee-sanders-board/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-06-23weekly0.7 https://aibio.space/news/sangamo-files-chapter-11-dip-financing-northridge-atm/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-06-23weekly0.7 https://aibio.space/news/calcimedica-pushes-avenue-loan-maturity-2029-cuts-warrant-price/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-06-23weekly0.7 https://aibio.space/news/cero-therapeutics-amends-1-413-600-promissory-note-srx-health/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-06-23weekly0.7 https://aibio.space/news/boundless-bio-signs-merger-agreement-serapha-bio-cuts-workforce/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-06-23weekly0.7 https://aibio.space/news/traws-pharma-prepares-updated-mhra-data-package-third-quarter/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-06-22weekly0.7 https://aibio.space/news/genprex-receives-canadian-notice-allowance-reqorsa-combination-patent/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-06-22weekly0.7 https://aibio.space/news/ligand-plans-550-million-convertible-notes-due-2031/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-06-22weekly0.7 https://aibio.space/news/aditxt-adds-769-230-77-senior-secured-convertible-notes/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-06-22weekly0.7 https://aibio.space/news/betterlife-closes-cad-2-000-000-convertible-debenture-financing/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-06-22weekly0.7 https://aibio.space/news/neogenomics-completes-316-25-million-convertible-notes-offering/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-06-22weekly0.7 https://aibio.space/news/former-spac-sponsor-sues-silexion-tel-aviv-note-conversions/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-06-22weekly0.7 https://aibio.space/news/akebia-stockholders-approve-raising-authorized-common-shares-500-000/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-06-22weekly0.7 https://aibio.space/news/allogene-holders-approve-800-000-000-shares-files-atm-supplement-up/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-06-22weekly0.7 https://aibio.space/news/allogene-therapeutics-registers-up-135-000-000-share-sales-td-cowen/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-06-22weekly0.7 https://aibio.space/news/cytomx-holders-approve-600-000-000-authorized-shares-larger-equity/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-06-22weekly0.7 https://aibio.space/news/definium-launches-500-million-offering-then-prices-20-588-236-shares/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-06-22weekly0.7 https://aibio.space/news/eledon-holders-approve-raising-authorized-common-shares-450-000-000/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-06-22weekly0.7 https://aibio.space/news/provectus-holders-authorize-reverse-split-between-1-10-1-50/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-06-22weekly0.7 https://aibio.space/news/uniqure-launches-150-000-000-offering-then-prices-upsized-225-million/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-06-22weekly0.7 https://aibio.space/news/petros-names-robert-weinstein-chief-accounting-officer/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-06-18weekly0.7 https://aibio.space/news/silo-pharma-regains-nasdaq-minimum-bid-price-compliance/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-06-18weekly0.7 https://aibio.space/news/kiora-reports-preclinical-epilepsy-data-ion-channel-modulator-kio-300/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-06-18weekly0.7 https://aibio.space/news/lixte-lend-6-5-million-nomad-before-acquisition-closes/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-06-18weekly0.7 https://aibio.space/news/sonoma-pharmaceuticals-lifts-market-offering-ceiling-3-641-703/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-06-18weekly0.7 https://aibio.space/news/gri-bio-receives-fda-orphan-drug-designation-gri-0621-ipf/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-06-18weekly0.7 https://aibio.space/news/ptc-therapeutics-closes-550-000-000-convertible-notes-offering/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-06-18weekly0.7 https://aibio.space/news/viatris-completes-650-000-000-public-offering-4-250-percent-senior/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-06-18weekly0.7 https://aibio.space/news/dyadic-international-gets-nasdaq-delisting-notice-bid-price-plans/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-06-18weekly0.7 https://aibio.space/news/iovance-biotherapeutics-files-automatic-shelf-89-650-167-atm/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-06-18weekly0.7 https://aibio.space/news/kardigan-prices-ipo-25-000-000-shares-16-00/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-06-18weekly0.7 https://aibio.space/news/prf-technologies-signs-15-0-million-equity-line-yorkville/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-06-18weekly0.7 https://aibio.space/news/redhill-biopharma-signs-6-million-private-placement-up-19-4-million/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-06-18weekly0.7 https://aibio.space/news/sl-science-closes-horizon-space-acquisition-ii-deal-files-shell/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-06-18weekly0.7 https://aibio.space/news/xencor-holders-approve-4-000-000-share-increase-2023-equity-plan/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-06-18weekly0.7 https://aibio.space/news/aspira-womens-health-names-interim-ceo-after-buhle-exit/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-06-17weekly0.7 https://aibio.space/news/protokinetix-names-keith-brunt-president-adds-two-directors/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-06-17weekly0.7 https://aibio.space/news/azitra-pauses-netherton-trial-moves-capital-cosmetics-proteins/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-06-17weekly0.7 https://aibio.space/news/jaguar-health-amends-streeterville-uptown-royalty-deals-extends-note/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-06-17weekly0.7 https://aibio.space/news/adaptive-biotechnologies-prices-upsized-300-million-convertible-notes/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-06-17weekly0.7 https://aibio.space/news/omeros-agrees-repurchase-up-16-0-million-convertible-notes/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-06-17weekly0.7 https://aibio.space/news/gossamer-bio-completes-exchange-2027-convertible-notes-secured-notes/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-06-17weekly0.7 https://aibio.space/news/rigel-pharmaceuticals-completes-vepdegestrant-license-pays-70-0/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-06-17weekly0.7 https://aibio.space/news/lakewood-amedex-biotherapeutics-sets-1-10-reverse-split-trading-june/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-06-17weekly0.7 https://aibio.space/news/legend-biotech-launches-225-000-000-ads-offering-then-prices-7-700-000/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-06-17weekly0.7 https://aibio.space/news/rigel-completes-vepdegestrant-license-arvinas-pfizer-pays-70-0-million/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-06-17weekly0.7 https://aibio.space/news/nuwellis-appoints-mike-mccormick-chief-executive-officer/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-06-16weekly0.7 https://aibio.space/news/dyne-therapeutics-draws-50-0-million-more-under-hercules-facility/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-06-16weekly0.7 https://aibio.space/news/prestige-consumer-healthcare-closes-1-045-billion-breathe-right/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-06-16weekly0.7 https://aibio.space/news/lifeloc-completes-spindetect-disk-tooling-sets-staged-rollout/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-06-15weekly0.7 https://aibio.space/news/global-innovative-platforms-updates-shareholders-studies-board/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-06-15weekly0.7 https://aibio.space/news/aim-immunotech-regains-nyse-american-stockholders-equity-compliance/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-06-15weekly0.7 https://aibio.space/news/polomar-health-ends-altanine-merger-patent-license/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-06-15weekly0.7 https://aibio.space/news/pds-biotechnology-closes-6-000-000-note-ya-ii-pn/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-06-15weekly0.7 https://aibio.space/news/adaptive-biotechnologies-plans-250-million-convertible-notes/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-06-15weekly0.7 https://aibio.space/news/neumora-cut-workforce-about-35-percent-end-navacaprant-after-phase-3/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-06-15weekly0.7 https://aibio.space/news/engene-therapeutics-cuts-workforce-about-50-percent-restructuring/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-06-15weekly0.7 https://aibio.space/news/alvotech-launches-125-million-share-sale-then-prices-22-666-667-shares/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-06-15weekly0.7 https://aibio.space/news/engene-cuts-about-50-percent-workforce-reports-285-2-million-cash/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-06-15weekly0.7 https://aibio.space/news/rockwell-medical-holders-approve-reverse-stock-split-amendment/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-06-15weekly0.7 https://aibio.space/news/adagio-medical-gets-nasdaq-bid-price-notice-has-until-december-9/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-06-12weekly0.7 https://aibio.space/news/traws-pharma-defers-txm-challenge-study-after-negative-mhra-review/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-06-12weekly0.7 https://aibio.space/news/nasdaq-staff-says-genprex-not-eligible-bid-price-compliance-period/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-06-12weekly0.7 https://aibio.space/news/lipellas-bankruptcy-court-approves-sale-substantially-all-assets/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-06-12weekly0.7 https://aibio.space/news/viatris-offers-650-000-000-4-250-percent-senior-notes-due-2033/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-06-12weekly0.7 https://aibio.space/news/clearmind-sells-1-000-000-convertible-notes-90-percent-principal/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-06-12weekly0.7 https://aibio.space/news/rocket-pharmaceuticals-closes-180-million-sale-priority-review-voucher/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-06-12weekly0.7 https://aibio.space/news/soligenix-gets-nasdaq-minimum-bid-price-notice-ends-hybryte-program/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-06-12weekly0.7 https://aibio.space/news/biocardia-believes-regained-nasdaq-stockholders-equity-compliance-2/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-06-12weekly0.7 https://aibio.space/news/celularity-gets-nasdaq-notice-market-value-listed-securities-has-until/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-06-12weekly0.7 https://aibio.space/news/annexon-holders-approve-raising-authorized-common-shares-500-000-000/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-06-12weekly0.7 https://aibio.space/news/cuprina-holdings-regains-nasdaq-compliance-july-7-2026-hearing/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-06-12weekly0.7 https://aibio.space/news/theriva-reports-phase-1-head-neck-cancer-results-journal/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-06-11weekly0.7 https://aibio.space/news/adial-acquires-azora-therapeutics-announces-up-64-million-financing/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-06-11weekly0.7 https://aibio.space/news/iqvia-issues-950-000-000-4-625-percent-senior-notes-due-2033/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-06-11weekly0.7 https://aibio.space/news/cdt-equity-repays-legacy-notes-signs-1-460-000-jj-astor-loan/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-06-11weekly0.7 https://aibio.space/news/xeris-exchanges-23-million-2028-convertible-notes-cash-stock/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-06-11weekly0.7 https://aibio.space/news/parabilis-medicines-closes-private-placement-4-166-666-shares/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-06-11weekly0.7 https://aibio.space/news/enliven-therapeutics-launches-250-000-000-offering-then-prices-upsized/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-06-11weekly0.7 https://aibio.space/news/veraxa-biotech-closes-voyager-spac-merger-nasdaq-trading-starts-june/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-06-11weekly0.7 https://aibio.space/news/bio-green-med-sells-1-103-338-shares-foreign-investors-794-403/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-06-10weekly0.7 https://aibio.space/news/palisade-bio-adds-jordan-zwick-board-raises-authorized-shares/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-06-10weekly0.7 https://aibio.space/news/aethlon-medical-reports-fiscal-2026-results-enters-third-cohort/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-06-10weekly0.7 https://aibio.space/news/biorestorative-sets-up-1-000-000-revolving-loan-bowery-group/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-06-10weekly0.7 https://aibio.space/news/precision-biosciences-extends-banc-california-term-loan/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-06-10weekly0.7 https://aibio.space/news/aptorum-group-now-niki-biosolutions-shareholders-approve-diamir-merger/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-06-10weekly0.7 https://aibio.space/news/parabilis-medicines-prices-ipo-33-500-000-shares-20-00-670-000-000/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-06-10weekly0.7 https://aibio.space/news/solid-biosciences-holders-approve-doubling-authorized-shares-480-000/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-06-10weekly0.7 https://aibio.space/news/voyager-therapeutics-holders-approve-doubling-common-stock-240-000-000/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-06-10weekly0.7 https://aibio.space/news/bluejay-stockholders-approve-reverse-split-authority/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-06-09weekly0.7 https://aibio.space/news/aditxt-signs-deal-take-ignite-proteomics-public-150-million-value/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-06-09weekly0.7 https://aibio.space/news/cocrystal-names-james-sapirstein-chief-executive-officer/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-06-09weekly0.7 https://aibio.space/news/enveric-files-2-425-000-market-offering-supplement-h-c-wainwright/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-06-09weekly0.7 https://aibio.space/news/idorsia-takes-up-chf-250-million-senior-secured-term-loan/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-06-09weekly0.7 https://aibio.space/news/jasper-therapeutics-receives-nasdaq-minimum-bid-price-notice-has-until/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-06-09weekly0.7 https://aibio.space/news/bgm-group-closes-us-12-000-000-private-placement-200-000-000-shares/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-06-09weekly0.7 https://aibio.space/news/relay-therapeutics-holders-approve-raising-authorized-shares-450-000/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-06-09weekly0.7 https://aibio.space/news/metavia-shareholders-approve-reverse-split-range-1-5-1-22/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-06-08weekly0.7 https://aibio.space/news/ptc-director-alethia-young-steps-down-stays-advisor/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-06-08weekly0.7 https://aibio.space/news/nuwellis-closes-6-0-million-public-offering-priced-0-30-share/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-06-08weekly0.7 https://aibio.space/news/vivos-therapeutics-issues-convertible-note-up-5-000-000/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-06-08weekly0.7 https://aibio.space/news/celcuity-completes-575-000-000-convertible-notes-offering-repays/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-06-08weekly0.7 https://aibio.space/news/atyr-pharma-gets-180-more-days-nasdaq-meet-1-00-minimum-bid-price/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-06-08weekly0.7 https://aibio.space/news/biontech-starts-buyback-up-usd-1-0-billion-adss-running-may-6-2027/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-06-08weekly0.7 https://aibio.space/news/savara-holders-approve-doubling-authorized-shares-600-000-000/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-06-08weekly0.7 https://aibio.space/news/aspira-womens-health-closes-1-485-million-private-placement/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-06-05weekly0.7 https://aibio.space/news/theriva-special-meeting-fails-reach-quorum-warrant-approval/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-06-05weekly0.7 https://aibio.space/news/petros-grants-7-000-000-restricted-shares-directors-officers/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-06-05weekly0.7 https://aibio.space/news/osr-health-postpones-2026-annual-meeting-no-new-date-set/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-06-05weekly0.7 https://aibio.space/news/igc-pharma-extends-12-000-000-bank-credit-facility-o-bank/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-06-05weekly0.7 https://aibio.space/news/cerus-takes-up-65-0-million-secured-term-loan-midcap/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-06-05weekly0.7 https://aibio.space/news/inotiv-enters-65-5-million-dip-credit-agreement-after-chapter-11/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-06-05weekly0.7 https://aibio.space/news/solid-biosciences-updates-resale-prospectus-add-selling-stockholders/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-06-05weekly0.7 https://aibio.space/news/kairos-pharma-signs-cl-741-term-sheet-lists-milestones-2026/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-06-04weekly0.7 https://aibio.space/news/aim-immunotech-releases-video-segment-ebola-ampligen/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-06-04weekly0.7 https://aibio.space/news/bio-green-med-agrees-all-stock-deal-acquire-future-nrg/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-06-04weekly0.7 https://aibio.space/news/imunon-raise-10-million-through-preferred-stock-secured-notes/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-06-04weekly0.7 https://aibio.space/news/luye-pharma-issue-us-180-000-000-bonds-due-2031/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-06-04weekly0.7 https://aibio.space/news/syndax-agrees-250-0-million-private-placement-2-25-percent-convertible/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-06-04weekly0.7 https://aibio.space/news/fulcrum-therapeutics-cut-workforce-approximately-85-percent-reviews/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-06-04weekly0.7 https://aibio.space/news/onkure-therapeutics-holders-approve-equity-plan-adding-3-231-638/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-06-04weekly0.7 https://aibio.space/news/syndax-agrees-sell-250-0-million-2-25-percent-convertible-notes-due/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-06-04weekly0.7 https://aibio.space/news/trevi-therapeutics-holders-approve-doubling-authorized-shares-400-000/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-06-04weekly0.7 https://aibio.space/news/valneva-registers-resale-up-31-787-634-ordinary-shares-selling-holders/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-06-04weekly0.7 https://aibio.space/news/minerva-stockholders-approve-charter-changes-officer-liability-forum/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-06-03weekly0.7 https://aibio.space/news/cocrystal-appoints-james-sapirstein-chief-executive-officer/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-06-03weekly0.7 https://aibio.space/news/conmed-agrees-buy-back-2-250-percent-convertible-notes-due-2027-cash/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-06-03weekly0.7 https://aibio.space/news/fonar-closes-merger-20-million-term-loan-15-million-revolver/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-06-03weekly0.7 https://aibio.space/news/aditxt-issues-senior-secured-convertible-notes-35-percent-discount/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-06-03weekly0.7 https://aibio.space/news/gossamer-bio-exchanges-181-052-000-2027-convertible-notes/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-06-03weekly0.7 https://aibio.space/news/celcuity-prices-upsized-500-000-000-convertible-notes-offering/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-06-03weekly0.7 https://aibio.space/news/helix-biopharma-closes-c-3-673-000-convertible-debenture-placement/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-06-03weekly0.7 https://aibio.space/news/briacell-closes-best-efforts-offering-1-449-300-shares-3-25-raising-4/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-06-03weekly0.7 https://aibio.space/news/regenxbio-starts-stock-option-exchange-offer-non-executive-employees/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-06-03weekly0.7 https://aibio.space/news/celcuity-proposes-400-000-000-convertible-notes-then-prices-500-000/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-06-03weekly0.7 https://aibio.space/news/mineralys-prices-150-million-stock-offering-26-50-fund-tanabe-royalty/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-06-03weekly0.7 https://aibio.space/news/regenxbio-starts-stock-option-exchange-non-executive-employees/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-06-03weekly0.7 https://aibio.space/news/bluejay-announces-u-s-manufacturing-partnership-argonaut/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-06-02weekly0.7 https://aibio.space/news/inotiv-plans-326-million-debt-cut-through-prepackaged-chapter-11/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-06-02weekly0.7 https://aibio.space/news/mineralys-signs-up-500-0-million-senior-secured-term-loan/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-06-02weekly0.7 https://aibio.space/news/sensus-healthcare-signs-15-000-000-revolving-note-city-national-bank/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-06-02weekly0.7 https://aibio.space/news/maravai-lifesciences-signs-150-0-million-term-loan-30-0-million/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-06-02weekly0.7 https://aibio.space/news/delaware-court-holds-heron-cinvanti-patent-claims-invalid-heron-plans/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-06-02weekly0.7 https://aibio.space/news/silo-pharma-completes-1-15-reverse-stock-split/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-06-01weekly0.7 https://aibio.space/news/teleflex-prices-500-0-million-5-875-percent-senior-notes-due-2032/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-06-01weekly0.7 https://aibio.space/news/clearmind-issue-1-500-000-convertible-promissory-notes/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-06-01weekly0.7 https://aibio.space/news/nutriband-extends-5-million-related-party-credit-line-tied-kindeva/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-06-01weekly0.7 https://aibio.space/news/fulcrum-therapeutics-drops-pociredir-starts-strategic-review-after-fda/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-06-01weekly0.7 https://aibio.space/news/american-shared-hospital-services-discloses-lender-default-notice/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-05-29weekly0.7 https://aibio.space/news/enveric-stockholders-vote-reverse-split-range-larger-authorized-share/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-05-29weekly0.7 https://aibio.space/news/nuo-therapeutics-closes-675-000-interim-loan-12-percent-interest/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-05-29weekly0.7 https://aibio.space/news/china-resources-pharmaceutical-plans-rmb5-billion-medium-term-notes/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-05-29weekly0.7 https://aibio.space/news/calidi-biotherapeutics-amends-warrant-up-17-391-304-shares-0-23-adds/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-05-29weekly0.7 https://aibio.space/news/cardiff-oncology-disputes-nervianos-termination-2017-license-agreement/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-05-29weekly0.7 https://aibio.space/news/soligenix-adds-2-956-000-market-sales-agreement/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-05-28weekly0.7 https://aibio.space/news/endra-expects-3-8-million-private-placement-stock-warrants/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-05-28weekly0.7 https://aibio.space/news/vyome-reports-first-quarter-2026-results-licensing-agreement/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-05-28weekly0.7 https://aibio.space/news/nasdaq-council-upholds-abpro-holdings-delisting-otc-pink-quotation/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-05-28weekly0.7 https://aibio.space/news/cdt-equity-gets-nasdaq-notice-late-first-quarter-10/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-05-28weekly0.7 https://aibio.space/news/foxo-licenses-epigenetics-technology-longevityfp/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-05-28weekly0.7 https://aibio.space/news/pelthos-ceo-present-jefferies-global-healthcare-conference-june-4-2026/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-05-28weekly0.7 https://aibio.space/news/medline-sells-1-250-0-million-750-0-million-senior-secured-notes/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-05-28weekly0.7 https://aibio.space/news/cero-therapeutics-issues-937-500-convertible-note-srx-health-solutions/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-05-28weekly0.7 https://aibio.space/news/polaryx-closes-10-million-private-placement-about-35-investors/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-05-28weekly0.7 https://aibio.space/news/silexion-completes-1-10-reverse-split-third-since-late-2024/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-05-28weekly0.7 https://aibio.space/news/royalty-pharma-signs-new-1-8-billion-revolving-credit-facility/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-05-28weekly0.7 https://aibio.space/news/sol-gel-says-33-1-million-march-offering-52-8-million-balance-fund/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-05-28weekly0.7 https://aibio.space/news/biorestorative-files-lance-alstodts-employment-agreement-terms/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-05-27weekly0.7 https://aibio.space/news/traws-pharma-unveils-dual-strike-antiviral-aimed-hantavirus-ebola/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-05-27weekly0.7 https://aibio.space/news/metavia-reports-da-1726-mean-weight-reduction-9-1-percent-48-mg/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-05-27weekly0.7 https://aibio.space/news/aptevo-niowave-launch-50-50-radiopharmaceutical-collaboration/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-05-27weekly0.7 https://aibio.space/news/minerva-sets-up-75-million-market-stock-sale-leerink-partners/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-05-27weekly0.7 https://aibio.space/news/nasdaq-letter-says-aditxt-falls-below-2-500-000-equity-minimum/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-05-27weekly0.7 https://aibio.space/news/osr-health-agrees-buy-vxm01-assets-vaximm-30-000-000/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-05-27weekly0.7 https://aibio.space/news/dermata-shareholders-approve-warrant-repricing-larger-equity-plan/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-05-27weekly0.7 https://aibio.space/news/medicus-pharma-closes-secured-notes-streeterville-capital/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-05-27weekly0.7 https://aibio.space/news/teleflex-enters-new-credit-agreement-jpmorgan-chase-agent/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-05-27weekly0.7 https://aibio.space/news/conmed-amends-jpmorgan-credit-agreement-add-delayed-draw-term-loan/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-05-27weekly0.7 https://aibio.space/news/biophytis-changes-hexagon-bond-facility-make-revolving/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-05-27weekly0.7 https://aibio.space/news/sintx-technologies-gets-nasdaq-stockholders-equity-deficiency-notice/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-05-27weekly0.7 https://aibio.space/news/aspira-womens-health-expands-cleveland-clinic-collaboration-ai/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-05-26weekly0.7 https://aibio.space/news/alaunos-combines-two-aln1003-mouse-studies-one-preclinical-readout/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-05-26weekly0.7 https://aibio.space/news/genprex-reports-asco-abstract-trop-2-pten-biomarkers-reqorsa/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-05-26weekly0.7 https://aibio.space/news/cocrystal-reports-pan-viral-inhibitors-active-against-hantavirus/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-05-26weekly0.7 https://aibio.space/news/scienture-cfo-resigns-narasimhan-mani-named-interim-cfo/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-05-26weekly0.7 https://aibio.space/news/bio-path-cancels-planned-reverse-split-approves-treasury-plan/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-05-26weekly0.7 https://aibio.space/news/tuhura-takes-first-1-700-000-draw-parkview-revolving-credit-facility/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-05-26weekly0.7 https://aibio.space/news/kardigan-files-ipo-plans-nasdaq-global-market-listing-kard/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-05-26weekly0.7 https://aibio.space/news/cartesian-therapeutics-signs-term-loan-up-150-0-million-k2/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-05-26weekly0.7 https://aibio.space/news/ensysce-receives-nasdaq-notice-stockholders-equity-requirement/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-05-22weekly0.7 https://aibio.space/news/foxo-settles-j-h-darbie-fees-seeks-reverse-stock-split/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-05-22weekly0.7 https://aibio.space/news/cartesian-therapeutics-signs-up-150-0-million-senior-secured-term/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-05-22weekly0.7 https://aibio.space/news/spyglass-countersues-glaukos-trade-secret-case-trial-moved-january/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-05-22weekly0.7 https://aibio.space/news/transcode-therapeutics-gets-nasdaq-stockholders-equity-deficiency/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-05-22weekly0.7 https://aibio.space/news/tempest-therapeutics-gets-nasdaq-notice-stockholders-equity-flags/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-05-22weekly0.7 https://aibio.space/news/cosmos-health-reports-first-quarter-2026-revenue-17-93-million/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-05-21weekly0.7 https://aibio.space/news/hcw-biologics-prices-about-4-0-million-private-placement-e-f-hutton/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-05-21weekly0.7 https://aibio.space/news/senti-biosciences-issues-10-0-million-senior-secured-convertible-notes/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-05-20weekly0.7 https://aibio.space/news/optimi-health-prices-us-ipo-2-400-000-shares-us-6-25/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-05-20weekly0.7 https://aibio.space/news/purple-biotech-files-200-000-000-replacement-shelf-atm-limited-824-331/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-05-20weekly0.7 https://aibio.space/news/inmed-agrees-all-stock-merger-mentari-therapeutics/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-05-19weekly0.7 https://aibio.space/news/onconetix-effect-1-10-reverse-stock-split-may-21-2026/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-05-19weekly0.7 https://aibio.space/news/aim-immunotech-pushes-streeterville-note-maturity-june-2027/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-05-19weekly0.7 https://aibio.space/news/clearmind-medicine-announces-1-10-reverse-split-effective-may-21-2026/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-05-19weekly0.7 https://aibio.space/news/larimar-therapeutics-holders-approve-raising-authorized-shares-215-000/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-05-19weekly0.7 https://aibio.space/news/parabilis-medicines-files-ipo-regeneron-agrees-buy-about-75-0-million/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-05-19weekly0.7 https://aibio.space/news/regencell-bioscience-agrees-20-0-million-registered-direct-offering-20/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-05-19weekly0.7 https://aibio.space/news/metavia-present-three-late-breaking-abstracts-ada-2026/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-05-18weekly0.7 https://aibio.space/news/alaunos-reports-updated-aln1003-mouse-data-insulin-liver-markers/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-05-18weekly0.7 https://aibio.space/news/evofem-reports-first-quarter-2026-net-loss-5-5-million/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-05-18weekly0.7 https://aibio.space/news/scienture-reports-q1-2026-revenue-56-thousand-95-6-percent-gross/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-05-18weekly0.7 https://aibio.space/news/sunshine-biopharma-prices-6-0-million-public-offering-units-series/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-05-18weekly0.7 https://aibio.space/news/assertios-23-50-cash-merger-would-give-2027-convertible-noteholders/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-05-18weekly0.7 https://aibio.space/news/gossamer-bio-launches-exchange-offer-5-00-percent-convertible-notes/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-05-18weekly0.7 https://aibio.space/news/palatin-technologies-move-stock-listing-nyse-american-nasdaq-capital/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-05-18weekly0.7 https://aibio.space/news/akari-therapeutics-files-nt-10-q-cites-public-offering-work-expected/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-05-18weekly0.7 https://aibio.space/news/nervgen-reports-16-6-million-cash-investments-after-nasdaq-listing/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-05-18weekly0.7 https://aibio.space/news/lifeloc-reports-first-quarter-2026-results-spindetect-milestone/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-05-15weekly0.7 https://aibio.space/news/healthy-extracts-acquires-adli-gummies-which-does-business-imarais/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-05-15weekly0.7 https://aibio.space/news/traws-pharma-reports-q1-2026-net-loss-7-1-million-financing/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-05-15weekly0.7 https://aibio.space/news/bioxcel-reports-first-quarter-2026-results-engages-mts-health-partners/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-05-15weekly0.7 https://aibio.space/news/retractable-technologies-reports-first-quarter-net-sales-7-2-million/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-05-15weekly0.7 https://aibio.space/news/mink-starts-randomized-phase-2-trial-acute-lung-injury/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-05-15weekly0.7 https://aibio.space/news/emmaus-reports-lower-first-quarter-revenue-wider-net-loss/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-05-15weekly0.7 https://aibio.space/news/enveric-reports-first-quarter-2026-net-loss-1-6-million/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-05-15weekly0.7 https://aibio.space/news/pavmed-reports-first-quarter-2026-results-simpler-capital-structure/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-05-15weekly0.7 https://aibio.space/news/vycor-medical-reports-first-quarter-2026-results/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-05-15weekly0.7 https://aibio.space/news/ensysce-reports-first-quarter-2026-results-starts-strategic-review/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-05-15weekly0.7 https://aibio.space/news/polomar-health-waives-altanine-merger-conditions-amends-ceo-pact/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-05-15weekly0.7 https://aibio.space/news/pelthos-changes-auditor-sets-out-separation-terms-former-cfo/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-05-15weekly0.7 https://aibio.space/news/wuxi-apptec-agrees-issue-rmb6-780-million-convertible-bonds/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-05-15weekly0.7 https://aibio.space/news/skye-bioscience-gets-nasdaq-notice-stockholders-equity-9-011-804-below/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-05-15weekly0.7 https://aibio.space/news/apimeds-pharmaceuticals-us-files-nt-10-q-says-quarterly-report-march/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-05-15weekly0.7 https://aibio.space/news/exicure-files-nt-10-q-late-filing-notice-expects-1-827-911-first/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-05-15weekly0.7 https://aibio.space/news/oramed-pharmaceuticals-files-nt-10-q-says-march-31-2026-quarterly/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-05-15weekly0.7 https://aibio.space/news/scilex-files-nt-10-q-late-filing-notice-expects-first-quarter-10-q-may/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-05-15weekly0.7 https://aibio.space/news/os-therapies-files-nt-10-q-says-first-quarter-report-will-late-after/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-05-15weekly0.7 https://aibio.space/news/rani-therapeutics-gets-nasdaq-minimum-bid-price-notice-cfo-svai/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-05-15weekly0.7 https://aibio.space/news/conexeu-sciences-issues-4-342-648-shares-warrant-exercises-about-1-963/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-05-15weekly0.7 https://aibio.space/news/abvc-biopharma-files-nt-10-q-late-filing-notice-quarter-ended-march-31/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-05-15weekly0.7 https://aibio.space/news/cumberland-pharmaceuticals-files-proxy-100-million-asset-sale-apotex/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-05-15weekly0.7 https://aibio.space/news/enlivex-gets-nasdaq-bid-price-notice-has-until-november-9-2026/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-05-15weekly0.7 https://aibio.space/news/dogwood-reports-first-quarter-2026-results-sp16-ind-approval/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-05-14weekly0.7 https://aibio.space/news/aditxt-plans-1-27-reverse-stock-split-effective-may-18/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-05-14weekly0.7 https://aibio.space/news/genprex-reports-preclinical-diabetes-gene-therapy-data-asgct/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-05-14weekly0.7 https://aibio.space/news/biofrontera-reports-first-quarter-2026-results-regains-nasdaq-bid/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-05-14weekly0.7 https://aibio.space/news/aim-immunotech-posts-kol-segment-ampligen-pancreatic-cancer/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-05-14weekly0.7 https://aibio.space/news/co-diagnostics-reports-first-quarter-2026-results-8-2-million-cash/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-05-14weekly0.7 https://aibio.space/news/calidi-reports-first-quarter-2026-results-cld-401-progress/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-05-14weekly0.7 https://aibio.space/news/preferred-stock-removed-nasdaq-bio-green-med-reports-first-quarter/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-05-14weekly0.7 https://aibio.space/news/hcw-biologics-reports-first-quarter-2026-net-income-trimmune-license/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-05-14weekly0.7 https://aibio.space/news/gri-bio-reports-first-quarter-2026-results-new-gri-0621-data/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-05-14weekly0.7 https://aibio.space/news/pelthos-issues-first-quarter-2026-results-release-posts-company/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-05-14weekly0.7 https://aibio.space/news/ocugen-closes-130-0-million-6-75-percent-convertible-notes/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-05-14weekly0.7 https://aibio.space/news/inotiv-amends-credit-agreement-40-0-million-bridge-facility/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-05-14weekly0.7 https://aibio.space/news/gilead-sells-senior-notes-due-2028-through-2034-public-offering/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-05-14weekly0.7 https://aibio.space/news/senti-biosciences-signs-up-40-million-convertible-note-financing/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-05-14weekly0.7 https://aibio.space/news/cell-sources-delayed-10-q-shows-1-240-cash-11-1-million-past-due-notes/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-05-14weekly0.7 https://aibio.space/news/cuprina-shareholders-approve-share-consolidation-higher-class-b-voting/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-05-14weekly0.7 https://aibio.space/news/zymeworks-authorizes-125-0-million-share-repurchase-program-ends-2025/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-05-14weekly0.7 https://aibio.space/news/aprea-reports-first-quarter-2026-results-46-5-million-cash/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-05-13weekly0.7 https://aibio.space/news/spruce-biosciences-details-50-0-million-avenue-capital-loan-facility/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-05-13weekly0.7 https://aibio.space/news/aptevo-completes-ceo-transition-secures-60-million-equity-line/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-05-13weekly0.7 https://aibio.space/news/equillium-names-snehal-naik-chief-development-officer-reports-q1-2026/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-05-13weekly0.7 https://aibio.space/news/onconetix-reports-q1-2026-progress-proteomedix/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-05-13weekly0.7 https://aibio.space/news/logicmark-revenue-rises-24-percent-first-quarter-2026/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-05-13weekly0.7 https://aibio.space/news/bionano-reports-first-quarter-2026-revenue-6-7-million/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-05-13weekly0.7 https://aibio.space/news/dermata-reports-first-quarter-2026-results-2-0-million-atm-proceeds/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-05-13weekly0.7 https://aibio.space/news/intelligent-bio-solutions-reports-fiscal-third-quarter-revenue-up-46/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-05-13weekly0.7 https://aibio.space/news/biomx-sets-up-2-000-000-credit-line-mandragola-12-percent-notes/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-05-13weekly0.7 https://aibio.space/news/armata-pharmaceuticals-takes-25-million-secured-loan-innoviva/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-05-13weekly0.7 https://aibio.space/news/armata-pharmaceuticals-signs-25-million-secured-loan-innoviva-14-0/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-05-13weekly0.7 https://aibio.space/news/whitehawk-therapeutics-agrees-87-5-million-private-placement-stock/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-05-13weekly0.7 https://aibio.space/news/allogene-cites-200-4-million-gross-proceeds-april-offering-runway-2029/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-05-13weekly0.7 https://aibio.space/news/fractyl-posts-first-quarter-profit-warrant-revaluation-cash-falls-63/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-05-12weekly0.7 https://aibio.space/news/mirum-prices-600-million-0-percent-convertible-notes-refinances-2029/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-05-12weekly0.7 https://aibio.space/news/nuwellis-reports-26-percent-first-quarter-revenue-growth-70-1-percent/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-05-12weekly0.7 https://aibio.space/news/bolt-biotherapeutics-reports-first-quarter-results-23-9-million-cash/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-05-12weekly0.7 https://aibio.space/news/therapeuticsmd-reports-first-quarter-2026-results-strategic-review/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-05-12weekly0.7 https://aibio.space/news/palisade-bio-reports-first-quarter-2026-results-132-6-million-cash/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-05-12weekly0.7 https://aibio.space/news/interpace-biosciences-reports-first-quarter-revenue-9-0-million/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-05-12weekly0.7 https://aibio.space/news/mirum-proposes-600-0-million-convertible-notes-offering/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-05-12weekly0.7 https://aibio.space/news/aquestive-enters-150-million-debt-facility-oaktree/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-05-12weekly0.7 https://aibio.space/news/foxo-exchanges-series-preferred-senior-unsecured-notes/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-05-12weekly0.7 https://aibio.space/news/tempus-ai-completes-460-0-million-convertible-notes-offering/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-05-12weekly0.7 https://aibio.space/news/collegium-completes-650-million-azstarys-acquisition-funded-cash-300/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-05-12weekly0.7 https://aibio.space/news/collegium-completes-azstarys-purchase-about-650-million-raises-2026/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-05-12weekly0.7 https://aibio.space/news/travere-sells-525-million-2032-convertible-notes-buy-back-221-million/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-05-11weekly0.7 https://aibio.space/news/viridian-raises-394-million-convertible-notes-stock-repays-hercules/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-05-11weekly0.7 https://aibio.space/news/metavia-present-da-1726-data-late-breaking-poster-easl-2026/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-05-11weekly0.7 https://aibio.space/news/adial-reports-first-quarter-2026-results-ad04-business-update/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-05-11weekly0.7 https://aibio.space/news/functional-brands-lowers-series-c-preferred-conversion-price-0-1636/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-05-11weekly0.7 https://aibio.space/news/nexgel-issues-1-000-000-convertible-note-new-director-brian-j-kieser/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-05-11weekly0.7 https://aibio.space/news/aurinia-completes-kezar-life-sciences-acquisition-after-tender-offer-6/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-05-11weekly0.7 https://aibio.space/news/anavex-life-sciences-files-late-filing-notice-10-q-after-ceo/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-05-11weekly0.7 https://aibio.space/news/odyssey-therapeutics-sells-1-388-889-shares-tpg-affiliate-18-00/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-05-11weekly0.7 https://aibio.space/news/arrivent-biopharma-files-up-250-000-000-market-stock-sales/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-05-11weekly0.7 https://aibio.space/news/conexeu-sciences-registers-9-481-123-shares-resale-ahead-planned/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-05-11weekly0.7 https://aibio.space/news/puretech-health-plc-files-form-25-delist-adss-nasdaq/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-05-11weekly0.7 https://aibio.space/news/scisparc-gets-conditional-nasdaq-compliance-letter-stockholders-equity/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-05-11weekly0.7 https://aibio.space/news/lifeloc-borrows-500-000-chairman-cfo/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-05-08weekly0.7 https://aibio.space/news/ispecimen-prices-2-5-million-private-placement-5-12-share/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-05-08weekly0.7 https://aibio.space/news/kiora-reports-first-quarter-2026-results-runway-late-2028/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-05-08weekly0.7 https://aibio.space/news/humacyte-gets-nasdaq-minimum-bid-price-deficiency-notice-has-until/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-05-08weekly0.7 https://aibio.space/news/artiva-biotherapeutics-prices-300-0-million-offering-shares-warrants/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-05-08weekly0.7 https://aibio.space/news/nektar-therapeutics-sets-up-150-000-000-market-stock-program/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-05-08weekly0.7 https://aibio.space/news/celldex-closes-345-million-raise-guides-funding-through-2028/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-05-07weekly0.7 https://aibio.space/news/ptc-raises-2026-product-revenue-guidance-after-first-quarter/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-05-07weekly0.7 https://aibio.space/news/quoin-reports-first-quarter-2026-results-fda-meeting-outcome/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-05-07weekly0.7 https://aibio.space/news/leonabio-reports-first-quarter-2026-results-elaine-3-amendment/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-05-07weekly0.7 https://aibio.space/news/revelation-biosciences-reports-first-quarter-2026-net-loss-3-0-million/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-05-07weekly0.7 https://aibio.space/news/in8bio-reports-first-quarter-2026-results-glioblastoma-survival/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-05-07weekly0.7 https://aibio.space/news/bluejay-gives-first-quarter-2026-corporate-update/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-05-07weekly0.7 https://aibio.space/news/oragenics-signs-letter-intent-license-cardiodialysis-tbi/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-05-07weekly0.7 https://aibio.space/news/aim-immunotech-arranges-warrant-inducement-through-ladenburg-thalmann/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-05-07weekly0.7 https://aibio.space/news/intensity-therapeutics-reports-q1-2026-results-enrollment-plans/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-05-07weekly0.7 https://aibio.space/news/gelteq-agrees-up-3-5-million-convertible-note-financing/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-05-07weekly0.7 https://aibio.space/news/capricor-sues-nippon-shinyaku-ns-pharma-deramiocel-u-s-distribution/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-05-07weekly0.7 https://aibio.space/news/arcturus-therapeutics-reports-213-4-million-cash-sees-runway-past-q2/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-05-07weekly0.7 https://aibio.space/news/structure-therapeutics-raises-market-limit-400-000-000/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-05-07weekly0.7 https://aibio.space/news/tg-therapeutics-raises-briumvi-sales-guidance-widens-buyback-300/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-05-06weekly0.7 https://aibio.space/news/inmed-reports-third-quarter-results-3-0-million-net-loss/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-05-06weekly0.7 https://aibio.space/news/aptevo-reports-87-percent-clinical-benefit-frontline-aml-through/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-05-06weekly0.7 https://aibio.space/news/viridian-completes-250-000-000-convertible-notes-offering/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-05-06weekly0.7 https://aibio.space/news/citius-oncology-prices-11-5-million-warrant-inducement-signs-avenue/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-05-06weekly0.7 https://aibio.space/news/citius-oncology-announces-up-36-5-million-loan-warrant-financing/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-05-06weekly0.7 https://aibio.space/news/inflarx-prices-150-000-000-share-offering-2-00-closes-day-later/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-05-06weekly0.7 https://aibio.space/news/exelixis-authorizes-another-750-million-buyback-first-quarter-revenue/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-05-05weekly0.7 https://aibio.space/news/theriva-reports-q1-2026-results-fda-agreement-phase-3-design/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-05-05weekly0.7 https://aibio.space/news/q32-bio-reports-q1-2026-results-first-patient-dosed-part-b-extension/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-05-05weekly0.7 https://aibio.space/news/minerva-reports-first-quarter-2026-results-starts-phase-3-trial/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-05-05weekly0.7 https://aibio.space/news/apimeds-pharmaceuticals-appoints-sungjoon-chae-co-chief-executive/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-05-05weekly0.7 https://aibio.space/news/ocugen-plans-115-million-convertible-senior-notes-offering/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-05-05weekly0.7 https://aibio.space/news/travere-proposes-400-million-convertible-notes-offering/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-05-05weekly0.7 https://aibio.space/news/pasithea-names-kartik-krishnan-chief-medical-officer/https://aibio.space/assets/img/a-researcher-pipetting-at-a-laboratory-bench-o00-1400.webp2026-05-04weekly0.7 https://aibio.space/news/lexicon-signs-up-100-million-loan-hercules-capital/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-05-04weekly0.7 https://aibio.space/news/cns-pharmaceuticals-agrees-about-22-5-million-private-placement-pre/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-05-04weekly0.7 https://aibio.space/news/lisata-kuva-labs-delay-tender-offer-start-may-29-kuva-pay-up-1-1/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-05-04weekly0.7 https://aibio.space/news/aura-biosciences-agrees-repurchase-matrix-capitals-6-922-870-shares-5/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-05-04weekly0.7 https://aibio.space/news/gyre-therapeutics-completes-all-stock-acquisition-cullgen-valued-about/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-05-04weekly0.7 https://aibio.space/news/rallybio-receive-50-000-000-fee-after-candid-ends-merger/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-05-03weekly0.7 https://aibio.space/news/cero-sells-convertible-note-500-000-face-value-keystone/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-05-01weekly0.7 https://aibio.space/news/shuttle-pharmaceuticals-agrees-merge-united-dogecoin/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-05-01weekly0.7 https://aibio.space/news/alphatec-signs-175-0-million-term-loan-125-0-million-revolver/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-05-01weekly0.7 https://aibio.space/news/veradermics-raises-about-472-million-100-share-follow-warrant-sale/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-05-01weekly0.7 https://aibio.space/news/senti-biosciences-agrees-sell-10-0-million-secured-convertible-notes/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-05-01weekly0.7 https://aibio.space/news/cue-biopharma-licenses-ascendant-221-ascendant-health-pay-15-0-million/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-05-01weekly0.7 https://aibio.space/news/hemab-therapeutics-holdings-prices-301-500-000-ipo-18-00-share/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-05-01weekly0.7 https://aibio.space/news/regentis-biomaterials-files-sell-3-333-334-shares-assumed-3-00/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-05-01weekly0.7 https://aibio.space/news/seaport-therapeutics-prices-ipo-14-160-000-shares-18-00/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-05-01weekly0.7 https://aibio.space/news/enveric-corrects-reverse-split-maximum-proxy-materials-1-15/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-04-30weekly0.7 https://aibio.space/news/cocrystal-presents-cdi-988-norovirus-data-icar-2026/https://aibio.space/assets/img/dna-sequencing-1400.webp2026-04-30weekly0.7 https://aibio.space/news/pds-biotechnology-agrees-sell-6-000-000-promissory-note/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-04-30weekly0.7 https://aibio.space/news/clearmind-amends-convertible-note-deal-leaving-10-million-available/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-04-30weekly0.7 https://aibio.space/news/perrigo-completes-sale-dermacosmetics-business-karo-305-6-million-cash/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-04-30weekly0.7 https://aibio.space/news/addex-therapeutics-files-late-filing-notice-2025-annual-report-form-20/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-04-30weekly0.7 https://aibio.space/news/avalyn-pharma-prices-ipo-16-666-667-shares-18-00/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-04-30weekly0.7 https://aibio.space/news/rockwell-medical-put-reverse-stock-split-vote-june-12-2026-meeting/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-04-30weekly0.7 https://aibio.space/news/tiziana-life-sciences-files-late-filing-notice-2025-annual-report-form/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-04-30weekly0.7 https://aibio.space/news/valneva-prices-37-million-private-placement-shares-attached-warrants/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-04-30weekly0.7 https://aibio.space/news/xtl-biopharmaceuticals-cannot-file-2025-form-20-f-citing-subsidiary/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-04-30weekly0.7 https://aibio.space/news/osr-health-licenses-vxm01-bcm-europe-up-815-million/https://aibio.space/assets/img/pipetting-into-a-multi-well-plate-c001-1400.webp2026-04-29weekly0.7 https://aibio.space/news/autolus-therapeutics-cut-about-13-percent-workforce-expects-about-8/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-04-29weekly0.7 https://aibio.space/news/autolus-therapeutics-cuts-about-13-percent-staff-targets-15-million/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-04-29weekly0.7 https://aibio.space/news/cormedix-asks-holders-ratify-past-changes-preferred-stock-terms/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-04-29weekly0.7 https://aibio.space/news/jyong-biotech-files-late-filing-notice-2025-annual-report-form-20/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-04-29weekly0.7 https://aibio.space/news/puretech-delist-adss-nasdaq-keep-primary-london-listing/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-04-29weekly0.7 https://aibio.space/news/soligenix-flash-2-trial-recommended-halt-futility/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-04-28weekly0.7 https://aibio.space/news/citius-oncology-gets-nasdaq-minimum-bid-price-deficiency-notice-has/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-04-28weekly0.7 https://aibio.space/news/avalo-therapeutics-agrees-pay-2-25-million-option-15-million-almatabio/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-04-28weekly0.7 https://aibio.space/news/inflarx-regains-nasdaq-bid-price-compliance/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-04-28weekly0.7 https://aibio.space/news/inmed-cuts-exercise-price-preferred-investment-options-0-80/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-04-27weekly0.7 https://aibio.space/news/evofem-signs-exclusive-solosec-distribution-deal-sub-saharan-africa/https://aibio.space/assets/img/removing-dna-from-a-microtube-with-a-pipette-c002-1400.webp2026-04-27weekly0.7 https://aibio.space/news/scienture-closes-8-million-note-purchase-streeterville-capital/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-04-27weekly0.7 https://aibio.space/news/ligand-pharmaceuticals-signs-merger-agreement-acquire-xoma-royalty-39/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-04-27weekly0.7 https://aibio.space/news/organon-agrees-acquired-sun-pharma-14-00-share-cash/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-04-27weekly0.7 https://aibio.space/news/intellia-therapeutics-proposes-150-000-000-stock-offering-prices-10-75/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-04-27weekly0.7 https://aibio.space/news/aspira-womens-health-names-john-strahley-chief-financial-officer/https://aibio.space/assets/img/a-researcher-pipetting-in-a-biology-laboratory-c003-1400.webp2026-04-26weekly0.7 https://aibio.space/news/onconetix-directors-oakley-meier-resign-dorf-named-chairman/https://aibio.space/assets/img/scientists-in-protective-clothing-working-in-a-cleanroom-o01-1400.webp2026-04-24weekly0.7 https://aibio.space/news/ispecimen-plans-1-40-reverse-stock-split-effective-april-27-2026/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-04-24weekly0.7 https://aibio.space/news/telomir-pharmaceuticals-completes-acquisition-teli-pharmaceuticals-34/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-04-24weekly0.7 https://aibio.space/news/citius-pharmaceuticals-prices-5-million-registered-direct-offering-0/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-04-24weekly0.7 https://aibio.space/news/lakewood-amedex-files-prospectus-nasdaq-direct-listing-4-689-177/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-04-23weekly0.7 https://aibio.space/news/amneal-agrees-acquire-kashiv-biosciences-375-000-000-cash-28-942-108/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-04-22weekly0.7 https://aibio.space/news/tevogen-bio-holdings-now-tevogen-inc-gets-two-nasdaq-deficiency/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-04-22weekly0.7 https://aibio.space/news/apimeds-pharmaceuticals-gets-nyse-american-late-filing-notice-2025/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-04-22weekly0.7 https://aibio.space/news/altimmune-launches-stock-warrant-offering-later-prices-3-00/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-04-22weekly0.7 https://aibio.space/news/cue-biopharma-sets-1-30-reverse-stock-split-april-23-2026/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-04-22weekly0.7 https://aibio.space/news/maze-therapeutics-prices-150-million-stock-pre-funded-warrant-offering/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-04-22weekly0.7 https://aibio.space/news/galera-obsidian-therapeutics-merger-moves-forward-gazelle-parent-s-4/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-04-22weekly0.7 https://aibio.space/news/hepion-raises-700-000-common-stock-private-placement/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-04-21weekly0.7 https://aibio.space/news/casi-pharmaceuticals-says-2025-form-20-f-late-expects-going-concern/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-04-21weekly0.7 https://aibio.space/news/oruka-therapeutics-substitutes-selling-stockholder-resale-prospectus/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-04-21weekly0.7 https://aibio.space/news/lilly-end-rigel-ocadusertib-license-effective-june-15-2026/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-04-21weekly0.7 https://aibio.space/news/spruce-biosciences-announces-proposed-underwritten-public-offering/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-04-20weekly0.7 https://aibio.space/news/semnur-terminates-two-share-purchase-agreements-tied-2025-merger/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-04-20weekly0.7 https://aibio.space/news/first-tracks-biotherapeutics-begins-nasdaq-trading-after-anaptysbio/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-04-20weekly0.7 https://aibio.space/news/dare-bioscience-closes-sale-20-000-units-regulation-preferred-stock/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-04-20weekly0.7 https://aibio.space/news/igc-pharma-sells-promissory-notes-firstfire-vanquish-funding-307-000/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-04-20weekly0.7 https://aibio.space/news/anaptysbio-completes-spin-off-first-tracks-biotherapeutics/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-04-20weekly0.7 https://aibio.space/news/kailera-therapeutics-completes-ipo-718-8-million-gross-proceeds-16-00/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-04-20weekly0.7 https://aibio.space/news/anaptysbio-completes-spin-off-first-tracks-biotherapeutics/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-04-20weekly0.7 https://aibio.space/news/an2-therapeutics-sets-up-80-000-000-share-sales-program-jefferies/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-04-20weekly0.7 https://aibio.space/news/first-tracks-biotherapeutics-begins-nasdaq-trading-trax-180-million/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-04-20weekly0.7 https://aibio.space/news/theriva-present-virage-trial-biomarker-data-aacr-2026/https://aibio.space/assets/img/laboratory-flasks-filled-with-white-solution-o06-1400.webp2026-04-17weekly0.7 https://aibio.space/news/emergent-biosolutions-closes-150-million-term-loan-orbimed-cuts-abl/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-04-17weekly0.7 https://aibio.space/news/alamar-biosciences-prices-ipo-11-250-000-shares-17-00-each/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-04-17weekly0.7 https://aibio.space/news/emergent-biosolutions-draws-150-million-orbimed-term-loan-repays-prior/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-04-17weekly0.7 https://aibio.space/news/kailera-therapeutics-prices-ipo-39-062-500-shares-16-00/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-04-17weekly0.7 https://aibio.space/news/odyssey-therapeutics-files-ipo-plans-nasdaq-capital-market-listing/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-04-17weekly0.7 https://aibio.space/news/emmaus-appoints-henry-du-board-audit-committee/https://aibio.space/assets/img/a-compound-microscope-with-its-objective-lenses-o13-1400.webp2026-04-16weekly0.7 https://aibio.space/news/oncotelic-reports-249-0-million-2025-profit-non-cash-joint-venture/https://aibio.space/assets/img/an-optical-research-setup-with-lenses-and-lasers-o07-1400.webp2026-04-16weekly0.7 https://aibio.space/news/enveric-announces-up-13-9-million-private-placement-priced-market/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-04-16weekly0.7 https://aibio.space/news/acurx-pharmaceuticals-prices-2-5-million-registered-direct-offering/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-04-16weekly0.7 https://aibio.space/news/achieve-life-sciences-agrees-180-million-private-placement-ceo-richard/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-04-16weekly0.7 https://aibio.space/news/meiragtx-buys-xlrp-gene-therapy-rights-janssen-25-000-000-upfront/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-04-16weekly0.7 https://aibio.space/news/altimmune-holders-approve-doubling-authorized-shares-400-000-000/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-04-16weekly0.7 https://aibio.space/news/meiragtx-agrees-buy-bota-vec-johnson-johnson-25-million-upfront/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-04-16weekly0.7 https://aibio.space/news/trevi-therapeutics-prices-150-million-stock-offering-13-00-share/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-04-16weekly0.7 https://aibio.space/news/traws-pharma-reports-2025-results-completes-up-60-million-pipe/https://aibio.space/assets/img/laboratory-equipment-and-glassware-c005-1400.webp2026-04-15weekly0.7 https://aibio.space/news/mustang-bio-receives-nasdaq-bid-price-deficiency-notice/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-04-15weekly0.7 https://aibio.space/news/cosmos-health-reports-2025-revenue-65-3-million-up-20-percent/https://aibio.space/assets/img/laboratory-equipment-in-a-chemistry-classroom-c006-1400.webp2026-04-15weekly0.7 https://aibio.space/news/wave-life-sciences-plans-move-parent-company-singapore-delaware/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-04-15weekly0.7 https://aibio.space/news/pelthos-ceo-attend-investor-meetings-piper-sandler-symposium-boston/https://aibio.space/assets/img/old-laboratory-glassware-in-a-display-case-c008-1400.webp2026-04-14weekly0.7 https://aibio.space/news/telix-pharmaceuticals-prices-upsized-us-600-million-convertible-bonds/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-04-14weekly0.7 https://aibio.space/news/oragenics-doses-first-patient-phase-iia-concussion-trial/https://aibio.space/assets/img/the-eyepieces-of-a-laboratory-microscope-o14-1400.webp2026-04-13weekly0.7 https://aibio.space/news/hepion-signs-separation-agreement-former-ceo-kaouthar-lbiati/https://aibio.space/assets/img/a-researcher-at-a-microscope-workstation-o15-1400.webp2026-04-13weekly0.7 https://aibio.space/news/imagenebio-agrees-sell-pre-funded-warrants-about-30-million-private/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-04-13weekly0.7 https://aibio.space/news/cue-biopharma-holders-approve-reverse-split-range-1-30-1-50/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-04-13weekly0.7 https://aibio.space/news/aim-immunotech-amends-market-sales-agreement-maxim-group/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-04-10weekly0.7 https://aibio.space/news/evofem-amends-adjuvant-convertible-note-terms-payment-date/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-04-10weekly0.7 https://aibio.space/news/hemab-therapeutics-holdings-files-ipo-plans-nasdaq-listing-coag/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-04-10weekly0.7 https://aibio.space/news/seaport-therapeutics-files-ipo-plans-nasdaq-listing-sptx/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-04-10weekly0.7 https://aibio.space/news/theriva-special-meeting-fails-quorum-new-meeting-called/https://aibio.space/assets/img/researchers-loading-samples-into-an-automated-instrument-p051-1400.webp2026-04-09weekly0.7 https://aibio.space/news/alaunos-receives-nasdaq-notice-stockholders-equity-requirement/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-04-09weekly0.7 https://aibio.space/news/kyntra-bio-gets-nasdaq-deficiency-notice-50-million-total-assets/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-04-09weekly0.7 https://aibio.space/news/gossamer-bio-receives-nasdaq-minimum-bid-price-deficiency-notice-has/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-04-09weekly0.7 https://aibio.space/news/an2-therapeutics-sets-up-80-million-market-program-jefferies/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-04-09weekly0.7 https://aibio.space/news/ensysce-biosciences-closes-2-million-series-b-preferred-stock-warrant/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-04-08weekly0.7 https://aibio.space/news/avalyn-pharma-files-ipo-plans-nasdaq-global-market-listing-avln/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-04-08weekly0.7 https://aibio.space/news/phio-pharmaceuticals-sets-up-6-360-000-market-program/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-04-08weekly0.7 https://aibio.space/news/adial-grants-restricted-stock-awards-executives-directors/https://aibio.space/assets/img/a-sample-tube-held-up-to-the-light-o16-1400.webp2026-04-07weekly0.7 https://aibio.space/news/protagenic-end-chief-financial-officers-employment-april-30-2026/https://aibio.space/assets/img/chemistry-glassware-in-a-black-and-white-photograph-p057-1400.webp2026-04-07weekly0.7 https://aibio.space/news/aquabounty-exchanges-4-000-000-senior-notes-preferred-stock/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-04-07weekly0.7 https://aibio.space/news/artelo-regains-nasdaq-listing-compliance-under-one-year-panel-monitor/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-04-07weekly0.7 https://aibio.space/news/supernus-acquires-navitors-nv-5138-assets-study-pledge-up-350-million/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-04-07weekly0.7 https://aibio.space/news/kiora-pharmaceuticals-closes-private-placement-up-24-million/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-04-07weekly0.7 https://aibio.space/news/northwest-biotherapeutics-reports-october-2025-closing-advent/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-04-07weekly0.7 https://aibio.space/news/sunshine-biopharma-reports-fiscal-2025-revenue-36-3-million/https://aibio.space/assets/img/a-researcher-holding-a-rack-of-test-tubes-p058-1400.webp2026-04-06weekly0.7 https://aibio.space/news/ensysce-director-curtis-rosebraugh-resigns-board/https://aibio.space/assets/img/a-gloved-hand-holding-a-blood-collection-tube-p122-1400.webp2026-04-03weekly0.7 https://aibio.space/news/matinas-biopharma-receives-nyse-american-notice-three-equity-standards/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-04-03weekly0.7 https://aibio.space/news/lisata-kuva-labs-push-back-tender-offer-start-april-13-2026/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-04-03weekly0.7 https://aibio.space/news/entera-bio-sells-7-827-789-units-bvf-affiliated-funds-1-2775-each/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-04-03weekly0.7 https://aibio.space/news/aurinia-unit-agrees-acquire-kezar-life-sciences-tender-offer-6-955/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-04-03weekly0.7 https://aibio.space/news/aeon-biopharma-receives-additional-nyse-american-notice-stockholders/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-04-03weekly0.7 https://aibio.space/news/aardvark-therapeutics-sets-up-150-000-000-share-sales-program-piper/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-04-03weekly0.7 https://aibio.space/news/kioras-chief-development-officer-eric-daniels-depart-april-17-2026/https://aibio.space/assets/img/a-blood-sample-drawn-into-a-pipette-p123-1400.webp2026-04-02weekly0.7 https://aibio.space/news/fda-grants-fast-track-designation-cdi-988-norovirus/https://aibio.space/assets/img/test-tubes-in-racks-under-blue-light-p124-1400.webp2026-04-02weekly0.7 https://aibio.space/news/caris-life-sciences-takes-400-000-000-term-loan-blue-owl-blackstone/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-04-02weekly0.7 https://aibio.space/news/adagene-prices-us-70-0-million-offering-18-666-000-adss-us-3-75/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-04-02weekly0.7 https://aibio.space/news/cyclerion-now-korsana-biosciences-agrees-all-stock-merger-korsana-380/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-04-01weekly0.7 https://aibio.space/news/quince-therapeutics-now-irulya-therapeutics-files-nt-10-k-after-phase/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-04-01weekly0.7 https://aibio.space/news/scilex-files-nt-10-k-needs-more-time-financial-statements-including/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-04-01weekly0.7 https://aibio.space/news/china-pharma-holdings-files-nt-10-k-late-annual-report-estimates-3-19/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-04-01weekly0.7 https://aibio.space/news/apollomics-signs-2-0-million-convertible-note-chairman-ceo/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-04-01weekly0.7 https://aibio.space/news/cardiol-therapeutics-reports-31-million-raised-cash-runway-q4-2027/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-04-01weekly0.7 https://aibio.space/news/therapeuticsmd-files-late-notice-after-printer-error-left-out-auditor/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-04-01weekly0.7 https://aibio.space/news/greenwich-lifesciences-inc-files-nt-10-k-says-annual-report-will-late/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-03-31weekly0.7 https://aibio.space/news/zenas-biopharma-closes-200-000-000-convertible-senior-notes-offering/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-03-31weekly0.7 https://aibio.space/news/geovax-labs-files-nt-10-k-says-2025-annual-report-will-late/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-03-31weekly0.7 https://aibio.space/news/oramed-closes-oratech-sale-lifeward-shares-warrants-revenue-share/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-03-31weekly0.7 https://aibio.space/news/traws-pharma-files-nt-10-k-cites-financing-efforts-going-concern/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-03-31weekly0.7 https://aibio.space/news/sunshine-biopharma-files-nt-10-k-says-annual-report-will-late/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-03-31weekly0.7 https://aibio.space/news/transcode-therapeutics-files-nt-10-k-says-2025-annual-report-will-late/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-03-31weekly0.7 https://aibio.space/news/scynexis-acquires-poxels-pxl-770-8-000-000-upfront-up-188-000-000/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-03-31weekly0.7 https://aibio.space/news/northwest-biotherapeutics-says-10-k-late-advent-bioservices-accounting/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-03-31weekly0.7 https://aibio.space/news/silo-issues-2-100-000-shares-qwikagents-software-domains/https://aibio.space/assets/img/microscope-inverted-1400.webp2026-03-30weekly0.7 https://aibio.space/news/inmed-pharmaceuticals-gets-nasdaq-minimum-bid-price-deficiency-notice/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-03-30weekly0.7 https://aibio.space/news/dyadic-international-gets-nasdaq-deficiency-notice-under-rule-5550/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-03-30weekly0.7 https://aibio.space/news/kazia-reports-aud-69-46-million-cash-after-us-46-51-million-pipe-half/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-03-30weekly0.7 https://aibio.space/news/onkure-therapeutics-agrees-150-0-million-private-placement-4-15-share/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-03-30weekly0.7 https://aibio.space/news/zivo-bioscience-delist-otc-markets-file-form-15-end-sec-reporting/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-03-30weekly0.7 https://aibio.space/news/palisade-bio-sells-3-0-million-stock-affiliate-iterative-health/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-03-27weekly0.7 https://aibio.space/news/alamar-biosciences-files-ipo-plans-nasdaq-listing-almr/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-03-27weekly0.7 https://aibio.space/news/anaptysbio-board-approves-first-tracks-spin-off-set-launch-180-million/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-03-27weekly0.7 https://aibio.space/news/kailera-therapeutics-files-ipo-plans-nasdaq-listing-klra/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-03-27weekly0.7 https://aibio.space/news/satellos-bioscience-reports-us-57-2-million-february-offering-runway/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-03-27weekly0.7 https://aibio.space/news/quantum-biopharma-reports-2025-results-believes-cash-lasts-past/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-03-27weekly0.7 https://aibio.space/news/maplight-annual-report-details-200-million-series-d-preferred/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-03-26weekly0.7 https://aibio.space/news/meiragtx-extends-perceptive-notes-may-2027-agrees-redeem-25-000-000/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-03-26weekly0.7 https://aibio.space/news/upstream-bio-sets-up-150-000-000-market-stock-program-leerink/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-03-26weekly0.7 https://aibio.space/news/nkarta-sets-up-100-000-000-market-stock-program-stifel/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-03-25weekly0.7 https://aibio.space/news/zhengye-biotechnology-shareholders-approve-share-reclassification/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-03-25weekly0.7 https://aibio.space/news/indaptus-therapeutics-reports-change-control-lazar-sells-preferred/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-03-24weekly0.7 https://aibio.space/news/cytodyn-extends-two-28-5-million-convertible-notes-36-months-cuts/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-03-24weekly0.7 https://aibio.space/news/galapagos-now-lakefront-biotherapeutics-advanced-talks-gilead-ouro/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-03-24weekly0.7 https://aibio.space/news/turn-therapeutics-draws-7-million-25-million-secured-loan-avenue/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-03-23weekly0.7 https://aibio.space/news/renovorx-closes-private-placement-about-10-million-gross-proceeds/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-03-23weekly0.7 https://aibio.space/news/aardvark-therapeutics-sets-up-150-000-000-market-stock-program/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-03-23weekly0.7 https://aibio.space/news/ernexa-therapeutics-gets-nasdaq-minimum-bid-price-notice-plans-request/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-03-20weekly0.7 https://aibio.space/news/xtl-biopharmaceuticals-change-ads-ratio-400-ordinary-shares-march-25/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-03-20weekly0.7 https://aibio.space/news/skye-bioscience-gets-nasdaq-bid-price-deficiency-notice-has-until/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-03-19weekly0.7 https://aibio.space/news/chemomab-reports-2025-results-cites-fda-alignment-partner-talks/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-03-19weekly0.7 https://aibio.space/news/niagen-bioscience-raises-share-buyback-authorization-20-million/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-03-19weekly0.7 https://aibio.space/news/nucana-says-24-3-million-cash-should-fund-operations-2029/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-03-19weekly0.7 https://aibio.space/news/biodexa-change-adr-ratio-500-000-shares-one-five-reverse-adr-split/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-03-18weekly0.7 https://aibio.space/news/stoke-therapeutics-files-automatic-shelf-150-000-000-atm-prospectus/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-03-18weekly0.7 https://aibio.space/news/purple-biotech-regains-nasdaq-minimum-bid-price-compliance/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-03-17weekly0.7 https://aibio.space/news/fennec-pharmaceuticals-settles-pedmark-patent-litigation-cipla/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-03-16weekly0.7 https://aibio.space/news/talphera-closes-third-private-placement-tranche-approximately-4-1/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-03-16weekly0.7 https://aibio.space/news/acumen-pharmaceuticals-agrees-35-75-million-private-placement-3-30/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-03-16weekly0.7 https://aibio.space/news/amphastar-adds-50-million-share-buyback-program/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-03-16weekly0.7 https://aibio.space/news/cytomx-files-250-000-000-stock-offering-prices-5-300-share/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-03-16weekly0.7 https://aibio.space/news/innocan-pharma-files-us-ipo-3-750-000-units-nyse-american-listing/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-03-16weekly0.7 https://aibio.space/news/zevra-agrees-sell-sdx-portfolio-commave-therapeutics-50-million/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-03-16weekly0.7 https://aibio.space/news/corvus-pharmaceuticals-raises-market-program-200-000-000/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-03-13weekly0.7 https://aibio.space/news/scisparc-unit-neurothera-labs-buy-54-01-percent-cliniquantum-shares/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-03-12weekly0.7 https://aibio.space/news/vyne-therapeutics-now-yarrow-bioscience-gets-nasdaq-bid-price/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-03-11weekly0.7 https://aibio.space/news/xenon-prices-650-million-stock-offering-57-after-epilepsy-data/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-03-10weekly0.7 https://aibio.space/news/an2-therapeutics-agrees-about-40-million-private-placement-2-85-share/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-03-10weekly0.7 https://aibio.space/news/septerna-files-automatic-shelf-150-000-000-atm-sales-agreement/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-03-10weekly0.7 https://aibio.space/news/relmada-therapeutics-agrees-approximately-160-0-million-private/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-03-09weekly0.7 https://aibio.space/news/longeveron-tells-nasdaq-lacks-audit-committee-financial-expert-after/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-03-09weekly0.7 https://aibio.space/news/dianthus-launches-400-000-000-stock-offering-then-prices-81-00-share/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-03-09weekly0.7 https://aibio.space/news/engene-holdings-now-engene-therapeutics-sets-up-100-000-000-stock/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-03-09weekly0.7 https://aibio.space/news/korro-bio-agrees-85-million-private-placement-led-venrock-healthcare/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-03-09weekly0.7 https://aibio.space/news/genentech-end-xencor-collaboration-license-agreement-september-4-2026/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-03-09weekly0.7 https://aibio.space/news/inmed-pharmaceuticals-wind-down-baymedica-only-revenue-generating/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-03-06weekly0.7 https://aibio.space/news/eupraxia-pharmaceuticals-reports-closing-us-63-2-million-public/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-03-06weekly0.7 https://aibio.space/news/nurix-therapeutics-lifts-market-program-total-413-65-million/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-03-06weekly0.7 https://aibio.space/news/solid-biosciences-agrees-240-0-million-private-placement-5-61-share/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-03-06weekly0.7 https://aibio.space/news/contineum-therapeutics-amends-share-sales-deal-registers-up-100/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-03-05weekly0.7 https://aibio.space/news/evaxion-says-cash-funds-operations-second-half-2027/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-03-05weekly0.7 https://aibio.space/news/mediwound-reports-53-6-million-cash-after-30-0-million-registered/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-03-05weekly0.7 https://aibio.space/news/regen-biopharma-issues-77-849-847-shares-settle-convertible-debt/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-03-04weekly0.7 https://aibio.space/news/arbutus-genevant-settle-moderna-lnp-patent-litigation-950-0-million/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-03-03weekly0.7 https://aibio.space/news/china-pharma-issue-12-600-000-shares-6-93-million-patent-transfer/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-03-03weekly0.7 https://aibio.space/news/gt-biopharma-issues-non-reliance-notice-will-restate-june-september/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-03-02weekly0.7 https://aibio.space/news/gyre-therapeutics-agrees-acquire-cullgen-all-stock-deal-valued-about/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-03-02weekly0.7 https://aibio.space/news/zymeworks-enters-250-million-royalty-backed-financing-royalty-pharma/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-03-02weekly0.7 https://aibio.space/news/acrivon-ends-akoya-companion-diagnostic-agreement-takes-testing-house/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-03-02weekly0.7 https://aibio.space/news/anebulo-pharmaceuticals-files-form-15-end-sec-reporting-duties/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-03-02weekly0.7 https://aibio.space/news/belite-bio-says-completed-402-million-public-offering-adss/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-03-02weekly0.7 https://aibio.space/news/geron-files-automatic-shelf-150-000-000-atm-prospectus-td-cowen/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-03-02weekly0.7 https://aibio.space/news/sionna-therapeutics-files-automatic-shelf-250-000-000-atm-sales/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-03-02weekly0.7 https://aibio.space/news/jupiter-neurosciences-gets-two-nasdaq-notices-minimum-bid-price-market/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-02-27weekly0.7 https://aibio.space/news/indaptus-stockholders-approve-preferred-stock-conversion-reverse-split/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-02-27weekly0.7 https://aibio.space/news/atrium-therapeutics-completes-spin-off-avidity-biosciences-starts/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-02-27weekly0.7 https://aibio.space/news/altamira-therapeutics-files-form-15-end-sec-reporting-duties/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-02-27weekly0.7 https://aibio.space/news/generate-biomedicines-prices-ipo-25-000-000-shares-16-00/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-02-27weekly0.7 https://aibio.space/news/xortx-auditor-flags-going-concern-doubt-2025-financials-cash-was-864/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-02-27weekly0.7 https://aibio.space/news/viatris-expects-700-million-850-million-restructuring-charges-plans-up/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-02-26weekly0.7 https://aibio.space/news/lipocine-raises-market-program-50-000-000/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-02-26weekly0.7 https://aibio.space/news/atrium-therapeutics-spin-off-avidity-give-holders-one-share-ten/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-02-26weekly0.7 https://aibio.space/news/larimar-launches-75-0-million-stock-offering-then-prices-100-000-000/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-02-25weekly0.7 https://aibio.space/news/bicara-therapeutics-launches-150-000-000-offering-then-prices-16-00/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-02-24weekly0.7 https://aibio.space/news/regentis-biomaterials-discloses-going-concern-qualification-2025-audit/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-02-24weekly0.7 https://aibio.space/news/moonlake-amends-hercules-loan-draws-25-0-million-keeps-up-400-0/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-02-23weekly0.7 https://aibio.space/news/fortress-subsidiary-cyprium-agrees-sell-priority-review-voucher-205/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-02-23weekly0.7 https://aibio.space/news/adc-therapeutics-amends-hcr-royalty-deal-issues-warrants-9-834-776/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-02-23weekly0.7 https://aibio.space/news/vir-biotechnology-receive-335-million-astellas-vir-5500-licensing-deal/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-02-23weekly0.7 https://aibio.space/news/galapagos-now-lakefront-biotherapeutics-lowers-wind-down-cost-estimate/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-02-23weekly0.7 https://aibio.space/news/oric-pharmaceuticals-files-new-200-0-million-market-prospectus/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-02-23weekly0.7 https://aibio.space/news/vir-biotechnology-signs-335-million-astellas-deal-then-prices-stock/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-02-23weekly0.7 https://aibio.space/news/opus-genetics-closes-private-placement-series-b-preferred-stock/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-02-19weekly0.7 https://aibio.space/news/psyence-biomedical-shareholders-approve-share-consolidation-up-250-1/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-02-19weekly0.7 https://aibio.space/news/sensei-biotherapeutics-acquires-faeth-therapeutics-agrees-200-million/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-02-18weekly0.7 https://aibio.space/news/outlook-therapeutics-gets-nasdaq-minimum-bid-price-deficiency-notice/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-02-18weekly0.7 https://aibio.space/news/atossa-therapeutics-regains-nasdaq-minimum-bid-price-compliance/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-02-17weekly0.7 https://aibio.space/news/mereo-biopharma-gets-nasdaq-minimum-bid-price-deficiency-notice-adss/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-02-17weekly0.7 https://aibio.space/news/geovax-closes-registered-direct-offering-2-31-share-net-proceeds-about/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-02-17weekly0.7 https://aibio.space/news/anebulo-pharmaceuticals-files-form-25-withdraw-stock-nasdaq/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-02-17weekly0.7 https://aibio.space/news/nutriband-terminates-planned-5-million-sale-pocono-unit/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-02-13weekly0.7 https://aibio.space/news/citius-pharmaceuticals-gets-nasdaq-minimum-bid-price-notice-compliance/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-02-13weekly0.7 https://aibio.space/news/werewolf-therapeutics-cuts-64-percent-workforce-cfo-cmo-resign/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-02-13weekly0.7 https://aibio.space/news/evommune-sells-125-million-stock-privately-27-88-share/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-02-12weekly0.7 https://aibio.space/news/lunai-bioworks-receives-nasdaq-delisting-determination-minimum-bid/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2026-02-12weekly0.7 https://aibio.space/news/regenxbio-registers-up-150-000-000-share-sales-through-leerink/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-02-12weekly0.7 https://aibio.space/news/spyglass-closes-172-5-million-ipo-after-underwriters-take-full-option/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-02-09weekly0.7 https://aibio.space/news/vistagen-gets-nasdaq-minimum-bid-price-deficiency-notice-until-august/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-02-06weekly0.7 https://aibio.space/news/agomab-therapeutics-prices-ipo-12-500-000-adss-16-00/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-02-06weekly0.7 https://aibio.space/news/anebulo-pharmaceuticals-delist-nasdaq-deregister-sec/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-02-06weekly0.7 https://aibio.space/news/veradermics-completes-294-8-million-ipo-full-overallotment-exercise/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-02-05weekly0.7 https://aibio.space/news/lb-pharmaceuticals-agrees-100-0-million-private-placement-21-17-share/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-02-05weekly0.7 https://aibio.space/news/eikon-therapeutics-prices-ipo-21-177-600-shares-18-00/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-02-05weekly0.7 https://aibio.space/news/maze-therapeutics-draws-40-0-million-under-hercules-term-loan-facility/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-02-04weekly0.7 https://aibio.space/news/generate-biomedicines-files-ipo-plans-nasdaq-listing-genb/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-02-04weekly0.7 https://aibio.space/news/maze-therapeutics-signs-hercules-loan-up-200-0-million-draws-40-0/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2026-02-04weekly0.7 https://aibio.space/news/replimune-amends-hercules-loan-draws-35-million-delays-repayment/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-02-03weekly0.7 https://aibio.space/news/amneal-cuts-term-loan-margin-50-basis-points-estimates-11-million/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-02-03weekly0.7 https://aibio.space/news/perspective-therapeutics-prices-175-million-stock-pre-funded-warrant/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-02-03weekly0.7 https://aibio.space/news/polaryx-begins-nasdaq-trading-through-direct-listing/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2026-02-02weekly0.7 https://aibio.space/news/umeworld-formerly-umeworld-limited-says-10-q-late-after-auditor/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2026-02-02weekly0.7 https://aibio.space/news/alx-oncology-raises-150-million-1-57-share-led-ra-capital-tcgx/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-01-30weekly0.7 https://aibio.space/news/tenaya-therapeutics-gets-nasdaq-minimum-bid-price-notice-has-until/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2026-01-30weekly0.7 https://aibio.space/news/bgm-group-files-late-notice-20-f-xy-management-acquisition-accounting/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2026-01-30weekly0.7 https://aibio.space/news/biomarin-prices-850-million-5-5-percent-notes-help-fund-4-8-billion/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-01-29weekly0.7 https://aibio.space/news/aprea-therapeutics-agrees-5-6-million-private-placement-priced-market/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-01-29weekly0.7 https://aibio.space/news/altimmune-agrees-75-million-registered-direct-offering-one-new/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-01-28weekly0.7 https://aibio.space/news/savara-amends-hercules-loan-agreement-resets-draw-terms-up-75-million/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-01-27weekly0.7 https://aibio.space/news/vivani-medical-prices-4-5-million-stock-offering-chairmans-affiliate/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-01-27weekly0.7 https://aibio.space/news/indivior-plc-now-indivior-pharmaceuticals-inc-completes/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-01-26weekly0.7 https://aibio.space/news/4d-molecular-swaps-common-stock-pre-funded-warrants-ra-capital-bvf/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-01-26weekly0.7 https://aibio.space/news/larimar-therapeutics-exchange-2-500-000-common-shares-series-preferred/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-01-22weekly0.7 https://aibio.space/news/larimar-swaps-2-500-000-common-shares-250-000-series-preferred-blue/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-01-22weekly0.7 https://aibio.space/news/bioage-sells-115-million-stock-19-50-after-nlrp3-pill-cuts-crp-86/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-01-21weekly0.7 https://aibio.space/news/aeon-biopharma-completes-daewoong-note-exchange-issuing-11-918-380/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2026-01-21weekly0.7 https://aibio.space/news/engene-holdings-now-engene-therapeutics-expands-hercules-loan-up-125/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-01-21weekly0.7 https://aibio.space/news/umeworld-begins-trading-otc-markets-umew-after-move-delaware/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2026-01-21weekly0.7 https://aibio.space/news/gri-bio-says-nasdaq-found-conditionally-regained-stockholders-equity/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2026-01-16weekly0.7 https://aibio.space/news/agenus-completes-75-0-million-manufacturing-asset-sale-zydus-16-0/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2026-01-16weekly0.7 https://aibio.space/news/nrx-pharmaceuticals-gets-nasdaq-notice-missing-annual-meeting-deadline/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2026-01-16weekly0.7 https://aibio.space/news/agomab-therapeutics-files-u-s-ipo-adss-seeks-nasdaq-listing-agmb/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2026-01-16weekly0.7 https://aibio.space/news/tiziana-life-sciences-closes-8-8-million-registered-direct-offering-1/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2026-01-16weekly0.7 https://aibio.space/news/bridgebio-prices-550-million-0-75-percent-convertible-notes-refinance/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2026-01-15weekly0.7 https://aibio.space/news/cell-source-closes-1-875-million-convertible-note-placement-plans/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2026-01-15weekly0.7 https://aibio.space/news/briacell-prices-30-million-offering-units-warrants-through-thinkequity/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2026-01-13weekly0.7 https://aibio.space/news/polaryx-completes-one-four-reverse-stock-split-ahead-nasdaq-listing/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2026-01-12weekly0.7 https://aibio.space/news/ibio-raises-26-million-frazier-led-investors-push-obesity-antibodies/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2026-01-09weekly0.7 https://aibio.space/news/eikon-therapeutics-files-ipo-common-stock-seeks-nasdaq-listing-eikn/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-01-09weekly0.7 https://aibio.space/news/monte-rosa-upsizes-stock-sale-300-million-after-oral-nek7-degrader/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2026-01-08weekly0.7 https://aibio.space/news/genelux-sells-20-million-stock-3-share-fund-ovarian-cancer-phase-3/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2026-01-08weekly0.7 https://aibio.space/news/aktis-oncology-prices-upsized-ipo-18-raising-about-318-million/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2026-01-08weekly0.7 https://aibio.space/news/alumis-raises-300-million-day-after-psoriasis-pill-beats-placebo/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2026-01-07weekly0.7 https://aibio.space/news/curis-raises-20-2-million-up-front-pipe-could-bring-up-80-8-million/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2026-01-07weekly0.7 https://aibio.space/news/propanc-biopharma-gets-nasdaq-minimum-bid-price-deficiency-notice-has/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2026-01-07weekly0.7 https://aibio.space/news/arrowhead-pharmaceuticals-prices-625-000-000-0-00-percent-convertible/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2026-01-07weekly0.7 https://aibio.space/news/phathom-pharmaceuticals-prices-stock-pre-funded-warrant-offering-16-00/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2026-01-07weekly0.7 https://aibio.space/news/praxis-prices-575-million-stock-offering-260-share-ahead-two-nda/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2026-01-06weekly0.7 https://aibio.space/news/immunic-gets-extra-180-days-nasdaq-bid-price-rule-after-transfer/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2026-01-06weekly0.7 https://aibio.space/news/galecto-now-damora-therapeutics-issues-warrant-up-628-302-shares-names/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2026-01-06weekly0.7 https://aibio.space/news/igc-pharma-agrees-sell-779-997-shares-0-30-direct-offering/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2026-01-06weekly0.7 https://aibio.space/news/salarius-pharmaceuticals-now-decoy-therapeutics-gets-nasdaq-delisting-2/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2026-01-02weekly0.7 https://aibio.space/news/zura-bio-issue-8-657-402-shares-pay-7-325-000-athanor-capital-ends/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2026-01-02weekly0.7 https://aibio.space/news/fibrobiologics-gets-nasdaq-delisting-notice-bid-price-plans-request/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2026-01-02weekly0.7 https://aibio.space/news/bausch-lomb-closes-2-802-125-000-term-loan-refinancing/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2026-01-02weekly0.7 https://aibio.space/news/eledon-pharmaceuticals-swaps-4-203-764-shares-pre-funded-warrant/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2026-01-02weekly0.7 https://aibio.space/news/cybin-inc-now-helus-pharma-files-form-25-leave-nyse-american/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2026-01-02weekly0.7 https://aibio.space/news/northwest-biotherapeutics-holders-approve-raising-authorized-shares-2/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2026-01-02weekly0.7 https://aibio.space/news/climb-bio-sues-alumis-acelyrin-3-million-budoprutug-milestone-payment/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-12-31weekly0.7 https://aibio.space/news/collegium-closes-980-million-syndicated-credit-facility-truist-bank/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-12-30weekly0.7 https://aibio.space/news/arcturus-files-500-000-000-replacement-shelf-187-765-319-atm/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-12-30weekly0.7 https://aibio.space/news/collegium-closes-980-million-syndicated-credit-facility-repays/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-12-30weekly0.7 https://aibio.space/news/mesoblast-registers-resale-up-500-000-adss-issuable-warrant-exercise/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-12-30weekly0.7 https://aibio.space/news/silo-pharma-gets-second-180-days-nasdaq-meet-1-00-minimum-bid-price/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-12-29weekly0.7 https://aibio.space/news/immunitybio-adds-up-459-972-480-market-stock-program/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-12-29weekly0.7 https://aibio.space/news/cassava-sciences-now-filana-therapeutics-agrees-31-25-million-class/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-12-23weekly0.7 https://aibio.space/news/anebulo-drops-reverse-split-plan-3-50-share-self-tender-up-300-000/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-12-22weekly0.7 https://aibio.space/news/apollomics-interim-report-shows-4-398-thousand-shareholders-deficit/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-12-22weekly0.7 https://aibio.space/news/biodexa-prices-10-million-best-efforts-offering-ads-units-warrants/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-12-18weekly0.7 https://aibio.space/news/sl-science-holding-files-f-4-horizon-space-acquisition-ii-sl-bio/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-12-18weekly0.7 https://aibio.space/news/larimar-therapeutics-swaps-blue-owl-funds-2-500-000-shares-series/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-12-17weekly0.7 https://aibio.space/news/nyse-american-accepts-azitras-stockholders-equity-compliance-plan-sets/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-12-17weekly0.7 https://aibio.space/news/cadrenal-therapeutics-agrees-2-2-million-registered-direct-offering/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-12-16weekly0.7 https://aibio.space/news/lexaria-closes-registered-direct-offering-warrant-placement-about-3-5/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-12-16weekly0.7 https://aibio.space/news/geron-begins-restructuring-cutting-about-one-third-roughly-260/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-12-16weekly0.7 https://aibio.space/news/geron-begins-restructuring-cuts-about-one-third-roughly-260-employees/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-12-16weekly0.7 https://aibio.space/news/radiopharm-theranostics-files-50-000-000-ads-shelf-sets-18-900-000/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-12-16weekly0.7 https://aibio.space/news/therapeuticsmd-holders-approve-raising-authorized-common-stock-640-000/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-12-16weekly0.7 https://aibio.space/news/turn-completes-first-gem-equity-draw-4-1-million-about-3-29-share/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-12-15weekly0.7 https://aibio.space/news/pharmacyte-biotech-files-nt-10-q-quarter-ended-october-31-2025-citing/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-12-15weekly0.7 https://aibio.space/news/immunome-proposes-400-million-stock-offering-later-sets-21-50-price/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-12-15weekly0.7 https://aibio.space/news/tiziana-life-sciences-files-best-efforts-share-offering-thinkequity/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-12-12weekly0.7 https://aibio.space/news/climb-bio-agrees-swap-20-440-000-ra-capital-shares-pre-funded-warrant/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-12-11weekly0.7 https://aibio.space/news/tivic-health-systems-now-valion-bio-buys-scorpius-cdmo-assets-16-253/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-12-11weekly0.7 https://aibio.space/news/addex-amends-h-c-wainwright-atm-deal-up-3-300-000-adss/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-12-10weekly0.7 https://aibio.space/news/c4-therapeutics-registers-125-000-000-share-sales-through-td-cowen/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-12-10weekly0.7 https://aibio.space/news/evaxion-registers-up-45-527-824-ads-sales-after-public-float-passes-75/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-12-10weekly0.7 https://aibio.space/news/dyne-therapeutics-borrows-50-0-million-second-tranche-under-amended/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-12-08weekly0.7 https://aibio.space/news/fulcrum-proposes-150-0-million-stock-offering-later-upsized-175-0/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-12-08weekly0.7 https://aibio.space/news/wave-life-sciences-proposes-250-000-000-offering-then-prices-upsized/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-12-08weekly0.7 https://aibio.space/news/pharmacyte-biotech-gets-nasdaq-minimum-bid-price-deficiency-notice-has/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-12-05weekly0.7 https://aibio.space/news/intensity-therapeutics-gets-second-180-days-meet-nasdaq-minimum-bid/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-12-05weekly0.7 https://aibio.space/news/natera-closes-foresight-diagnostics-acquisition-agrees-issue-1-127-982/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-12-05weekly0.7 https://aibio.space/news/polyrizon-agrees-sell-552-269-shares-9-00-registered-direct-offering/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-12-05weekly0.7 https://aibio.space/news/crescent-biopharma-agrees-185-million-private-placement-kelun-biotech/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-12-04weekly0.7 https://aibio.space/news/baxter-closes-three-series-senior-notes-offering-about-1-99-billion/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-12-04weekly0.7 https://aibio.space/news/immuron-issue-45-472-000-shares-aud-0-07910-placement/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-12-04weekly0.7 https://aibio.space/news/gri-bio-gets-nasdaq-deficiency-notice-minimum-stockholders-equity/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-12-02weekly0.7 https://aibio.space/news/kazia-therapeutics-prices-50-0-million-private-placement-5-00-ads/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-12-02weekly0.7 https://aibio.space/news/omeros-closes-zaltenibart-sale-novo-nordisk-receives-240-0-million/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-12-01weekly0.7 https://aibio.space/news/q32-bio-sells-adx-097-akebia-therapeutics-7-0-million-upfront/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-12-01weekly0.7 https://aibio.space/news/gt-biopharma-gets-nasdaq-minimum-bid-price-notice-has-until-may-19/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-11-26weekly0.7 https://aibio.space/news/akari-therapeutics-gets-nasdaq-minimum-bid-price-deficiency-notice-has/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-11-26weekly0.7 https://aibio.space/news/metavia-gets-180-day-nasdaq-extension-may-26-2026-minimum-bid-price/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-11-26weekly0.7 https://aibio.space/news/mesoblast-holders-approve-convertible-notes-warrants-director-cova/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-11-26weekly0.7 https://aibio.space/news/polypid-raises-share-sales-program-limit-8-250-000-15-000-000/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-11-26weekly0.7 https://aibio.space/news/artelo-biosciences-gets-nasdaq-delisting-determination-stockholders/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-11-25weekly0.7 https://aibio.space/news/cumberland-pharmaceuticals-extends-pinnacle-bank-credit-line-october/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-11-24weekly0.7 https://aibio.space/news/verrica-pharmaceuticals-agrees-about-50-million-private-placement/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-11-24weekly0.7 https://aibio.space/news/anaptysbio-sues-tesaro-gsk-delaware-chancery-court-jemperli/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-11-21weekly0.7 https://aibio.space/news/moleculin-biotech-gets-nasdaq-delisting-determination-plans-hearing/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-11-21weekly0.7 https://aibio.space/news/cullinan-unit-ends-mit-license-cln-617-after-dropping-program/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-11-21weekly0.7 https://aibio.space/news/abbott-agrees-acquire-exact-sciences-105-share-cash-about-21-billion/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-11-20weekly0.7 https://aibio.space/news/harrow-completes-melt-pharmaceuticals-acquisition-approximately-4-3/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-11-18weekly0.7 https://aibio.space/news/cogent-biosciences-completes-230-000-000-offering-1-625-percent/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-11-18weekly0.7 https://aibio.space/news/bristol-myers-squibb-amends-cash-tender-offers-sets-early-settlement/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-11-18weekly0.7 https://aibio.space/news/soligenix-regains-nasdaq-stockholders-equity-compliance-after-august/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-11-18weekly0.7 https://aibio.space/news/shuttle-pharmaceuticals-believes-2-5-million-private-placement/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-11-17weekly0.7 https://aibio.space/news/biodexa-pharmaceuticals-plans-offering-up-3-377-110-ads-warrant-units/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-11-17weekly0.7 https://aibio.space/news/advanced-biomed-files-nt-10-q-says-review-september-30-2025-quarter/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-11-14weekly0.7 https://aibio.space/news/igc-pharma-subsidiary-closes-vancouver-facility-asset-sale-valued/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-11-14weekly0.7 https://aibio.space/news/nanoviricides-closes-registered-direct-offering-gross-proceeds-about-6/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-11-14weekly0.7 https://aibio.space/news/q-c-technologies-files-nt-10-q-late-filing-notice-september-2025/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-11-14weekly0.7 https://aibio.space/news/igc-pharma-unit-sold-vancouver-facility-assets-supply-rights-not-cash/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-11-14weekly0.7 https://aibio.space/news/acumen-pharmaceuticals-registers-50-000-000-share-sales-three-agents/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-11-13weekly0.7 https://aibio.space/news/black-diamond-therapeutics-files-500-000-000-replacement-shelf-150-000/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-11-13weekly0.7 https://aibio.space/news/cassava-sciences-now-filana-therapeutics-files-200-000-000-shelf-50/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-11-13weekly0.7 https://aibio.space/news/korro-bio-cuts-approximately-34-percent-workforce-restructuring-pauses/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-11-12weekly0.7 https://aibio.space/news/arcturus-therapeutics-files-nt-10-q-after-technical-error-delays-third/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-11-12weekly0.7 https://aibio.space/news/annexon-proposes-75-000-000-stock-offering-prices-shares-2-60/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-11-12weekly0.7 https://aibio.space/news/arcturus-therapeutics-10-q-gets-november-12-filing-date-after/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-11-12weekly0.7 https://aibio.space/news/cosciens-biopharma-delisted-nasdaq-september-applies-otcqb-quotation/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-11-12weekly0.7 https://aibio.space/news/precision-biosciences-prices-75-000-093-stock-warrant-offering/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-11-12weekly0.7 https://aibio.space/news/korro-bio-cuts-about-34-percent-workforce-expects-cash-runway-second/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-11-12weekly0.7 https://aibio.space/news/galecto-now-damora-therapeutics-buys-damora-agrees-about-285-million/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-11-10weekly0.7 https://aibio.space/news/lyell-immunopharma-licenses-lyl273-car-t-candidate-40-million-1-9/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-11-10weekly0.7 https://aibio.space/news/evommune-closes-nyse-ipo-10-8-million-shares-16-nets-157-0-million/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-11-07weekly0.7 https://aibio.space/news/biofrontera-sells-xepi-cream-assets-pelthos-therapeutics-gets-3/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-11-07weekly0.7 https://aibio.space/news/altimmune-expands-hercules-loan-facility-125-million-draws-20-million/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-11-06weekly0.7 https://aibio.space/news/phio-pharmaceuticals-warrant-inducement-brings-approximately-12-6/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-11-06weekly0.7 https://aibio.space/news/4d-molecular-therapeutics-prices-99-999-993-stock-offering-10-5100/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-11-06weekly0.7 https://aibio.space/news/halozyme-expands-revolver-750-000-000-proposes-two-650-million/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-11-05weekly0.7 https://aibio.space/news/absci-totient-sellers-agree-final-milestone-payout-under-2021-merger/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-11-04weekly0.7 https://aibio.space/news/prelude-therapeutics-signs-incyte-option-deal-get-35-million-cash-25/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-11-04weekly0.7 https://aibio.space/news/taysha-gene-therapies-files-new-shelf-up-200-000-000-market-prospectus/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-11-04weekly0.7 https://aibio.space/news/tscan-therapeutics-cuts-about-30-percent-workforce-66-roles-extend/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-11-03weekly0.7 https://aibio.space/news/kyverna-signs-oxford-finance-loan-facility-up-150-0-million-expects/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-11-03weekly0.7 https://aibio.space/news/ardelyx-files-automatic-shelf-100-000-000-atm-sales-agreement/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-11-03weekly0.7 https://aibio.space/news/cytodyn-secures-30-million-stock-purchase-commitment-yorkville/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-11-03weekly0.7 https://aibio.space/news/gelteq-files-late-notice-20-f-says-needs-more-time-financials/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-11-03weekly0.7 https://aibio.space/news/calidi-biotherapeutics-sells-75-percent-nova-cell-stake-6-000-000/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-10-31weekly0.7 https://aibio.space/news/4d-molecular-therapeutics-licenses-4d-150-otsuka-asia-pacific-deal-85/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-10-31weekly0.7 https://aibio.space/news/alterity-reports-54-56m-cash-after-20m-placement-quarter/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-10-31weekly0.7 https://aibio.space/news/kazia-therapeutics-says-20-f-late-audit-procedures-not-complete/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-10-31weekly0.7 https://aibio.space/news/lunai-bioworks-gets-nasdaq-deficiency-notice-35-million-market-value/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-10-30weekly0.7 https://aibio.space/news/savara-prices-130-0-million-stock-offering-4-20-share/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-10-29weekly0.7 https://aibio.space/news/maplight-ipo-closes-additional-share-option-brings-gross-proceeds-288/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-10-28weekly0.7 https://aibio.space/news/biofrontera-inc-closes-purchase-u-s-ameluz-rhodoled-rights-sells-2-5/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-10-24weekly0.7 https://aibio.space/news/enveric-biosciences-gets-nasdaq-delisting-notice-sets-1-12-reverse/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-10-23weekly0.7 https://aibio.space/news/minerva-neurosciences-agrees-80-million-private-placement-up-200/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-10-22weekly0.7 https://aibio.space/news/alkermes-agrees-buy-avadel-18-50-share-plus-cvr-jpmorgan-bridge-loan/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-10-22weekly0.7 https://aibio.space/news/alector-cuts-workforce-about-49-percent-after-latozinemab-phase-3/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-10-21weekly0.7 https://aibio.space/news/oragenics-regains-nyse-american-equity-compliance-settles-ladenburg/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-10-21weekly0.7 https://aibio.space/news/biontech-opens-exchange-offer-curevac-15-061-575-new-adss-registered/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-10-20weekly0.7 https://aibio.space/news/keros-therapeutics-starts-tender-offer-up-10-950-165-shares-17-75/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-10-20weekly0.7 https://aibio.space/news/lexeo-therapeutics-prices-public-offering-8-00-share-plus-10-million/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-10-17weekly0.7 https://aibio.space/news/medicus-pharma-sells-1-088-048-shares-yorkville-under-standby-equity/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-10-17weekly0.7 https://aibio.space/news/aspire-biopharma-holdings-now-aspire-lakewood-holdings-seeks-nasdaq/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-10-17weekly0.7 https://aibio.space/news/hcw-biologics-wins-nasdaq-panel-extension-meet-equity-rule-december-31/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-10-16weekly0.7 https://aibio.space/news/c4-therapeutics-prices-stock-warrant-offering-2-47-expects-117-0/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-10-16weekly0.7 https://aibio.space/news/kura-oncology-files-amended-2023-inducement-option-plan-3-250-000/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-10-16weekly0.7 https://aibio.space/news/quoin-closes-16-6-million-private-placement-warrants-could-add-up-88-0/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-10-15weekly0.7 https://aibio.space/news/keros-therapeutics-repurchase-10-176-595-shares-about-181-million/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-10-15weekly0.7 https://aibio.space/news/keros-agrees-buy-back-adar1-pontifax-shares-17-75-plans-tender-offer/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-10-15weekly0.7 https://aibio.space/news/allogene-discloses-factor-bioscience-patent-suit-against-licensor/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-10-14weekly0.7 https://aibio.space/news/candel-signs-trinity-capital-term-loan-up-130-0-million-draws-50-0/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-10-14weekly0.7 https://aibio.space/news/karyopharm-closes-recapitalization-9-00-percent-convertible-notes-12-5/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-10-14weekly0.7 https://aibio.space/news/cellectar-biosciences-gets-about-5-8-million-gross-warrant-inducement/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-10-10weekly0.7 https://aibio.space/news/cellectar-biosciences-raises-about-5-8-million-warrant-inducement-deal/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-10-10weekly0.7 https://aibio.space/news/xenetic-biosciences-prices-4-5-million-offering-735-000-shares-6-12/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-10-10weekly0.7 https://aibio.space/news/agenus-takes-up-10-000-000-loan-zydus-pledges-822-910-mink-shares/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-10-09weekly0.7 https://aibio.space/news/alzamend-neuro-issues-361-743-shares-conversion-series-b-preferred/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-10-09weekly0.7 https://aibio.space/news/mindwalk-authorizes-buyback-up-2-3-million-shares/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-10-09weekly0.7 https://aibio.space/news/karyopharm-agrees-debt-equity-deals-says-give-100-million-flexibility/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-10-08weekly0.7 https://aibio.space/news/lenz-therapeutics-sells-1-748-634-shares-45-75-80-000-000-block-trade/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-10-08weekly0.7 https://aibio.space/news/transcode-agrees-buy-polynoma-sell-ck-life-sciences-25-million/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-10-08weekly0.7 https://aibio.space/news/spruce-biosciences-agrees-50-0-million-private-placement-68-00-share/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-10-08weekly0.7 https://aibio.space/news/zenas-biopharma-licenses-orelabrutinib-innocare-announces-120-0/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-10-08weekly0.7 https://aibio.space/news/elutia-closes-cied-business-sale-boston-scientific-puts-8-million/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-10-07weekly0.7 https://aibio.space/news/adicet-bio-gets-until-april-6-2026-meet-nasdaq-bid-price-rule-moves/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-10-07weekly0.7 https://aibio.space/news/elutia-closes-88-million-sale-bioenvelope-business-boston-scientific/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-10-07weekly0.7 https://aibio.space/news/humacyte-prices-60-0-million-registered-direct-offering-stock-warrants/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-10-07weekly0.7 https://aibio.space/news/jade-biosciences-agrees-135-million-private-placement-9-14-share/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-10-07weekly0.7 https://aibio.space/news/biomea-fusion-prices-24-999-898-offering-stock-warrants-2-05/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-10-06weekly0.7 https://aibio.space/news/salarius-now-decoy-therapeutics-says-share-sales-lift-equity-above/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-10-06weekly0.7 https://aibio.space/news/entero-therapeutics-now-gridai-technologies-acquires-grid-ai-whose/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-10-06weekly0.7 https://aibio.space/news/werewolf-therapeutics-breaks-nasdaq-audit-committee-rule-after/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-10-06weekly0.7 https://aibio.space/news/nasdaq-files-form-25-delist-zyversa-therapeutics-common-stock/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-10-06weekly0.7 https://aibio.space/news/halozyme-signs-merger-agreement-acquire-elektrofi-750-million-cash/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-10-03weekly0.7 https://aibio.space/news/microbot-medical-holder-exercises-600-000-options-2-10-gets-series/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-10-03weekly0.7 https://aibio.space/news/ovid-therapeutics-agrees-pipe-financing-80-8-million-initial-gross/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-10-03weekly0.7 https://aibio.space/news/xilio-therapeutics-moves-nasdaq-capital-market-gets-until-march-30/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-10-03weekly0.7 https://aibio.space/news/azitra-gets-nyse-american-notice-minimum-stockholders-equity/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-10-03weekly0.7 https://aibio.space/news/abpro-holdings-faces-nasdaq-delisting-after-missing-1-00-bid-price/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-10-03weekly0.7 https://aibio.space/news/azitra-gets-nyse-american-notice-4-million-stockholders-equity/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-10-03weekly0.7 https://aibio.space/news/onconetix-sells-convertible-preferred-warrants-approximately-6-25/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-10-03weekly0.7 https://aibio.space/news/xilio-therapeutics-moves-nasdaq-capital-market-gets-180-more-days-1-00/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-10-03weekly0.7 https://aibio.space/news/bolt-biotherapeutics-cuts-workforce-about-50-percent-extends-cash/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-10-02weekly0.7 https://aibio.space/news/theriva-biologics-cuts-32-percent-workforce-expects-cash-runway-second/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-10-02weekly0.7 https://aibio.space/news/biocardia-regains-compliance-nasdaq-equity-rule/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-10-02weekly0.7 https://aibio.space/news/kala-bio-receives-oxford-finance-default-notice-lender-declares-29-1/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-10-01weekly0.7 https://aibio.space/news/jaguar-health-agrees-sell-shares-pre-funded-warrants-brown-stone-1-56/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-10-01weekly0.7 https://aibio.space/news/edesa-biotech-amends-canada-funding-deal-first-repayment-moves-2032/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-09-30weekly0.7 https://aibio.space/news/alpha-cognition-prices-34-999-052-public-offering-shares-6-25/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-09-30weekly0.7 https://aibio.space/news/artelo-biosciences-prices-1-999-984-67-offering-4-40-share/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-09-30weekly0.7 https://aibio.space/news/enanta-launches-50-000-000-stock-offering-later-prices-65-000-000/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-09-30weekly0.7 https://aibio.space/news/mira-pharmaceuticals-closes-skny-acquisition-all-stock-deal/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-09-30weekly0.7 https://aibio.space/news/kala-bio-cut-51-percent-workforce-ends-kpi-012-after-phase-2b-trial/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-09-29weekly0.7 https://aibio.space/news/sutro-biopharma-plans-cut-workforce-about-one-third-expects-cash/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-09-29weekly0.7 https://aibio.space/news/bon-natural-lifes-interim-results-reflect-1-25-share-consolidation/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-09-29weekly0.7 https://aibio.space/news/estrella-immunopharma-regains-nasdaq-compliance-bid-price-market-value/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-09-29weekly0.7 https://aibio.space/news/journey-medical-extends-swk-term-loan-maturity-june-2028-credit/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-09-26weekly0.7 https://aibio.space/news/tevogen-bio-holdings-inc-now-tevogen-inc-gets-nasdaq-minimum-bid-price/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-09-26weekly0.7 https://aibio.space/news/ani-pharmaceuticals-forces-conversion-last-series-preferred-482-320/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-09-26weekly0.7 https://aibio.space/news/longeveron-gets-nasdaq-minimum-bid-price-notice-has-until-march-23/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-09-26weekly0.7 https://aibio.space/news/adaptimmune-gets-nasdaq-panel-exception-until-december-1-2025-fix-bid/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-09-26weekly0.7 https://aibio.space/news/fractyl-health-prices-60-million-stock-offering-1-00-share/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-09-26weekly0.7 https://aibio.space/news/longeveron-gets-nasdaq-notice-trading-below-1-00-minimum-bid-price/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-09-26weekly0.7 https://aibio.space/news/q-c-technologies-formerly-tnf-pharmaceuticals-starts-trading-qcls/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-09-26weekly0.7 https://aibio.space/news/alzamend-neuro-issues-300-000-shares-conversion-series-b-preferred/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-09-25weekly0.7 https://aibio.space/news/silexion-therapeutics-regains-nasdaq-equity-bid-price-compliance/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-09-25weekly0.7 https://aibio.space/news/curanex-repays-400-000-loans-ceos-wife-weeks-after-ipo/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-09-24weekly0.7 https://aibio.space/news/uniqure-amends-hercules-term-loan-draws-50-million-refinance-debt/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-09-24weekly0.7 https://aibio.space/news/biocardia-believes-regained-nasdaq-stockholders-equity-compliance/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-09-24weekly0.7 https://aibio.space/news/immuneering-prices-offering-9-23-share-sanofi-unit-buy-25-0-million/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-09-24weekly0.7 https://aibio.space/news/pepgen-prices-100-000-000-public-offering-31-250-000-shares-3-200/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-09-24weekly0.7 https://aibio.space/news/allarity-therapeutics-agrees-2-5-million-private-placement-7-5-million/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-09-22weekly0.7 https://aibio.space/news/cytokinetics-issues-750-0-million-1-75-percent-convertible-senior/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-09-22weekly0.7 https://aibio.space/news/allarity-therapeutics-agrees-2-5-million-private-placement-7-5-million/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-09-22weekly0.7 https://aibio.space/news/bioatla-wins-nasdaq-panel-extension-deadlines-fix-price-equity-gaps/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-09-22weekly0.7 https://aibio.space/news/mbx-biosciences-files-10-000-000-share-offering-later-sells-11-108-055/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-09-22weekly0.7 https://aibio.space/news/oruka-therapeutics-announces-180-million-private-placement-led-viking/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-09-22weekly0.7 https://aibio.space/news/equillium-expands-market-stock-program-up-75-000-000/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-09-19weekly0.7 https://aibio.space/news/igc-pharma-files-sell-up-11-309-229-stock-market/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-09-19weekly0.7 https://aibio.space/news/longeveron-sets-up-10-700-000-market-stock-program-h-c-wainwright/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-09-19weekly0.7 https://aibio.space/news/prelude-therapeutics-regains-compliance-nasdaq-1-00-minimum-bid-price/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-09-19weekly0.7 https://aibio.space/news/soligenix-prices-7-5-million-public-offering-shares-warrants-1-35/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-09-19weekly0.7 https://aibio.space/news/vaxart-delisted-nasdaq-after-missing-hearings-panel-conditions/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-09-19weekly0.7 https://aibio.space/news/jasper-therapeutics-prices-30-million-offering-stock-warrants/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-09-18weekly0.7 https://aibio.space/news/medicus-pharma-issues-8-0-million-debenture-yorkville-fund/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-09-18weekly0.7 https://aibio.space/news/nasdaq-complete-delisting-zyversa-therapeutics-stock-form-25-filing/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-09-18weekly0.7 https://aibio.space/news/arvinas-cut-about-15-percent-staff-seek-vepdegestrant-partner-approves/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-09-17weekly0.7 https://aibio.space/news/x4-pharmaceuticals-cuts-workforce-50-percent-restructuring-four-senior/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-09-17weekly0.7 https://aibio.space/news/aquabounty-regains-compliance-nasdaq-1-00-minimum-bid-price-rule/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-09-17weekly0.7 https://aibio.space/news/arvinas-cuts-about-15-percent-staff-authorizes-100-million-buyback/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-09-17weekly0.7 https://aibio.space/news/neuphoria-therapeutics-gets-nasdaq-extension-december-29-2025-hold/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-09-16weekly0.7 https://aibio.space/news/biocardia-files-best-efforts-stock-warrant-offering-later-prices-1-25/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-09-16weekly0.7 https://aibio.space/news/bio-green-med-solution-preferred-stock-falls-short-nasdaq-1-million/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-09-16weekly0.7 https://aibio.space/news/microbot-medical-expects-25-2-million-first-closing-option-exercises/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-09-16weekly0.7 https://aibio.space/news/ovid-therapeutics-regains-compliance-nasdaq-1-00-bid-price-rule/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-09-16weekly0.7 https://aibio.space/news/relmada-therapeutics-regains-compliance-nasdaq-1-00-bid-price-rule/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-09-16weekly0.7 https://aibio.space/news/revelation-biosciences-gets-9-6-million-gross-proceeds-warrant/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-09-15weekly0.7 https://aibio.space/news/revelation-biosciences-agrees-9-6-million-immediate-warrant-exercise/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-09-15weekly0.7 https://aibio.space/news/benitec-biopharma-says-two-quarterly-financial-reports-should-not/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-09-12weekly0.7 https://aibio.space/news/vyne-therapeutics-now-yarrow-bioscience-gets-nasdaq-minimum-bid-price/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-09-12weekly0.7 https://aibio.space/news/traws-pharma-buys-antiviral-compound-assets-related-party-viriom-2-350/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-09-12weekly0.7 https://aibio.space/news/cocrystal-pharma-prices-4-7-million-direct-offering-1-70-share/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-09-12weekly0.7 https://aibio.space/news/curanex-pharmaceuticals-raises-2-250-000-more-ipo-underwriters/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-09-12weekly0.7 https://aibio.space/news/lb-pharmaceuticals-prices-ipo-19-000-000-shares-15-00/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-09-12weekly0.7 https://aibio.space/news/nrx-pharmaceuticals-completes-acquisition-dura-medical-clinics-through/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-09-12weekly0.7 https://aibio.space/news/pluri-regains-nasdaq-audit-committee-compliance-after-naming/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-09-12weekly0.7 https://aibio.space/news/silexion-therapeutics-prices-6-0-million-offering-4-00-share-warrants/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-09-12weekly0.7 https://aibio.space/news/traws-pharma-buys-antiviral-assets-viriom-2-350-000-related-party-deal/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-09-12weekly0.7 https://aibio.space/news/vyne-therapeutics-now-yarrow-bioscience-gets-nasdaq-notice-sub-1-00/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-09-12weekly0.7 https://aibio.space/news/bausch-health-completes-durect-acquisition-after-tender-offer-draws/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-09-11weekly0.7 https://aibio.space/news/tuhura-biosciences-investors-agree-buy-3-2-million-deferred-stock-now/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-09-11weekly0.7 https://aibio.space/news/sellas-life-sciences-expects-23-6-million-gross-investors-warrant/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-09-11weekly0.7 https://aibio.space/news/anixa-biosciences-files-200-000-000-replacement-shelf-100-000-000-atm/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-09-10weekly0.7 https://aibio.space/news/camp4-therapeutics-signs-private-placement-up-100-million-50-million/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-09-10weekly0.7 https://aibio.space/news/celcuity-upsizes-term-loan-facility-500-million-innovatus-oxford/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-09-10weekly0.7 https://aibio.space/news/talphera-raises-about-17-million-private-placement-cormedix-investors/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-09-10weekly0.7 https://aibio.space/news/actuate-therapeutics-prices-2-142-858-shares-7-00-15-000-006-gross/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-09-09weekly0.7 https://aibio.space/news/osr-holdings-now-osr-health-gets-nasdaq-notice-after-30-days-below-1/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-09-09weekly0.7 https://aibio.space/news/rein-therapeutics-draws-second-1-0-million-advance-yorkville/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-09-09weekly0.7 https://aibio.space/news/abivax-expects-cash-q4-2027-after-747-5-million-gross-offering/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-09-08weekly0.7 https://aibio.space/news/coherus-oncology-regains-nasdaq-compliance-1-00-minimum-bid-price-rule/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-09-08weekly0.7 https://aibio.space/news/nrx-pharmaceuticals-says-8-8-million-raise-had-no-warrants-repricing/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-09-08weekly0.7 https://aibio.space/news/pharvaris-signs-registration-rights-agreement-general-atlantic-ph/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-09-08weekly0.7 https://aibio.space/news/rapport-therapeutics-prices-250-million-stock-offering-26-00-share/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-09-08weekly0.7 https://aibio.space/news/dbv-technologies-sets-up-market-program-up-150-million-adss-nasdaq/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-09-05weekly0.7 https://aibio.space/news/fibrogen-now-kyntra-bio-completes-220-million-china-unit-sale/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-09-05weekly0.7 https://aibio.space/news/nucana-says-nasdaq-confirmed-compliance-closed-listing-matter/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-09-05weekly0.7 https://aibio.space/news/optimi-health-files-u-s-ipo-nasdaq-uplisting-canadian-exchange/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-09-05weekly0.7 https://aibio.space/news/pharmacyte-biotech-adds-3-million-stake-tnf-pharmaceuticals/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-09-05weekly0.7 https://aibio.space/news/ac-immune-cut-about-30-percent-workforce-sees-chf-127-1-million/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-09-04weekly0.7 https://aibio.space/news/bone-biologics-expects-cash-fund-operations-second-quarter-2026/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-09-04weekly0.7 https://aibio.space/news/cyclacel-now-bio-green-med-solution-swaps-series-c-warrants-559-395/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-09-04weekly0.7 https://aibio.space/news/cero-therapeutics-appeals-nasdaq-delisting-2-500-000-stockholders/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-09-04weekly0.7 https://aibio.space/news/equillium-regains-compliance-nasdaqs-1-00-minimum-bid-price-rule/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-09-04weekly0.7 https://aibio.space/news/mesoblast-signs-option-issue-up-us-50-million-convertible-notes/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-09-04weekly0.7 https://aibio.space/news/nutriband-reports-5-31-million-warrant-exercises-six-months-july-31/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-09-03weekly0.7 https://aibio.space/news/precigen-draws-100-0-million-closing-pharmakon-senior-secured-term/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-09-03weekly0.7 https://aibio.space/news/adial-pharmaceuticals-gets-180-day-nasdaq-extension-1-00-bid-price/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-09-03weekly0.7 https://aibio.space/news/celularity-regains-nasdaq-compliance-after-filing-two-late-quarterly/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-09-03weekly0.7 https://aibio.space/news/ironwood-pharmaceuticals-regains-compliance-nasdaq-1-00-bid-price-rule/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-09-03weekly0.7 https://aibio.space/news/medicus-pharma-completes-antev-acquisition-about-us-3-0-million-cash-1/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-09-02weekly0.7 https://aibio.space/news/cormedix-completes-melinta-therapeutics-acquisition-300-million/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-09-02weekly0.7 https://aibio.space/news/context-therapeutics-gets-nasdaq-extension-february-23-2026-minimum/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-09-02weekly0.7 https://aibio.space/news/zenas-biopharma-signs-royalty-financing-royalty-pharma-up-300-million/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-09-02weekly0.7 https://aibio.space/news/context-therapeutics-gets-180-more-days-nasdaq-meet-1-00-bid-price/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-09-02weekly0.7 https://aibio.space/news/mangoceuticals-sells-709-677-shares-1-55-1-100-000-private-placement/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-09-02weekly0.7 https://aibio.space/news/vtv-therapeutics-agrees-private-placement-about-80-million/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-09-02weekly0.7 https://aibio.space/news/zenas-biopharma-signs-royalty-pharma-funding-deal-worth-up-300-million/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-09-02weekly0.7 https://aibio.space/news/envoy-medical-asks-nasdaq-panel-review-delisting-determination-market/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-08-29weekly0.7 https://aibio.space/news/enveric-biosciences-gets-nasdaq-stockholders-equity-deficiency-notice/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-08-29weekly0.7 https://aibio.space/news/enveric-biosciences-falls-short-nasdaq-2-500-000-stockholders-equity/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-08-29weekly0.7 https://aibio.space/news/century-therapeutics-gets-180-more-days-meet-nasdaq-bid-price-rule/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-08-29weekly0.7 https://aibio.space/news/moleculin-biotech-raise-up-6-0-million-through-warrant-inducement-deal/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-08-29weekly0.7 https://aibio.space/news/purple-biotech-files-f-1-ads-offering-later-prices-6-million-deal-1-00/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-08-29weekly0.7 https://aibio.space/news/rallybio-moves-nasdaq-capital-market-gets-180-more-days-bid-price/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-08-29weekly0.7 https://aibio.space/news/xilio-therapeutics-gets-nasdaq-notice-stockholders-equity-below-10-0/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-08-28weekly0.7 https://aibio.space/news/imunon-regains-compliance-nasdaq-minimum-bid-price-requirement/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-08-28weekly0.7 https://aibio.space/news/journey-medical-sets-up-new-market-program-3-750-000-shares/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-08-28weekly0.7 https://aibio.space/news/imunon-regains-nasdaq-minimum-bid-price-compliance-after-hearings/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-08-28weekly0.7 https://aibio.space/news/curanex-raises-15-million-ipo-then-2-25-million-more-overallotment/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-08-27weekly0.7 https://aibio.space/news/grace-therapeutics-nda-acceptance-opens-window-up-7-6-million-warrants/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-08-27weekly0.7 https://aibio.space/news/veru-regains-compliance-nasdaq-minimum-bid-price-rule/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-08-27weekly0.7 https://aibio.space/news/indivior-plc-now-indivior-pharmaceuticals-inc-expects-39-50-million/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-08-26weekly0.7 https://aibio.space/news/briacell-plans-1-10-share-consolidation-meet-nasdaq-listing-rules/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-08-26weekly0.7 https://aibio.space/news/cognition-therapeutics-regains-compliance-nasdaq-1-00-bid-price-rule/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-08-26weekly0.7 https://aibio.space/news/plus-therapeutics-now-cerenome-wins-nasdaq-equity-nod-more-time-1-00/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-08-26weekly0.7 https://aibio.space/news/cosciens-biopharma-files-form-25-withdraw-shares-nasdaq/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-08-26weekly0.7 https://aibio.space/news/bright-minds-biosciences-files-250-000-000-shelf-100-000-000-atm/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-08-26weekly0.7 https://aibio.space/news/evofem-signs-sixth-amendment-aditxt-merger-agreement/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-08-26weekly0.7 https://aibio.space/news/shattuck-labs-closes-private-placement-up-103-million-led-orbimed/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-08-26weekly0.7 https://aibio.space/news/liminatus-pharma-gets-nasdaq-deficiency-notice-late-form-10/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-08-25weekly0.7 https://aibio.space/news/dermata-therapeutics-regains-nasdaq-compliance-after-hearing-panel/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-08-25weekly0.7 https://aibio.space/news/curis-gets-nasdaq-delisting-determination-market-value-rule-plans/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-08-22weekly0.7 https://aibio.space/news/curis-appeal-nasdaq-delisting-after-missing-35-000-000-market-value/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-08-22weekly0.7 https://aibio.space/news/iovance-restates-jefferies-market-deal-allowing-sales-up-350-0-million/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-08-22weekly0.7 https://aibio.space/news/protalix-renews-20-000-000-market-stock-program-h-c-wainwright/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-08-22weekly0.7 https://aibio.space/news/novavax-agrees-issue-225-0-million-4-625-percent-convertible-senior/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-08-21weekly0.7 https://aibio.space/news/sarepta-agrees-swap-about-700-0-million-2027-convertible-notes-sell-20/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-08-21weekly0.7 https://aibio.space/news/atossa-therapeutics-gets-180-more-days-meet-nasdaq-1-00-bid-price-rule/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-08-21weekly0.7 https://aibio.space/news/enanta-files-patent-infringement-suit-against-pfizer-paxlovid-eu/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-08-20weekly0.7 https://aibio.space/news/genprex-gets-second-nasdaq-delisting-basis-stockholders-equity/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-08-20weekly0.7 https://aibio.space/news/invivyd-prices-offering-74-811-404-shares-0-52-each/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-08-20weekly0.7 https://aibio.space/news/i-mab-now-novabridge-biosciences-cites-61-2-million-net-august/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-08-20weekly0.7 https://aibio.space/news/windtree-therapeutics-delisted-nasdaq-shares-move-otc-market/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-08-20weekly0.7 https://aibio.space/news/evogene-cuts-30-percent-workforce-reports-11-7-million-cash-18-71/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-08-19weekly0.7 https://aibio.space/news/hcw-biologics-faces-nasdaq-suspension-equity-rule-plans-request/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-08-19weekly0.7 https://aibio.space/news/unicycive-discloses-securities-class-action-oxylanthanum-carbonate/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-08-18weekly0.7 https://aibio.space/news/genprex-gets-second-nasdaq-deficiency-notice-equity-1-391-195/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-08-18weekly0.7 https://aibio.space/news/pharmacyte-biotech-agrees-7-0-million-convertible-preferred-private/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-08-18weekly0.7 https://aibio.space/news/propanc-biopharma-prices-4-million-offering-moves-nasdaq/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-08-18weekly0.7 https://aibio.space/news/cingulate-files-nt-10-q-citing-management-changes-quarter-ended-june/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-08-15weekly0.7 https://aibio.space/news/os-therapies-files-nt-10-q-late-filing-notice-second-quarter-cites/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-08-15weekly0.7 https://aibio.space/news/heron-therapeutics-adopts-rights-plan-4-99-percent-trigger-protect-tax/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-08-15weekly0.7 https://aibio.space/news/agentix-corp-says-june-quarter-report-will-late/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-08-15weekly0.7 https://aibio.space/news/cero-therapeutics-delays-q2-report-estimates-18-5-million-quarterly/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-08-15weekly0.7 https://aibio.space/news/cingulate-delays-quarterly-report-after-management-changes/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-08-15weekly0.7 https://aibio.space/news/calidi-biotherapeutics-prices-6-million-public-offering-units-2-00/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-08-15weekly0.7 https://aibio.space/news/cosmos-health-files-late-notice-june-30-2025-quarterly-report/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-08-15weekly0.7 https://aibio.space/news/hcw-biologics-delays-quarterly-report-period-ended-june-30-2025/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-08-15weekly0.7 https://aibio.space/news/heron-therapeutics-adopts-rights-plan-protect-1-37-billion-tax-losses/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-08-15weekly0.7 https://aibio.space/news/liminatus-pharma-files-late-notice-quarterly-report-june-30-2025/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-08-15weekly0.7 https://aibio.space/news/os-therapies-delays-quarterly-report-period-ended-june-30-2025/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-08-15weekly0.7 https://aibio.space/news/sigyn-therapeutics-delays-quarterly-report-period-ended-june-30-2025/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-08-15weekly0.7 https://aibio.space/news/sol-gel-reports-24-2-million-cash-expects-runway-early-2027/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-08-15weekly0.7 https://aibio.space/news/soligenix-gets-nasdaq-notice-stockholders-equity-below-2-500-000/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-08-15weekly0.7 https://aibio.space/news/cdt-equity-formerly-conduit-pharmaceuticals-says-q1-2025-financials/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-08-14weekly0.7 https://aibio.space/news/allarity-therapeutics-files-nt-10-q-says-june-30-2025-quarterly-report/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-08-14weekly0.7 https://aibio.space/news/nrx-pharmaceuticals-files-nt-10-q-says-second-quarter-form-10-q-will/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-08-14weekly0.7 https://aibio.space/news/allarity-therapeutics-delays-quarterly-report-while-auditors-finish/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-08-14weekly0.7 https://aibio.space/news/apimeds-pharmaceuticals-delays-quarterly-report-period-ended-june-30/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-08-14weekly0.7 https://aibio.space/news/aquestive-therapeutics-prices-85-000-000-stock-offering-4-00-share/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-08-14weekly0.7 https://aibio.space/news/eloxx-pharmaceuticals-lacks-funds-auditor-review-expects-0-6-million/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-08-14weekly0.7 https://aibio.space/news/goldenwell-biotech-files-late-notice-june-quarter-report/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-08-14weekly0.7 https://aibio.space/news/jupiter-neurosciences-delays-quarterly-report-period-ended-june-30/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-08-14weekly0.7 https://aibio.space/news/nrx-pharmaceuticals-files-late-notice-quarterly-report-june-30-2025/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-08-14weekly0.7 https://aibio.space/news/neonc-technologies-delays-quarterly-report-finish-review-stock-unit/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-08-14weekly0.7 https://aibio.space/news/ocean-biomedical-delays-quarterly-report-period-ended-june-30-2025/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-08-14weekly0.7 https://aibio.space/news/protagenic-therapeutics-delays-10-q-after-approving-move-virtual-model/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-08-14weekly0.7 https://aibio.space/news/tnf-pharmaceuticals-now-q-c-technologies-delays-june-quarter-report/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-08-14weekly0.7 https://aibio.space/news/denali-capital-acquisition-corp-now-semnur-pharmaceuticals-delays-june/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-08-14weekly0.7 https://aibio.space/news/windtree-therapeutics-files-late-notice-quarterly-report-june-30-2025/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-08-14weekly0.7 https://aibio.space/news/helix-acquisition-corp-ii-now-bridgebio-oncology-therapeutics/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-08-13weekly0.7 https://aibio.space/news/vivani-medical-agrees-sell-7-936-507-shares-1-26-private-placement/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-08-13weekly0.7 https://aibio.space/news/enliven-therapeutics-files-automatic-shelf-200-0-million-atm/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-08-13weekly0.7 https://aibio.space/news/promis-neurosciences-files-50-000-000-shelf-up-17-988-524-share-sales/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-08-13weekly0.7 https://aibio.space/news/vivani-medical-agrees-10-0-million-private-placement-1-26-share/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-08-13weekly0.7 https://aibio.space/news/armata-pharmaceuticals-enters-15-million-secured-term-loan-innoviva-14/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-08-12weekly0.7 https://aibio.space/news/cormedix-completes-150-000-000-convertible-senior-notes-offering-due/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-08-12weekly0.7 https://aibio.space/news/oric-pharmaceuticals-cuts-20-percent-workforce-closes-discovery/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-08-12weekly0.7 https://aibio.space/news/fate-therapeutics-approves-restructuring-12-percent-workforce/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-08-12weekly0.7 https://aibio.space/news/compass-therapeutics-prices-119-999-329-stock-warrant-offering-3-00/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-08-12weekly0.7 https://aibio.space/news/mosaic-immunoengineering-delays-june-30-2025-quarterly-report/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-08-12weekly0.7 https://aibio.space/news/cormedix-completes-150-000-000-convertible-senior-notes-offering-due/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-08-12weekly0.7 https://aibio.space/news/diamedica-therapeutics-sets-up-100-0-million-market-share-program-td/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-08-12weekly0.7 https://aibio.space/news/intensity-therapeutics-regains-nasdaq-stockholders-equity-compliance/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-08-12weekly0.7 https://aibio.space/news/oric-cuts-20-percent-staff-after-244-million-gross-financing-expects/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-08-12weekly0.7 https://aibio.space/news/veru-completes-1-10-reverse-stock-split-nasdaq/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-08-12weekly0.7 https://aibio.space/news/verrica-pharmaceuticals-details-1-10-reverse-split-8-0-million-torii/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-08-12weekly0.7 https://aibio.space/news/x4-pharmaceuticals-agrees-60-million-private-placement-replaces-ceo/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-08-12weekly0.7 https://aibio.space/news/biovie-closes-public-offering-units-warrants-net-proceeds-about-10-4/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-08-11weekly0.7 https://aibio.space/news/ocugen-agrees-sell-20-000-000-stock-warrants-janus-henderson-1-00/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-08-11weekly0.7 https://aibio.space/news/oragenics-says-series-h-preferred-raise-brought-16-5-million-gross/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-08-11weekly0.7 https://aibio.space/news/immunitybio-gets-preliminary-court-approval-shareholder-derivative/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-08-08weekly0.7 https://aibio.space/news/biovie-prices-12-million-public-offering-units-2-00/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-08-08weekly0.7 https://aibio.space/news/fibrobiologics-gets-nasdaq-notice-market-value-below-35-0-million/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-08-08weekly0.7 https://aibio.space/news/processa-pharmaceuticals-gets-second-180-day-nasdaq-period-fix-bid/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-08-08weekly0.7 https://aibio.space/news/estrella-immunopharma-gets-nasdaq-deficiency-notice-35-000-000-market/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-08-07weekly0.7 https://aibio.space/news/ptc-therapeutics-pays-about-225-0-million-cancel-censa-sales-payments/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-08-07weekly0.7 https://aibio.space/news/processa-pharmaceuticals-sells-5-467-181-shares-1-3-million-private/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-08-07weekly0.7 https://aibio.space/news/cormedix-buy-melinta-therapeutics-closing-targeted-early-september-1/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-08-07weekly0.7 https://aibio.space/news/ptc-therapeutics-pays-about-225-0-million-cancel-censa-sales-payments/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-08-07weekly0.7 https://aibio.space/news/adma-biologics-enters-300-million-credit-agreement-led-j-p-morgan/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-08-06weekly0.7 https://aibio.space/news/helix-acquisition-corp-ii-now-bridgebio-oncology-keeps-120-million/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-08-06weekly0.7 https://aibio.space/news/cosmos-health-signs-note-facility-up-300-million-ethereum-treasury/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-08-06weekly0.7 https://aibio.space/news/oncotelic-therapeutics-issues-560-000-secured-convertible-note-mast/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-08-06weekly0.7 https://aibio.space/news/sana-biotechnology-prices-75-0-million-offering-3-35-share/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-08-06weekly0.7 https://aibio.space/news/nutriband-distributes-3-million-series-preferred-shares-convertible/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-08-05weekly0.7 https://aibio.space/news/bon-natural-life-says-nasdaq-closed-bid-price-matter-one-year-panel/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-08-05weekly0.7 https://aibio.space/news/ocean-biomedicals-nasdaq-delisting-becomes-final-after-board-declines/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-08-05weekly0.7 https://aibio.space/news/intensity-therapeutics-raises-6-6-million-july-2025-market-sales/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-08-04weekly0.7 https://aibio.space/news/exicure-regains-compliance-nasdaq-periodic-filing-rule/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-08-04weekly0.7 https://aibio.space/news/protalix-says-delaware-stockholder-class-action-bylaws-dismissed-160/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-08-01weekly0.7 https://aibio.space/news/celcuity-completes-201-250-000-offering-2-750-percent-convertible/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-08-01weekly0.7 https://aibio.space/news/alzamend-neuro-issues-243-429-shares-series-b-preferred-conversions/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-08-01weekly0.7 https://aibio.space/news/geovax-receives-nasdaq-bid-price-deficiency-notice-has-until-january/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-08-01weekly0.7 https://aibio.space/news/ibio-receives-nasdaq-notice-trading-below-1-00-minimum-bid-price/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-08-01weekly0.7 https://aibio.space/news/neonc-technologies-signs-up-50-million-investment-deal-quazar-25-share/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-08-01weekly0.7 https://aibio.space/news/supernus-completes-sage-therapeutics-acquisition-after-tender-offer-8/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-07-31weekly0.7 https://aibio.space/news/adaptimmune-sells-cell-therapy-assets-us-worldmeds-55-million-upfront/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-07-31weekly0.7 https://aibio.space/news/veraxa-biotech-holding-ag-now-veraxa-biotech-ag-files-f-4-voyager-spac/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-07-31weekly0.7 https://aibio.space/news/propanc-biopharma-sells-112-350-convertible-note-107-000-22-percent/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-07-30weekly0.7 https://aibio.space/news/aim-immunotech-prices-8-0-million-unit-offering-works-fix-equity/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-07-30weekly0.7 https://aibio.space/news/dyadic-international-prices-6-052-000-share-offering-0-95-below-last/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-07-30weekly0.7 https://aibio.space/news/prime-medicine-prices-38-000-000-share-offering-3-30-125-400-000-gross/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-07-30weekly0.7 https://aibio.space/news/ikena-oncology-now-imagenebio-completes-inmagene-merger-issues/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-07-29weekly0.7 https://aibio.space/news/merck-approves-2025-restructuring-program-about-3-0-billion-pretax/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-07-29weekly0.7 https://aibio.space/news/splash-beverage-group-now-endovia-health-sciences-faces-nyse-american/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-07-29weekly0.7 https://aibio.space/news/immunoprecise-antibodies-now-mindwalk-holdings-reports-fiscal-2025/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-07-29weekly0.7 https://aibio.space/news/imagenebio-says-ikena-oncology-imagene-merger-completed-july-2025/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-07-29weekly0.7 https://aibio.space/news/ocugen-regains-compliance-nasdaq-1-00-minimum-bid-price-rule/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-07-29weekly0.7 https://aibio.space/news/passage-bio-regains-compliance-nasdaq-minimum-bid-price-rule/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-07-29weekly0.7 https://aibio.space/news/pharmacyte-biotech-delays-annual-report-year-ended-april-30-2025/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-07-29weekly0.7 https://aibio.space/news/cingulate-reports-unregistered-share-issuances-lender-exchange-debt/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-07-25weekly0.7 https://aibio.space/news/palisade-bio-sets-0-9047-warrant-inducement-about-3-9-million-gross/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-07-25weekly0.7 https://aibio.space/news/anavex-signs-market-sales-agreement-td-cowen-up-150-million/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-07-25weekly0.7 https://aibio.space/news/chemomab-signs-market-agreement-lifesci-capital-up-7-258-687/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-07-25weekly0.7 https://aibio.space/news/cytodyn-files-100-000-000-shelf-registration-stock-warrants-units/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-07-25weekly0.7 https://aibio.space/news/lyell-immunopharma-signs-private-placement-up-100-million-13-32-share/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-07-25weekly0.7 https://aibio.space/news/omeros-prices-22-million-registered-direct-offering-4-10-share/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-07-25weekly0.7 https://aibio.space/news/processa-pharmaceuticals-registers-up-5-239-073-market-stock-sales/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-07-25weekly0.7 https://aibio.space/news/advanced-biomed-gets-nasdaq-bid-price-notice-has-until-january-14-2026/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-07-24weekly0.7 https://aibio.space/news/incannex-healthcare-adds-up-100-000-000-market-stock-program/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-07-24weekly0.7 https://aibio.space/news/rocket-pharmaceuticals-starts-restructuring-workforce-reduction-about/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-07-23weekly0.7 https://aibio.space/news/adicet-bio-announces-workforce-reduction-about-30-percent-ends-adi-270/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-07-23weekly0.7 https://aibio.space/news/oramed-gives-scilex-option-buy-back-warrants-27-000-000/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-07-23weekly0.7 https://aibio.space/news/lantheus-completes-life-molecular-imaging-acquisition-350-million/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-07-22weekly0.7 https://aibio.space/news/diamedica-therapeutics-agrees-30-1-million-private-placement-existing/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-07-21weekly0.7 https://aibio.space/news/sab-biotherapeutics-agrees-175-million-private-placement-sanofi/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-07-21weekly0.7 https://aibio.space/news/sab-biotherapeutics-agrees-175-million-private-placement-sanofi/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-07-21weekly0.7 https://aibio.space/news/abeona-therapeutics-cuts-term-loan-rate-11-75-percent-issues-avenue/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-07-18weekly0.7 https://aibio.space/news/neuphoria-therapeutics-gets-nasdaq-notice-annual-meeting-requirement/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-07-18weekly0.7 https://aibio.space/news/nasdaq-files-form-25-delist-avenue-therapeutics-common-stock/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-07-18weekly0.7 https://aibio.space/news/60-degrees-pharmaceuticals-prices-5-million-offering-warrants-5/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-07-18weekly0.7 https://aibio.space/news/gain-therapeutics-prices-public-offering-shares-warrants-7-0-million/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-07-17weekly0.7 https://aibio.space/news/connect-biopharma-regains-compliance-nasdaq-1-00-minimum-bid-price/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-07-17weekly0.7 https://aibio.space/news/i-mab-now-novabridge-biosciences-buy-bridge-health-biotech-1-8-million/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-07-17weekly0.7 https://aibio.space/news/windtree-agrees-60-million-preferred-stock-sale-fund-bnb-treasury/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-07-17weekly0.7 https://aibio.space/news/cell-source-keeps-filing-delayed-reports-after-july-2025-form-15/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-07-16weekly0.7 https://aibio.space/news/indaptus-therapeutics-regains-nasdaq-compliance-1-00-bid-price-rule/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-07-16weekly0.7 https://aibio.space/news/onconetix-signs-merger-deal-ocuvex-ocuvex-holders-would-own-90-percent/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-07-16weekly0.7 https://aibio.space/news/imunon-gets-nasdaq-hearing-panel-exception-after-delisting/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-07-14weekly0.7 https://aibio.space/news/prokidney-sets-up-market-program-up-200-000-000-stock-jefferies/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-07-14weekly0.7 https://aibio.space/news/artelo-biosciences-updated-2024-statements-carry-auditor-going-concern/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-07-11weekly0.7 https://aibio.space/news/helix-acquisition-corp-ii-now-bridgebio-oncology-therapeutics-says-s-4/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-07-11weekly0.7 https://aibio.space/news/nasdaq-files-form-25-remove-bio-path-holdings-common-stock-listing/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-07-11weekly0.7 https://aibio.space/news/i-mab-now-novabridge-biosciences-lifts-ads-sale-limit-50-000-000/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-07-11weekly0.7 https://aibio.space/news/rani-therapeutics-registers-resale-13-160-172-series-d-warrant-shares/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-07-11weekly0.7 https://aibio.space/news/denali-capital-now-semnur-pharmaceuticals-extends-spac-deadline-august/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-07-11weekly0.7 https://aibio.space/news/pacira-biosciences-announces-workforce-reduction-71-employees-about-8/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-07-10weekly0.7 https://aibio.space/news/jupiter-neurosciences-regains-compliance-nasdaq-1-00-minimum-bid-price/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-07-10weekly0.7 https://aibio.space/news/pacira-biosciences-cuts-about-70-jobs-decommissions-45-liter-exparel/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-07-10weekly0.7 https://aibio.space/news/vor-bio-names-sandy-mahatme-cfo-grants-13-882-750-inducement-rsus/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-07-10weekly0.7 https://aibio.space/news/jasper-therapeutics-cuts-workforce-about-50-percent-halts-other/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-07-09weekly0.7 https://aibio.space/news/sensei-biotherapeutics-now-faeth-therapeutics-regains-nasdaq-bid-price/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-07-09weekly0.7 https://aibio.space/news/galectin-therapeutics-gets-new-10-million-credit-line-chairman-richard/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-07-09weekly0.7 https://aibio.space/news/nasus-pharma-files-1-000-000-share-nyse-american-ipo-expects-10-00-12/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-07-09weekly0.7 https://aibio.space/news/rallybio-sells-50-percent-stake-enpp1-joint-venture-recursion-cash/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-07-08weekly0.7 https://aibio.space/news/recursion-buys-rallybios-50-percent-enpp1-venture-stake-paying-1-457/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-07-08weekly0.7 https://aibio.space/news/entero-therapeutics-now-gridai-technologies-regains-nasdaq-annual/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-07-08weekly0.7 https://aibio.space/news/rallybio-sells-enpp1-joint-venture-stake-recursion-initial-7-500-000/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-07-08weekly0.7 https://aibio.space/news/unicycive-regains-nasdaq-minimum-bid-price-compliance-after-reverse/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-07-08weekly0.7 https://aibio.space/news/pacira-biosciences-enters-300-0-million-revolving-credit-facility/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-07-07weekly0.7 https://aibio.space/news/century-therapeutics-plans-about-51-percent-workforce-cut-cfo-chief/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-07-07weekly0.7 https://aibio.space/news/collegium-pharmaceutical-authorizes-buyback-up-150-million/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-07-07weekly0.7 https://aibio.space/news/pacira-signs-300-0-million-revolving-credit-facility-repays-term-loan/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-07-07weekly0.7 https://aibio.space/news/promis-neurosciences-gets-second-180-day-period-meet-nasdaq-bid-price/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-07-07weekly0.7 https://aibio.space/news/coherus-oncology-gets-nasdaq-minimum-bid-price-deficiency-notice-has/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-07-03weekly0.7 https://aibio.space/news/pluri-gets-nasdaq-audit-committee-notice-after-director-doron-birger/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-07-03weekly0.7 https://aibio.space/news/silo-pharma-gets-nasdaq-minimum-bid-price-notice-has-until-december-24/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-07-03weekly0.7 https://aibio.space/news/lantern-pharma-sets-up-15-530-000-market-stock-program-thinkequity/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-07-03weekly0.7 https://aibio.space/news/lexicon-pharmaceuticals-moves-nasdaq-capital-market-get-more-time-1/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-07-03weekly0.7 https://aibio.space/news/silo-pharma-gets-nasdaq-bid-price-notice-has-until-december-24-2025/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-07-03weekly0.7 https://aibio.space/news/tevogen-bio-holdings-sets-up-50-000-000-market-stock-program/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-07-03weekly0.7 https://aibio.space/news/universe-pharmaceuticals-reports-3-3-million-six-month-loss-cash-47/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-07-03weekly0.7 https://aibio.space/news/channel-therapeutics-now-pelthos-therapeutics-closes-merger-50-1/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-07-02weekly0.7 https://aibio.space/news/alaunos-therapeutics-tells-nasdaq-falls-short-audit-committee-rule/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-07-02weekly0.7 https://aibio.space/news/oragenics-closes-public-offering-series-h-preferred-about-16-5-million/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-07-02weekly0.7 https://aibio.space/news/abeona-closes-155-million-sale-rare-pediatric-disease-priority-review/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-07-02weekly0.7 https://aibio.space/news/abeona-therapeutics-closes-155-million-sale-priority-review-voucher/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-07-02weekly0.7 https://aibio.space/news/geovax-labs-sells-9-235-000-units-0-65-public-offering/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-07-02weekly0.7 https://aibio.space/news/channel-therapeutics-now-pelthos-sets-10-one-reverse-split-ahead/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-07-02weekly0.7 https://aibio.space/news/ocugen-gets-180-more-days-nasdaq-meet-minimum-bid-price-until-december/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-07-01weekly0.7 https://aibio.space/news/ikena-oncology-now-imagenebio-files-merger-partner-inmagenes-phase-2b/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-07-01weekly0.7 https://aibio.space/news/tuhura-biosciences-completes-kineta-acquisition-paying-0-185298-tuhura/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-06-30weekly0.7 https://aibio.space/news/aptevo-says-15-9-million-new-equity-puts-back-line-nasdaq-rule/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-06-30weekly0.7 https://aibio.space/news/biofrontera-agrees-11-0-million-preferred-stock-sale-fund-u-s-ameluz/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-06-30weekly0.7 https://aibio.space/news/tuhura-biosciences-completes-acquisition-kineta-all-stock-deal/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-06-30weekly0.7 https://aibio.space/news/in8bio-regains-compliance-nasdaq-1-00-minimum-bid-price-rule/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-06-30weekly0.7 https://aibio.space/news/inmed-pharmaceuticals-agrees-sell-shares-2-561-5-million-private/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-06-30weekly0.7 https://aibio.space/news/inmune-bio-agrees-sell-3-000-000-shares-6-30-19-million-direct/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-06-30weekly0.7 https://aibio.space/news/medicus-pharma-agrees-buy-antev-2-666-600-shares-plus-up-us-65-million/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-06-30weekly0.7 https://aibio.space/news/bausch-lomb-closes-675-million-secured-notes-offering-refinances-2027/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-06-27weekly0.7 https://aibio.space/news/immunic-gets-nasdaq-notice-after-stock-falls-below-1-00-30-days/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-06-27weekly0.7 https://aibio.space/news/pasithea-therapeutics-gets-nasdaq-notice-trading-below-1-00-bid-price/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-06-27weekly0.7 https://aibio.space/news/moleculin-biotech-gets-nasdaq-bid-price-notice-has-until-december-24/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-06-27weekly0.7 https://aibio.space/news/nektar-therapeutics-regains-compliance-nasdaq-minimum-bid-price-rule/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-06-27weekly0.7 https://aibio.space/news/zymeworks-issues-5-086-480-shares-ecor1-funds-exercise-pre-funded/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-06-27weekly0.7 https://aibio.space/news/cell-source-auditor-marcum-resigns-after-cbiz-takes-attest-business/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-06-26weekly0.7 https://aibio.space/news/actuate-therapeutics-agrees-sell-666-497-shares-7-00-private-placement/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-06-26weekly0.7 https://aibio.space/news/scynexis-gets-nasdaq-minimum-bid-price-notice-has-until-december-17/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-06-26weekly0.7 https://aibio.space/news/achieve-life-sciences-prices-45-000-000-offering-stock-warrants-3-00/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-06-26weekly0.7 https://aibio.space/news/bone-biologics-regains-compliance-nasdaq-1-00-minimum-bid-price-rule/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-06-26weekly0.7 https://aibio.space/news/rani-therapeutics-gets-nasdaq-notice-1-00-minimum-bid-price/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-06-26weekly0.7 https://aibio.space/news/scynexis-receives-nasdaq-notice-stock-below-1-00-has-until-december-17/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-06-26weekly0.7 https://aibio.space/news/vor-bio-licenses-telitacicept-remegen-45-million-plus-80-million/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-06-26weekly0.7 https://aibio.space/news/lipella-pharmaceuticals-ceo-says-company-will-seek-relisting-after/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-06-25weekly0.7 https://aibio.space/news/sutro-biopharma-receives-nasdaq-notice-falling-below-1-00-bid-price/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-06-25weekly0.7 https://aibio.space/news/amarin-licenses-vazkepa-europe-recordati-25-million-upfront-plans/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-06-24weekly0.7 https://aibio.space/news/amarin-licenses-vazkepa-europe-recordati-25-million-upfront-plans/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-06-24weekly0.7 https://aibio.space/news/candel-therapeutics-agrees-sell-about-15-0-million-stock-direct/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-06-24weekly0.7 https://aibio.space/news/aytu-biopharma-extends-eclipse-term-loan-revolver-2029-adds-1-5/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-06-23weekly0.7 https://aibio.space/news/impact-biomedical-signs-reverse-merger-agreement-dr-ashleys-limited/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-06-23weekly0.7 https://aibio.space/news/caribou-biosciences-regains-compliance-nasdaq-1-00-bid-price-rule/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-06-23weekly0.7 https://aibio.space/news/impact-biomedical-agrees-reverse-merger-hong-kong-drugmaker-dr-ashleys/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-06-23weekly0.7 https://aibio.space/news/ocugen-unit-orthocellix-merge-carisma-alongside-planned-25-0-million/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-06-23weekly0.7 https://aibio.space/news/enzon-pharmaceuticals-now-viskase-holdings-agrees-all-stock-merger/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-06-23weekly0.7 https://aibio.space/news/aim-immunotech-gets-new-nyse-american-notice-stockholders-deficit/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-06-20weekly0.7 https://aibio.space/news/an2-therapeutics-swaps-shares-pre-funded-warrants-two-coastlands/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-06-20weekly0.7 https://aibio.space/news/nyse-accepts-annovis-bio-plan-regain-listing-compliance/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-06-20weekly0.7 https://aibio.space/news/theriva-biologics-files-sell-up-2-534-352-stock-through-market-program/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-06-20weekly0.7 https://aibio.space/news/glycomimetics-now-crescent-biopharma-completes-merger-200-million/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-06-18weekly0.7 https://aibio.space/news/prothena-cuts-workforce-about-63-percent-after-ending-birtamimab/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-06-18weekly0.7 https://aibio.space/news/c4-therapeutics-holders-approve-doubling-authorized-shares-300-000-000/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-06-18weekly0.7 https://aibio.space/news/reshape-lifesciences-now-vyome-holdings-says-equity-tops-nasdaq-2-5/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-06-18weekly0.7 https://aibio.space/news/jyong-biotech-prices-20-million-ipo-2-666-667-shares-7-50-nasdaq/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-06-18weekly0.7 https://aibio.space/news/prothena-cuts-about-63-percent-workforce-after-ending-birtamimab/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-06-18weekly0.7 https://aibio.space/news/biontech-files-purchase-agreement-acquire-curevac-through-exchange/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-06-17weekly0.7 https://aibio.space/news/plus-therapeutics-now-cerenome-cancels-warrants-signs-50-million/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-06-17weekly0.7 https://aibio.space/news/polypid-agrees-26-7-million-warrant-exercises-3-50-share/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-06-17weekly0.7 https://aibio.space/news/nextcure-licenses-sim0505-12-million-upfront-agrees-sell-2-0-million/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-06-16weekly0.7 https://aibio.space/news/aptevo-files-stock-warrant-offering-signs-25-0-million-yorkville/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-06-16weekly0.7 https://aibio.space/news/rezolute-sells-1-295-383-shares-private-placement-4-209-994-75/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-06-13weekly0.7 https://aibio.space/news/equillium-gets-180-more-days-nasdaq-meet-minimum-bid-price-requirement/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-06-13weekly0.7 https://aibio.space/news/quince-therapeutics-now-irulya-agrees-11-5-million-private-placement/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-06-13weekly0.7 https://aibio.space/news/incannex-healthcare-applies-move-listing-nasdaq-capital-market/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-06-13weekly0.7 https://aibio.space/news/aim-immunotech-regains-nyse-american-compliance-1-100-reverse-stock/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-06-12weekly0.7 https://aibio.space/news/adc-therapeutics-plans-about-30-percent-workforce-cut-u-k-closure-100/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-06-12weekly0.7 https://aibio.space/news/spruce-biosciences-wins-nasdaq-panel-appeal-bid-price-deadline-august/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-06-12weekly0.7 https://aibio.space/news/i-mab-now-novabridge-biosciences-regains-nasdaq-minimum-bid-price/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-06-12weekly0.7 https://aibio.space/news/scinai-immunotherapeutics-raises-1-38-million-through-yorkville-equity/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-06-12weekly0.7 https://aibio.space/news/spruce-biosciences-wins-nasdaq-appeal-must-meet-bid-price-rule-august/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-06-12weekly0.7 https://aibio.space/news/tempest-therapeutics-prices-6-25-registered-direct-offering-expects-4/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-06-12weekly0.7 https://aibio.space/news/cogent-biosciences-draws-50-million-term-loan-facility-up-400-million/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-06-11weekly0.7 https://aibio.space/news/salarius-now-decoy-therapeutics-cuts-valuation-2-31-million-merger/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-06-11weekly0.7 https://aibio.space/news/okyo-pharma-files-up-15-500-000-market-share-sales/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-06-11weekly0.7 https://aibio.space/news/tonix-sets-up-programs-sell-up-150-0-million-75-0-million-stock/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-06-11weekly0.7 https://aibio.space/news/integra-lifesciences-amends-credit-agreement-covenant-relief-leverage/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-06-09weekly0.7 https://aibio.space/news/aytu-biopharma-signs-exxua-commercialization-deal-fabre-kramer-pays-3/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-06-06weekly0.7 https://aibio.space/news/bolt-biotherapeutics-sets-1-20-reverse-stock-split-trading-adjusted/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-06-06weekly0.7 https://aibio.space/news/aytu-biopharma-pays-3-000-000-upfront-u-s-rights-depression-drug-exxua/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-06-06weekly0.7 https://aibio.space/news/bolt-biotherapeutics-effects-1-20-reverse-stock-split/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-06-06weekly0.7 https://aibio.space/news/tango-therapeutics-holders-approve-doubling-authorized-shares-400-000/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-06-06weekly0.7 https://aibio.space/news/fortress-biotech-receive-about-28-0-million-checkpoint-sale-sun-pharma/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-06-05weekly0.7 https://aibio.space/news/cellectar-biosciences-agrees-warrant-inducement-deal-about-2-5-million/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-06-05weekly0.7 https://aibio.space/news/talphera-gets-second-180-day-nasdaq-bid-price-period-december-1-2025/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-06-05weekly0.7 https://aibio.space/news/harmony-biosciences-settles-wakix-patent-suit-lupin-generic-entry-set/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-06-05weekly0.7 https://aibio.space/news/avalo-therapeutics-sets-up-75-000-000-market-program-td-cowen/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-06-05weekly0.7 https://aibio.space/news/fortress-biotech-receive-about-28-0-million-checkpoint-sale-sun-pharma/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-06-05weekly0.7 https://aibio.space/news/talphera-gets-second-180-day-nasdaq-period-until-december-1-2025-fix/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-06-05weekly0.7 https://aibio.space/news/elicio-therapeutics-takes-10-million-secured-loan-investor-gkcc/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-06-04weekly0.7 https://aibio.space/news/nektar-sets-one-fifteen-reverse-split-effective-june-8-2025/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-06-04weekly0.7 https://aibio.space/news/relay-therapeutics-agrees-end-binney-street-lease-early-move-smaller/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-06-04weekly0.7 https://aibio.space/news/ironwood-pharmaceuticals-gets-nasdaq-minimum-bid-price-deficiency/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-06-03weekly0.7 https://aibio.space/news/alto-neuroscience-buys-depression-drug-candidates-chase-therapeutics/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-06-03weekly0.7 https://aibio.space/news/bon-natural-life-announces-share-buyback-up-1-0-million/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-06-03weekly0.7 https://aibio.space/news/taysha-gene-therapies-holders-approve-raising-authorized-shares-700/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-06-03weekly0.7 https://aibio.space/news/actuate-therapeutics-presentation-repeats-going-concern-doubt-need/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-06-02weekly0.7 https://aibio.space/news/editas-medicine-holders-approve-doubling-authorized-common-stock-390/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-06-02weekly0.7 https://aibio.space/news/adagene-files-sell-up-us-100-000-000-adss-market/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-05-30weekly0.7 https://aibio.space/news/adlai-nortye-drops-buparlisib-after-phase-iii-miss-plans-workforce-cut/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-05-30weekly0.7 https://aibio.space/news/reshape-lifesciences-now-vyome-holdings-sets-up-9-700-000-market/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-05-30weekly0.7 https://aibio.space/news/metavia-gets-nasdaq-minimum-bid-price-notice-deadline-november-25-2025/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-05-30weekly0.7 https://aibio.space/news/reviva-pharmaceuticals-sets-up-50-million-market-stock-program/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-05-30weekly0.7 https://aibio.space/news/keros-therapeutics-plans-workforce-reduction-approximately-45-percent/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-05-29weekly0.7 https://aibio.space/news/taysha-gene-therapies-prices-public-offering-46-868-687-shares-pre/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-05-29weekly0.7 https://aibio.space/news/keros-therapeutics-drops-cibotercept-pah-cuts-about-45-percent-staff/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-05-29weekly0.7 https://aibio.space/news/oric-pharmaceuticals-agrees-125-million-private-placement-led-sr-one/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-05-28weekly0.7 https://aibio.space/news/maia-biotechnology-agrees-695-000-private-placement-warrants/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-05-28weekly0.7 https://aibio.space/news/cytomx-therapeutics-regains-compliance-nasdaq-minimum-bid-price/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-05-28weekly0.7 https://aibio.space/news/immunic-launches-pre-funded-warrant-offering-final-terms-total-64-991/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-05-28weekly0.7 https://aibio.space/news/lexeo-therapeutics-agrees-80-million-private-placement-stock-warrants/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-05-27weekly0.7 https://aibio.space/news/mind-medicine-now-definium-therapeutics-grants-new-cfo-inducement/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-05-27weekly0.7 https://aibio.space/news/gt-biopharma-enlarges-preferred-stock-private-placement-5-950-000-00/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-05-27weekly0.7 https://aibio.space/news/lexeo-therapeutics-agrees-80-million-private-placement-2-8825-share/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-05-27weekly0.7 https://aibio.space/news/emergent-biosolutions-derivative-lawsuit-settlement-gets-preliminary/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-05-23weekly0.7 https://aibio.space/news/artelo-biosciences-gets-nasdaq-notice-652-000-stockholders-equity/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-05-23weekly0.7 https://aibio.space/news/boundless-bio-cuts-about-one-third-workforce-narrows-pipeline-sees/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-05-23weekly0.7 https://aibio.space/news/plus-therapeutics-now-cerenome-gets-nasdaq-deficiency-notice-late-form/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-05-23weekly0.7 https://aibio.space/news/biofrontera-falls-below-nasdaq-2-500-000-stockholders-equity/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-05-23weekly0.7 https://aibio.space/news/q32-bio-gets-nasdaq-notice-after-reporting-stockholders-deficit-4-0/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-05-23weekly0.7 https://aibio.space/news/onconetix-gets-nasdaq-notice-unfiled-10-q-issues-294-117-65-note/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-05-22weekly0.7 https://aibio.space/news/aptevo-therapeutics-gets-nasdaq-stockholders-equity-notice-sets-1-20/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-05-22weekly0.7 https://aibio.space/news/sol-gel-technologies-regains-nasdaq-minimum-bid-price-compliance-after/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-05-22weekly0.7 https://aibio.space/news/alumis-completes-acelyrin-merger-0-4814-alumis-shares-acelyrin-share/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-05-21weekly0.7 https://aibio.space/news/telomir-pharmaceuticals-raises-3-million-private-placement-largest/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-05-21weekly0.7 https://aibio.space/news/alumis-completes-merger-acelyrin-0-4814-shares-acelyrin-share/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-05-21weekly0.7 https://aibio.space/news/nasdaq-panel-moves-delist-petros-pharmaceuticals-trading-shift-otc/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-05-21weekly0.7 https://aibio.space/news/intensity-therapeutics-gets-nasdaq-stockholders-equity-deficiency/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-05-20weekly0.7 https://aibio.space/news/rani-therapeutics-cuts-warrant-exercise-price-0-65-about-4-3-million/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-05-20weekly0.7 https://aibio.space/news/acadia-pharmaceuticals-wins-delaware-ruling-nuplazid-formulation/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-05-20weekly0.7 https://aibio.space/news/regenxbio-receives-150-million-closing-royalty-bond-loan-healthcare/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-05-19weekly0.7 https://aibio.space/news/royalty-pharma-completes-acquisition-rp-llc-200-000-000-cash-24-530/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-05-19weekly0.7 https://aibio.space/news/protagenic-therapeutics-combines-phytanix-bio-all-stock-deal/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-05-19weekly0.7 https://aibio.space/news/china-sxt-sells-10-000-000-shares-warrants-5-100-000-gross/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-05-19weekly0.7 https://aibio.space/news/dermata-regains-nasdaq-stockholders-equity-compliance-but-gets-bid/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-05-16weekly0.7 https://aibio.space/news/neumora-gets-nasdaq-minimum-bid-price-notice-has-until-november-10/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-05-16weekly0.7 https://aibio.space/news/neumora-therapeutics-gets-nasdaq-notice-stock-below-1-00-bid-price/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-05-16weekly0.7 https://aibio.space/news/reshape-lifesciences-now-vyome-holdings-files-nt-10-q-delaying-first/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-05-15weekly0.7 https://aibio.space/news/exicure-files-nt-10-q-late-filing-notice-needs-more-time-march-31-2025/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-05-15weekly0.7 https://aibio.space/news/pulmatrix-says-cullgen-merger-registration-effective-plans-divest/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-05-15weekly0.7 https://aibio.space/news/eloxx-pharmaceuticals-files-nt-10-q-cites-lack-funds-accountant-review/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-05-15weekly0.7 https://aibio.space/news/omeros-exchanges-70-8-million-2026-convertible-notes-9-50-percent/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-05-15weekly0.7 https://aibio.space/news/plus-therapeutics-now-cerenome-says-first-quarter-10-q-will-late/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-05-15weekly0.7 https://aibio.space/news/atara-biotherapeutics-prices-about-16-0-million-registered-direct/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-05-15weekly0.7 https://aibio.space/news/aspira-womens-health-delays-first-quarter-report-finish-debt-equity/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-05-15weekly0.7 https://aibio.space/news/plus-therapeutics-now-cerenome-delays-q1-report-warrant-accounting/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-05-15weekly0.7 https://aibio.space/news/greenwich-lifesciences-delays-first-quarter-report-expects-file-may-20/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-05-15weekly0.7 https://aibio.space/news/hcw-biologics-closes-5-0-million-offering-671-140-units-7-45/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-05-15weekly0.7 https://aibio.space/news/hepion-pharmaceuticals-delays-quarterly-report-three-months-ended/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-05-15weekly0.7 https://aibio.space/news/reshape-lifesciences-now-vyome-holdings-delays-first-quarter-10/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-05-15weekly0.7 https://aibio.space/news/neuphoria-therapeutics-delays-quarterly-report-period-ended-march-31/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-05-15weekly0.7 https://aibio.space/news/novelstem-international-delays-first-quarter-2025-report-auditors/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-05-15weekly0.7 https://aibio.space/news/osr-holdings-now-osr-health-delays-quarterly-report-expects-11-4/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-05-15weekly0.7 https://aibio.space/news/pulmatrix-says-cullgen-merger-filing-effective-expects-june-2025-close/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-05-15weekly0.7 https://aibio.space/news/tivic-health-now-valion-bio-ends-quarter-669-000-cash-lines-up/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-05-15weekly0.7 https://aibio.space/news/exicure-delays-first-quarter-report-gpcr-acquisition-accounting/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-05-15weekly0.7 https://aibio.space/news/metavia-closes-private-placement-about-10-0-million-gross-proceeds/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-05-14weekly0.7 https://aibio.space/news/jade-biosciences-files-q1-financials-after-aerovate-merger-334-2/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-05-14weekly0.7 https://aibio.space/news/citius-oncology-10-q-cites-auditors-going-concern-doubt/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-05-14weekly0.7 https://aibio.space/news/citius-pharmaceuticals-10-q-cites-going-concern-doubt-nasdaq/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-05-14weekly0.7 https://aibio.space/news/jade-biosciences-formerly-aerovate-details-334-2-million-pre-merger/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-05-14weekly0.7 https://aibio.space/news/metavia-announces-10-0-million-private-placement-priced-market/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-05-14weekly0.7 https://aibio.space/news/oncolytics-biotech-flags-going-concern-doubt-first-quarter-statements/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-05-14weekly0.7 https://aibio.space/news/altimmune-draws-15-0-million-under-hercules-loan-agreement-up-100-0/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-05-13weekly0.7 https://aibio.space/news/sangamo-therapeutics-prices-23-0-million-offering-stock-warrants-0-50/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-05-13weekly0.7 https://aibio.space/news/united-therapeutics-files-patent-infringement-suit-against-liquidia/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-05-12weekly0.7 https://aibio.space/news/atara-biotherapeutics-cuts-workforce-about-30-percent-expects-1-4/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-05-12weekly0.7 https://aibio.space/news/abeona-therapeutics-agrees-sell-priority-review-voucher-155-million/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-05-12weekly0.7 https://aibio.space/news/cervomed-sets-up-market-program-up-50-000-000-leerink-partners/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-05-12weekly0.7 https://aibio.space/news/nasdaq-panel-delists-hepion-pharmaceuticals-company-expects-otc/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-05-12weekly0.7 https://aibio.space/news/immunome-reports-317-3-million-cash-expects-runway-2027/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-05-12weekly0.7 https://aibio.space/news/tango-therapeutics-files-400-000-000-replacement-shelf-100-000-000-atm/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-05-12weekly0.7 https://aibio.space/news/zeo-scientifix-issues-100-000-shares-warrants-500-000-shares/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-05-12weekly0.7 https://aibio.space/news/apimeds-pharmaceuticals-us-prices-13-5-million-ipo-4-00-share/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-05-09weekly0.7 https://aibio.space/news/nuvectis-pharma-sets-up-60-million-market-stock-program-leerink/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-05-09weekly0.7 https://aibio.space/news/vor-biopharma-winds-down-clinical-operations-cuts-147-jobs-explores/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-05-08weekly0.7 https://aibio.space/news/elutia-issues-1-105-528-shares-ligand-settle-2-2-million-royalties/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-05-08weekly0.7 https://aibio.space/news/liquidia-files-2024-financials-going-concern-doubt-revised-debt/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-05-08weekly0.7 https://aibio.space/news/korro-bio-announces-20-percent-workforce-reduction-expects-cash-runway/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-05-07weekly0.7 https://aibio.space/news/cosmos-health-gets-second-180-day-nasdaq-period-lift-stock-above-1-00/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-05-07weekly0.7 https://aibio.space/news/design-therapeutics-files-300-000-000-shelf-100-000-000-atm-sales/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-05-07weekly0.7 https://aibio.space/news/cyclerion-therapeutics-now-korsana-biosciences-sets-up-atm-program/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-05-07weekly0.7 https://aibio.space/news/nucana-plc-prices-best-efforts-offering-2-452-935-adss-warrants/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-05-07weekly0.7 https://aibio.space/news/transcode-therapeutics-faces-nasdaq-delisting-no-grace-period-plans/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-05-07weekly0.7 https://aibio.space/news/cogent-biosciences-files-50-000-000-market-stock-sales/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-05-06weekly0.7 https://aibio.space/news/exicure-buys-about-3-125-million-convertible-bonds-south-korean/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-05-06weekly0.7 https://aibio.space/news/evolus-signs-amended-loan-agreement-150-000-000-first-tranche/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-05-05weekly0.7 https://aibio.space/news/palisade-bio-gets-nasdaq-minimum-bid-price-deficiency-notice-has-180/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-05-02weekly0.7 https://aibio.space/news/palisade-bio-gets-nasdaq-notice-trading-below-1-00-minimum-bid-price/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-05-02weekly0.7 https://aibio.space/news/pds-biotechnology-sells-convertible-debentures-20-000-000-retire/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-05-02weekly0.7 https://aibio.space/news/arvinas-cuts-workforce-about-33-percent-drops-two-phase-3/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-05-01weekly0.7 https://aibio.space/news/aerovate-therapeutics-now-jade-biosciences-completes-merger-private/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-05-01weekly0.7 https://aibio.space/news/pliant-therapeutics-cut-workforce-about-45-percent-expects-3-6-million/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-05-01weekly0.7 https://aibio.space/news/an2-therapeutics-reports-ebo-301-miss-projects-78-5-million-cash-lasts/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-05-01weekly0.7 https://aibio.space/news/armata-pharmaceuticals-flags-going-concern-paragraph-gets-4-65-million/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-05-01weekly0.7 https://aibio.space/news/pasithea-therapeutics-files-share-warrant-offering-later-prices-1-40/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-05-01weekly0.7 https://aibio.space/news/nymox-says-20-f-late-citing-unfinished-work-slow-vendor-replies/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-05-01weekly0.7 https://aibio.space/news/xortx-therapeutics-files-late-filing-notice-2024-annual-report/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-05-01weekly0.7 https://aibio.space/news/abvc-biopharma-gets-nasdaq-equity-notice-sells-724-372-shares-offshore/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-04-30weekly0.7 https://aibio.space/news/avenue-therapeutics-ends-aj201-license-transfers-program-back-annji/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-04-30weekly0.7 https://aibio.space/news/quoin-pharmaceuticals-regains-compliance-nasdaq-1-00-minimum-bid-price/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-04-30weekly0.7 https://aibio.space/news/scilex-holding-regains-compliance-nasdaq-minimum-bid-price-rule/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-04-30weekly0.7 https://aibio.space/news/trisalus-agrees-sell-5-500-000-shares-4-00-22-0-million-private/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-04-30weekly0.7 https://aibio.space/news/xtl-biopharmaceuticals-20-f-lists-going-concern-delisting-risks/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-04-30weekly0.7 https://aibio.space/news/entrada-therapeutics-plans-workforce-reduction-about-20-percent-focus/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-04-29weekly0.7 https://aibio.space/news/pfizer-expands-cost-realignment-program-adds-1-2-billion-expected/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-04-29weekly0.7 https://aibio.space/news/amarin-regains-compliance-nasdaq-minimum-bid-price-requirement/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-04-29weekly0.7 https://aibio.space/news/scinai-files-late-20-f-notice-accounting-29-million-loan-conversion/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-04-29weekly0.7 https://aibio.space/news/entrada-therapeutics-cut-about-20-percent-workforce-strategic-plan/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-04-29weekly0.7 https://aibio.space/news/zhengye-biotechnology-files-late-filing-notice-auditor-needs-more-time/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-04-29weekly0.7 https://aibio.space/news/in8bio-expects-about-1-9-million-reduced-price-warrant-exercises/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-04-28weekly0.7 https://aibio.space/news/serina-therapeutics-sets-up-13-270-500-market-share-sales-program/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-04-28weekly0.7 https://aibio.space/news/tempest-therapeutics-regains-compliance-nasdaq-1-00-bid-price-rule/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-04-28weekly0.7 https://aibio.space/news/salarius-pharmaceuticals-now-decoy-therapeutics-gets-nasdaq-delisting/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-04-25weekly0.7 https://aibio.space/news/incannex-healthcare-inc-gets-nasdaq-minimum-bid-price-notice-has-until/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-04-25weekly0.7 https://aibio.space/news/spruce-biosciences-gets-nasdaq-delisting-notice-suspension-set-april/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-04-25weekly0.7 https://aibio.space/news/verastem-agrees-75-million-private-placement-stock-pre-funded-warrants/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-04-25weekly0.7 https://aibio.space/news/nyse-american-accepts-aeon-biopharma-plan-sets-august-3-2026-deadline/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-04-25weekly0.7 https://aibio.space/news/pluri-swaps-976-139-shares-held-directors-company-pre-funded-warrants/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-04-25weekly0.7 https://aibio.space/news/verastem-oncology-announces-75-million-private-placement-led-rtw/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-04-25weekly0.7 https://aibio.space/news/caribou-biosciences-cuts-47-jobs-drops-programs-sees-cash-runway/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-04-24weekly0.7 https://aibio.space/news/nucana-files-offering-up-16-049-383-adss-series-b-warrants/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-04-24weekly0.7 https://aibio.space/news/rezolute-prices-registered-direct-offering-about-90-million-3-25-share/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-04-23weekly0.7 https://aibio.space/news/cero-therapeutics-signs-up-8-million-series-d-convertible-preferred/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-04-22weekly0.7 https://aibio.space/news/pacira-biosciences-approves-new-buyback-up-300-0-million/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-04-22weekly0.7 https://aibio.space/news/invivyd-signs-term-loan-facility-up-30-million-silicon-valley-bank/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-04-21weekly0.7 https://aibio.space/news/mind-medicine-mindmed-inc-now-definium-therapeutics-inc-refinances-42/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-04-21weekly0.7 https://aibio.space/news/jazz-pharmaceuticals-completes-acquisition-chimerix-about-935-million/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-04-21weekly0.7 https://aibio.space/news/mind-medicine-now-definium-therapeutics-amends-k2-loan-up-120-0/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-04-21weekly0.7 https://aibio.space/news/scilex-unit-semnur-amends-denali-merger-deal-moves-outside-date/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-04-21weekly0.7 https://aibio.space/news/citius-pharmaceuticals-sells-ceo-one-series-preferred-share-100-ahead/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-04-18weekly0.7 https://aibio.space/news/tempest-therapeutics-cuts-21-26-employees-explores-strategic/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-04-18weekly0.7 https://aibio.space/news/aspire-biopharma-now-aspire-lakewood-holdings-gets-two-nasdaq/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-04-18weekly0.7 https://aibio.space/news/tenaya-therapeutics-gets-nasdaq-notice-trading-below-1-00/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-04-18weekly0.7 https://aibio.space/news/zura-bio-swaps-shares-pre-funded-warrants-venrock-affiliates-ai/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-04-17weekly0.7 https://aibio.space/news/atea-pharmaceuticals-authorizes-25-million-buyback-reaches-agreement/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-04-17weekly0.7 https://aibio.space/news/cuprina-holdings-files-late-notice-2024-annual-report-form-20/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-04-17weekly0.7 https://aibio.space/news/cadrenal-therapeutics-files-sell-up-2-169-272-more-stock-through-atm/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-04-17weekly0.7 https://aibio.space/news/painreform-now-prf-technologies-says-nasdaq-found-compliant-rule-5550/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-04-17weekly0.7 https://aibio.space/news/nasdaq-panel-delists-aspira-womens-health-2-5-million-equity-rule/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-04-16weekly0.7 https://aibio.space/news/athira-pharma-now-leonabio-wins-nasdaq-capital-market-move-180-more/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-04-16weekly0.7 https://aibio.space/news/cara-therapeutics-now-tvardi-therapeutics-closes-merger-tvardi-1-3/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-04-15weekly0.7 https://aibio.space/news/abpro-holdings-restates-prior-statements-understated-license/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-04-15weekly0.7 https://aibio.space/news/os-therapies-completes-purchase-advaxis-immunotherapy-assets-ayala/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-04-15weekly0.7 https://aibio.space/news/coherus-biosciences-now-coherus-oncology-completes-udenyca-sale-gets/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-04-14weekly0.7 https://aibio.space/news/coherus-now-coherus-oncology-completes-udenyca-sale-intas-483-4/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-04-14weekly0.7 https://aibio.space/news/mira-pharmaceuticals-gets-nasdaq-notice-2-5-million-stockholders/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-04-11weekly0.7 https://aibio.space/news/nasdaq-closes-creative-medical-technology-clawback-policy-compliance/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-04-11weekly0.7 https://aibio.space/news/mira-pharmaceuticals-gets-nasdaq-notice-2-5-million-equity-rule/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-04-11weekly0.7 https://aibio.space/news/pulmatrix-cullgen-amend-merger-agreement-switching-one-step-merger/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-04-10weekly0.7 https://aibio.space/news/palatin-technologies-gets-nyse-american-delisting-notice-plans-appeal/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-04-10weekly0.7 https://aibio.space/news/pulmatrix-amends-cullgen-merger-agreement-one-step-merger/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-04-10weekly0.7 https://aibio.space/news/immunic-inc-prices-5-1-million-registered-direct-offering-0-90-share/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-04-09weekly0.7 https://aibio.space/news/amarin-sets-1-20-ads-ratio-change-april-11-keep-nasdaq-listing/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-04-09weekly0.7 https://aibio.space/news/nasdaq-moves-delist-denali-capital-now-semnur-pharmaceuticals-semnur/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-04-09weekly0.7 https://aibio.space/news/zevra-therapeutics-closes-150-million-sale-rare-pediatric-disease/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-04-07weekly0.7 https://aibio.space/news/neogen-refinances-term-loan-revolver-450-million-term-loan-250-million/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-04-07weekly0.7 https://aibio.space/news/aim-immunotech-gets-nyse-american-delisting-notice-low-stock-price/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-04-07weekly0.7 https://aibio.space/news/traws-pharma-sets-market-sales-limit-7-427-749-under-baby-shelf-cap/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-04-07weekly0.7 https://aibio.space/news/xbiotech-tells-nasdaq-audit-committee-vacancy-after-director-retires/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-04-07weekly0.7 https://aibio.space/news/meiragtx-signs-new-new-york-lab-lease-ends-sublease-early/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-04-04weekly0.7 https://aibio.space/news/arbutus-says-court-moved-moderna-patent-trial-september-29-2025/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-04-03weekly0.7 https://aibio.space/news/moonlake-draws-75-0-million-hercules-capital-loan-facility-up-500-0/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-04-03weekly0.7 https://aibio.space/news/dogwood-therapeutics-says-has-regained-nasdaq-stockholders-equity/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-04-03weekly0.7 https://aibio.space/news/lantheus-completes-evergreen-theragnostics-acquisition-paying-about/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-04-01weekly0.7 https://aibio.space/news/onconetix-files-nt-10-k-late-filing-notice-says-cash-fell-0-6-million/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-04-01weekly0.7 https://aibio.space/news/reshape-lifesciences-now-vyome-holdings-files-nt-10-k-late-notice-2024/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-04-01weekly0.7 https://aibio.space/news/cara-therapeutics-now-tvardi-therapeutics-stockholders-approve-tvardi/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-04-01weekly0.7 https://aibio.space/news/lyell-immunopharma-close-west-hills-plant-cut-about-73-jobs-reiterates/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-04-01weekly0.7 https://aibio.space/news/eloxx-pharmaceuticals-files-nt-10-k-cannot-fund-audit-expects-going/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-04-01weekly0.7 https://aibio.space/news/abpro-holdings-delays-annual-report-fiscal-year-ended-december-31-2024/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-04-01weekly0.7 https://aibio.space/news/boundless-bio-files-400-0-million-shelf-14-5-million-jefferies-stock/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-04-01weekly0.7 https://aibio.space/news/conduit-pharmaceuticals-now-cdt-equity-says-meets-nasdaq-equity/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-04-01weekly0.7 https://aibio.space/news/coherus-now-coherus-oncology-repurchase-about-170-million-convertible/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-04-01weekly0.7 https://aibio.space/news/emmaus-life-sciences-delays-2024-annual-report-sees-revenue-down-more/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-04-01weekly0.7 https://aibio.space/news/genprex-delays-2024-annual-report-finish-financial-statements-audit/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-04-01weekly0.7 https://aibio.space/news/entero-therapeutics-now-gridai-technologies-delays-10-k-accounting/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-04-01weekly0.7 https://aibio.space/news/onconetix-delays-10-k-cash-falls-0-6-million-year-end/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-04-01weekly0.7 https://aibio.space/news/tevogen-bio-holdings-now-tevogen-delays-10-k-sees-2024-loss-about-13-7/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-04-01weekly0.7 https://aibio.space/news/vaccinex-delays-annual-report-fiscal-year-ended-december-31-2024/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-04-01weekly0.7 https://aibio.space/news/abvc-biopharma-files-nt-10-k-late-filing-notice-2024-annual-report/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-03-31weekly0.7 https://aibio.space/news/greenwich-lifesciences-files-nt-10-k-expects-late-annual-report-april/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-03-31weekly0.7 https://aibio.space/news/matinas-biopharma-files-nt-10-k-says-needs-more-time-complete-2024/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-03-31weekly0.7 https://aibio.space/news/sunshine-biopharma-files-nt-10-k-late-filing-notice-2024-annual-report/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-03-31weekly0.7 https://aibio.space/news/renovorx-files-nt-10-k-says-annual-report-will-late/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-03-31weekly0.7 https://aibio.space/news/aspire-biopharma-holdings-now-aspire-lakewood-holdings-files-nt-10/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-03-31weekly0.7 https://aibio.space/news/rein-therapeutics-formerly-aileron-files-nt-10-k-expects-37-0-million/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-03-31weekly0.7 https://aibio.space/news/abvc-biopharma-delays-annual-report-fiscal-year-ended-december-31-2024/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-03-31weekly0.7 https://aibio.space/news/akari-therapeutics-delays-2024-annual-report-merger-accounting/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-03-31weekly0.7 https://aibio.space/news/aspire-biopharma-now-aspire-lakewood-holdings-delays-2024-annual/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-03-31weekly0.7 https://aibio.space/news/cyclacel-now-bio-green-med-solution-delays-2024-annual-report/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-03-31weekly0.7 https://aibio.space/news/bioxytran-delays-annual-report-auditor-needs-more-time-2024-audit/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-03-31weekly0.7 https://aibio.space/news/celularity-delays-2024-annual-report-citing-liquidity-staffing/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-03-31weekly0.7 https://aibio.space/news/cns-pharmaceuticals-regains-nasdaq-bid-price-compliance-faces-one-year/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-03-31weekly0.7 https://aibio.space/news/dbv-technologies-delays-annual-report-while-works-private-placement/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-03-31weekly0.7 https://aibio.space/news/emergent-biosolutions-authorizes-repurchase-up-50-million-stock/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-03-31weekly0.7 https://aibio.space/news/matinas-biopharma-delays-annual-report-year-ended-december-31-2024/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-03-31weekly0.7 https://aibio.space/news/oncotelic-therapeutics-delays-2024-annual-report-expects-file-within/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-03-31weekly0.7 https://aibio.space/news/prokidney-files-move-incorporation-cayman-islands-delaware/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-03-31weekly0.7 https://aibio.space/news/transcode-therapeutics-delays-2024-annual-report-account-direct/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-03-31weekly0.7 https://aibio.space/news/rein-therapeutics-delays-10-k-expects-37-0-million-impairment-lti-01/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-03-31weekly0.7 https://aibio.space/news/renovorx-files-late-notice-2024-annual-report-cites-auditor-accounting/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-03-31weekly0.7 https://aibio.space/news/reviva-pharmaceuticals-delays-2024-annual-report-expects-report/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-03-31weekly0.7 https://aibio.space/news/sunshine-biopharma-files-late-notice-annual-report-december-31-2024/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-03-31weekly0.7 https://aibio.space/news/skinvisible-delays-annual-report-year-ended-december-31-2024/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-03-31weekly0.7 https://aibio.space/news/spruce-biosciences-delays-annual-report-flags-going-concern-doubt/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-03-31weekly0.7 https://aibio.space/news/savara-ends-100-0-million-market-stock-program-evercore/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-03-31weekly0.7 https://aibio.space/news/instil-bio-sets-up-100-million-market-stock-sale-program-jefferies/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-03-31weekly0.7 https://aibio.space/news/surrozen-closes-first-tranche-private-placement-about-76-4-million/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-03-28weekly0.7 https://aibio.space/news/trisalus-life-sciences-files-nt-10-k-citing-errors-material-weaknesses/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-03-28weekly0.7 https://aibio.space/news/acurx-pharmaceuticals-gets-nasdaq-stockholders-equity-deficiency/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-03-28weekly0.7 https://aibio.space/news/cell-source-delays-annual-report-year-ended-december-31-2024/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-03-28weekly0.7 https://aibio.space/news/dermata-therapeutics-expects-6-2-million-holders-exercise-warrants-1/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-03-28weekly0.7 https://aibio.space/news/kairos-pharma-delays-annual-report-2024/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-03-28weekly0.7 https://aibio.space/news/fibrogen-now-kyntra-bio-extends-fortis-merger-option-deadline-december/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-03-28weekly0.7 https://aibio.space/news/lipella-pharmaceuticals-files-register-5-617-259-shares-resale-then/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-03-28weekly0.7 https://aibio.space/news/trisalus-life-sciences-delays-10-k-after-finding-errors-material/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-03-28weekly0.7 https://aibio.space/news/annovis-bio-gets-nyse-continued-listing-notice-will-submit-compliance/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-03-27weekly0.7 https://aibio.space/news/ironwood-pharmaceuticals-gets-nasdaq-deficiency-notice-late-2024-form/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-03-27weekly0.7 https://aibio.space/news/nkarta-cut-34-percent-workforce-restructuring-expects-cash-runway-2029/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-03-26weekly0.7 https://aibio.space/news/relmada-licenses-ndv-01-trigone-agrees-pay-3-500-000-issue-3-017-420/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-03-26weekly0.7 https://aibio.space/news/whitehawk-therapeutics-formerly-aadi-bioscience-completes-102-4/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-03-26weekly0.7 https://aibio.space/news/savara-draws-30-million-under-hercules-capital-loan-agreement-repays/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-03-26weekly0.7 https://aibio.space/news/benitec-biopharma-prices-30-million-stock-sale-13-00-share/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-03-26weekly0.7 https://aibio.space/news/precision-biosciences-updates-stock-sales-limit-14-868-926/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-03-26weekly0.7 https://aibio.space/news/maia-biotechnology-cuts-market-program-11-200-000-30-000-000/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-03-26weekly0.7 https://aibio.space/news/nkarta-cuts-34-percent-workforce-53-positions-sees-380-5-million-cash/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-03-26weekly0.7 https://aibio.space/news/whitehawk-therapeutics-completes-sale-aadi-subsidiary-kaken-102-4/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-03-26weekly0.7 https://aibio.space/news/dermata-therapeutics-gets-nasdaq-stockholders-equity-deficiency-notice/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-03-25weekly0.7 https://aibio.space/news/jupiter-neurosciences-gets-nasdaq-minimum-bid-price-deficiency-notice/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-03-25weekly0.7 https://aibio.space/news/climb-bio-sets-up-22-350-000-market-stock-program-oppenheimer/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-03-25weekly0.7 https://aibio.space/news/genelux-prices-10-5-million-underwritten-offering-3-000-000-shares-3/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-03-25weekly0.7 https://aibio.space/news/entero-now-gridai-technologies-signs-deal-unwind-immunogenx-merger/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-03-25weekly0.7 https://aibio.space/news/gri-bio-prices-5-0-million-public-offering-3-60-three-warrant-series/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-03-25weekly0.7 https://aibio.space/news/neonc-technologies-sets-nasdaq-direct-listing-registers-2-101-313/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-03-25weekly0.7 https://aibio.space/news/transcode-therapeutics-agrees-sell-10-250-000-shares-warrants-0-98/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-03-25weekly0.7 https://aibio.space/news/opus-genetics-closes-public-offering-20-0-million-gross-proceeds-plus/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-03-24weekly0.7 https://aibio.space/news/senti-biosciences-files-300-000-000-shelf-sets-up-17-500-000-market/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-03-24weekly0.7 https://aibio.space/news/tnf-pharmaceuticals-now-q-c-technologies-gets-nasdaq-minimum-bid/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-03-21weekly0.7 https://aibio.space/news/tnf-pharmaceuticals-now-q-c-technologies-gets-nasdaq-minimum-bid/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-03-21weekly0.7 https://aibio.space/news/vaxart-sets-up-50-000-000-market-stock-program/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-03-21weekly0.7 https://aibio.space/news/cns-pharmaceuticals-increases-market-stock-program-43-5-million/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-03-20weekly0.7 https://aibio.space/news/foghorn-therapeutics-cuts-market-program-100-million-200-million/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-03-20weekly0.7 https://aibio.space/news/bausch-health-launches-4-0-billion-senior-secured-notes-offering/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-03-19weekly0.7 https://aibio.space/news/akebia-launches-stock-offering-then-prices-25-000-000-shares-2-00-50-0/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-03-19weekly0.7 https://aibio.space/news/minerva-neurosciences-keeps-nasdaq-listing-after-meeting-500-000-net/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-03-19weekly0.7 https://aibio.space/news/allovir-now-kalaris-therapeutics-completes-kalaris-merger-shares-trade/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-03-18weekly0.7 https://aibio.space/news/kalaris-therapeutics-closes-merger-allovir-stock-trades-klrs-march-19/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-03-18weekly0.7 https://aibio.space/news/milestone-pharmaceuticals-lifts-jefferies-market-program-up-77-800-000/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-03-18weekly0.7 https://aibio.space/news/harrow-files-nt-10-k-late-filing-notice-2024-annual-report-citing/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-03-17weekly0.7 https://aibio.space/news/entera-bio-signs-opko-oral-glp-1-glucagon-deal-sells-opko-shares-8-0/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-03-17weekly0.7 https://aibio.space/news/fibrogen-now-kyntra-bio-appeals-nasdaq-delisting-notice-after-missing/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-03-17weekly0.7 https://aibio.space/news/nasdaq-panel-delists-avenue-therapeutics-stock-moves-otc-march-19-2025/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-03-17weekly0.7 https://aibio.space/news/opko-health-buys-3-685-226-entera-bio-shares-2-17-obesity/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-03-17weekly0.7 https://aibio.space/news/metagenomi-files-250-000-000-shelf-75-000-000-market-program/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-03-17weekly0.7 https://aibio.space/news/vaccinex-files-form-25-voluntarily-withdraw-stock-nasdaq/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-03-17weekly0.7 https://aibio.space/news/gelteq-signs-deal-sell-up-12-000-000-shares-lincoln-park/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-03-14weekly0.7 https://aibio.space/news/tiziana-life-sciences-regains-compliance-nasdaq-minimum-bid-price-rule/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-03-14weekly0.7 https://aibio.space/news/pliant-therapeutics-inc-adopts-stockholder-rights-plan-12-64-exercise/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-03-13weekly0.7 https://aibio.space/news/sutro-biopharma-cut-about-50-percent-workforce-restructuring-names-new/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-03-13weekly0.7 https://aibio.space/news/pliant-therapeutics-adopts-one-year-shareholder-rights-plan-after/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-03-13weekly0.7 https://aibio.space/news/rallybio-cuts-market-stock-program-9-550-000-100-000-000/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-03-13weekly0.7 https://aibio.space/news/shuttle-pharma-prices-5-75-million-underwritten-offering-0-30-share/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-03-13weekly0.7 https://aibio.space/news/allovir-now-kalaris-therapeutics-stockholders-approve-kalaris-merger/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-03-12weekly0.7 https://aibio.space/news/eterna-therapeutics-now-ernexa-therapeutics-issues-1-500-000-note/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-03-12weekly0.7 https://aibio.space/news/dogwood-therapeutics-exchanges-19-5-million-conjoint-loan-preferred/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-03-12weekly0.7 https://aibio.space/news/armata-pharmaceuticals-signs-10-million-loan-largest-holder-innoviva/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-03-12weekly0.7 https://aibio.space/news/allovir-now-kalaris-therapeutics-stockholders-approve-merger-kalaris/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-03-12weekly0.7 https://aibio.space/news/anika-therapeutics-sells-parcus-medical-medacta-4-500-000-cash/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-03-11weekly0.7 https://aibio.space/news/viking-therapeutics-agrees-150-million-prepayments-cordenpharma-vk2735/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-03-11weekly0.7 https://aibio.space/news/anika-therapeutics-completes-sale-parcus-medical-medacta-group/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-03-11weekly0.7 https://aibio.space/news/helix-acquisition-corp-ii-now-bridgebio-oncology-therapeutics-files/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-03-11weekly0.7 https://aibio.space/news/xilio-therapeutics-sets-up-50-000-000-market-stock-program-leerink/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-03-11weekly0.7 https://aibio.space/news/alector-cut-workforce-approximately-13-percent-expects-2-4-million/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-03-10weekly0.7 https://aibio.space/news/acurx-pharmaceuticals-agrees-1-1-million-registered-direct-offering-0/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-03-10weekly0.7 https://aibio.space/news/fortress-biotechs-checkpoint-unit-agrees-sun-pharma-deal-4-10-share/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-03-10weekly0.7 https://aibio.space/news/creative-medical-technology-holdings-signs-warrant-inducement-about-3/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-03-07weekly0.7 https://aibio.space/news/adial-pharmaceuticals-gets-nasdaq-minimum-bid-price-deficiency-notice/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-03-07weekly0.7 https://aibio.space/news/arrowhead-registers-resale-11-926-301-shares-selling-stockholder/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-03-07weekly0.7 https://aibio.space/news/replimune-adds-baker-bros-employee-board-grants-bba-funds-resale/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-03-07weekly0.7 https://aibio.space/news/nuvation-bio-files-automatic-shelf-200-000-000-atm-sales-agreement/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-03-06weekly0.7 https://aibio.space/news/tenax-therapeutics-agrees-25-million-private-placement-rtw-investments/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-03-06weekly0.7 https://aibio.space/news/alx-oncology-approves-30-percent-workforce-reduction-will-eliminate/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-03-05weekly0.7 https://aibio.space/news/calcimedica-signs-loan-agreement-up-32-5-million-funds-10-million/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-03-05weekly0.7 https://aibio.space/news/jazz-pharmaceuticals-agrees-acquire-chimerix-8-55-share-cash/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-03-05weekly0.7 https://aibio.space/news/aadi-bioscience-now-whitehawk-therapeutics-closes-100-million-private/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-03-04weekly0.7 https://aibio.space/news/adma-biologics-files-nt-10-k-says-2024-annual-report-will-late/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-03-03weekly0.7 https://aibio.space/news/envoy-medical-receives-nasdaq-deficiency-notice-35-000-000-market/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-03-03weekly0.7 https://aibio.space/news/ibio-files-form-25-withdraw-common-stock-nyse-american/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-03-03weekly0.7 https://aibio.space/news/ironwood-pharmaceuticals-delays-10-k-expects-material-weakness-finding/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-03-03weekly0.7 https://aibio.space/news/aerovate-therapeutics-now-jade-biosciences-files-merger-material-jade/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-03-03weekly0.7 https://aibio.space/news/tenaya-therapeutics-prices-52-5-million-offering-75-000-000-units-0-70/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-03-03weekly0.7 https://aibio.space/news/court-denies-liquidias-challenge-fda-exclusivity-tyvaso-dpi/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-02-28weekly0.7 https://aibio.space/news/mustang-bio-sells-worcester-equipment-abbvie-1-0-million-exits/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-02-27weekly0.7 https://aibio.space/news/curis-gets-nasdaq-deficiency-notice-market-value-listed-securities/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-02-27weekly0.7 https://aibio.space/news/abcellera-biologics-files-automatic-shelf-registration-shares-debt/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-02-27weekly0.7 https://aibio.space/news/altimmune-files-400-000-000-shelf-150-000-000-equity-distribution/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-02-27weekly0.7 https://aibio.space/news/crescent-still-expects-glycomimetics-reverse-merger-close-second/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-02-27weekly0.7 https://aibio.space/news/mustang-bio-sells-fixed-assets-abbvie-1-0-million-exits-worcester/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-02-27weekly0.7 https://aibio.space/news/shuttle-pharmaceuticals-pays-alto-75-000-waive-rights-10-million-notes/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-02-27weekly0.7 https://aibio.space/news/zevra-therapeutics-agrees-sell-priority-review-voucher-150-million/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-02-27weekly0.7 https://aibio.space/news/sintx-technologies-closes-5-0-million-private-placement-warrants/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-02-26weekly0.7 https://aibio.space/news/cytomx-therapeutics-gets-nasdaq-minimum-bid-price-deficiency-notice/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-02-26weekly0.7 https://aibio.space/news/agenus-extends-10-5-million-2015-notes-july-2026-reprices-warrants-3/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-02-26weekly0.7 https://aibio.space/news/kiniksa-ends-abiprubart-phase-2b-trial-terminates-mavrilimumab-license/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-02-25weekly0.7 https://aibio.space/news/rallybio-gets-nasdaq-minimum-bid-price-notice-has-until-august-25-2025/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-02-25weekly0.7 https://aibio.space/news/maia-biotechnology-prices-1-43-million-private-placement-shares/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-02-25weekly0.7 https://aibio.space/news/universe-pharmaceuticals-gets-nasdaq-delisting-notice-delayed-form-20/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-02-25weekly0.7 https://aibio.space/news/atossa-therapeutics-gets-nasdaq-minimum-bid-price-deficiency-notice/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-02-24weekly0.7 https://aibio.space/news/inhibikase-acquires-corhepta-merger-paying-15-0-million-4-979-101/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-02-24weekly0.7 https://aibio.space/news/fibrogen-now-kyntra-bio-sets-up-30-0-million-market-stock-program/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-02-24weekly0.7 https://aibio.space/news/urogen-pharma-issues-374-843-shares-iconovir-icvb-1042-asset-purchase/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-02-20weekly0.7 https://aibio.space/news/heron-therapeutics-extends-hercules-loan-maturity-late-september-1/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-02-20weekly0.7 https://aibio.space/news/pharming-lifts-stake-abliva-92-70-percent-extends-cash-offer-march-6/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-02-20weekly0.7 https://aibio.space/news/urogen-buys-iconovir-assets-374-843-shares-possible-15-0-million/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-02-20weekly0.7 https://aibio.space/news/conduit-pharmaceuticals-now-cdt-equity-repays-nirland-note-nasdaq/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-02-19weekly0.7 https://aibio.space/news/trisalus-life-sciences-receives-10-million-second-loan-tranche-issues/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-02-19weekly0.7 https://aibio.space/news/abbvie-prices-four-series-senior-notes-expects-about-3-98-billion-net/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-02-19weekly0.7 https://aibio.space/news/petros-pharmaceuticals-prices-9-6-million-offering-stock-warrants-0-24/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-02-19weekly0.7 https://aibio.space/news/painreform-now-prf-technologies-agrees-buy-deepsolar-business-shares/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-02-18weekly0.7 https://aibio.space/news/cumberland-pharmaceuticals-registers-up-10-000-000-share-sales/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-02-14weekly0.7 https://aibio.space/news/citius-pharmaceuticals-reports-1-1-million-cash-expects-raise-capital/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-02-14weekly0.7 https://aibio.space/news/nasdaq-withdraws-evaxion-biotech-now-evaxion-s-delisting-determination/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-02-14weekly0.7 https://aibio.space/news/xencor-says-2023-2024-interim-financials-cant-relied-will-restate/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-02-13weekly0.7 https://aibio.space/news/ovid-therapeutics-gets-nasdaq-minimum-bid-price-notice-has-until/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-02-13weekly0.7 https://aibio.space/news/bio-rad-restructuring-cut-about-5-percent-workforce-45-million-50/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-02-13weekly0.7 https://aibio.space/news/briacell-therapeutics-regains-compliance-nasdaq-minimum-bid-price/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-02-13weekly0.7 https://aibio.space/news/edesa-biotech-closes-15-0-million-private-placement-led-velan-capital/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-02-13weekly0.7 https://aibio.space/news/genprex-gets-nasdaq-minimum-bid-price-deficiency-notice-has-until/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-02-12weekly0.7 https://aibio.space/news/aligos-therapeutics-announces-105-million-private-placement/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-02-12weekly0.7 https://aibio.space/news/microbot-medical-agrees-13-0-million-registered-direct-offering-2-13/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-02-11weekly0.7 https://aibio.space/news/q32-bio-announces-restructuring-workforce-reduction-focus-bempikibart/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-02-10weekly0.7 https://aibio.space/news/grace-therapeutics-agrees-private-placement-expects-about-13-8-million/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-02-10weekly0.7 https://aibio.space/news/akebia-therapeutics-draws-10-0-million-tranche-c-loan-kreos-receives-9/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-02-07weekly0.7 https://aibio.space/news/akebia-extends-kreos-loan-tranche-draws-10-0-million-issues-1-153-846/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-02-07weekly0.7 https://aibio.space/news/belite-bio-sells-258-309-adss-warrants-15-000-004/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-02-07weekly0.7 https://aibio.space/news/mustang-bio-prices-8-million-offering-3-01-two-series-warrants/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-02-07weekly0.7 https://aibio.space/news/sionna-therapeutics-prices-ipo-10-588-233-shares-18-00/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-02-07weekly0.7 https://aibio.space/news/60-degrees-pharmaceuticals-sells-1-503-500-shares-1-075-million/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-02-06weekly0.7 https://aibio.space/news/x4-pharmaceuticals-announces-restructuring-workforce-reduction-43/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-02-06weekly0.7 https://aibio.space/news/alumis-agrees-all-stock-merger-acelyrin-pro-forma-cash-about-737/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-02-06weekly0.7 https://aibio.space/news/alumis-acelyrin-agree-all-stock-merger-737-million-pro-forma-cash/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-02-06weekly0.7 https://aibio.space/news/renovorx-prices-11-523-810-share-offering-1-05-12-100-001-gross/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-02-06weekly0.7 https://aibio.space/news/briacell-closes-3-05-million-best-efforts-public-offering-762-500/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-02-05weekly0.7 https://aibio.space/news/baxter-completes-kidney-care-business-sale-receives-about-3-71-billion/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-02-03weekly0.7 https://aibio.space/news/alto-neuroscience-files-300-000-000-shelf-75-000-000-market-program/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-02-03weekly0.7 https://aibio.space/news/annovis-bio-prices-21-000-000-public-offering-units-4-00/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-02-03weekly0.7 https://aibio.space/news/arrivent-biopharma-files-automatic-shelf-250-000-000-atm-sales/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-02-03weekly0.7 https://aibio.space/news/enveric-biosciences-prices-5-million-public-offering-3-00-share/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-02-03weekly0.7 https://aibio.space/news/beta-bionics-closes-ipo-17-00-private-placement-229-1-million-gross/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-01-31weekly0.7 https://aibio.space/news/maze-therapeutics-prices-ipo-8-750-000-shares-16-00/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-01-31weekly0.7 https://aibio.space/news/tectonic-cites-159-million-cash-runway-then-agrees-185-0-million/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-01-30weekly0.7 https://aibio.space/news/zentalis-pharmaceuticals-announces-restructuring-workforce-reduction/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-01-28weekly0.7 https://aibio.space/news/lineage-cell-therapeutics-closes-second-tranche-offering-proceeds/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-01-27weekly0.7 https://aibio.space/news/china-sxt-pharmaceuticals-files-securities-purchase-agreement-priced-0/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-01-27weekly0.7 https://aibio.space/news/universe-pharmaceuticals-says-20-f-will-late-expects-20-33-million-net/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-01-27weekly0.7 https://aibio.space/news/ascentage-pharma-prices-u-s-ipo-7-325-000-adss-us-17-25/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-01-24weekly0.7 https://aibio.space/news/aardvark-therapeutics-files-ipo-common-stock-seeks-nasdaq-listing-aard/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-01-23weekly0.7 https://aibio.space/news/arvinas-subsidiary-ends-new-haven-lab-lease-effective-december-31-2024/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-01-22weekly0.7 https://aibio.space/news/provectus-biopharmaceuticals-approves-plan-seek-up-10-000-000/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-01-22weekly0.7 https://aibio.space/news/pluri-gets-nasdaq-extension-may-24-2025-regain-stockholders-equity/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-01-21weekly0.7 https://aibio.space/news/aadi-bioscience-now-whitehawk-therapeutics-seeks-vote-100-million/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-01-21weekly0.7 https://aibio.space/news/phio-pharmaceuticals-closes-registered-direct-offering-warrants-nets/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2025-01-17weekly0.7 https://aibio.space/news/kairos-pharma-closes-3-497-500-private-placement-pre-funded-units/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2025-01-17weekly0.7 https://aibio.space/news/polypid-says-14-5-million-private-placement-restored-nasdaq-equity/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2025-01-17weekly0.7 https://aibio.space/news/sionna-therapeutics-files-ipo-common-stock-seeks-nasdaq-listing-sion/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-01-17weekly0.7 https://aibio.space/news/alto-neuroscience-amends-k2-healthventures-loan-20-0-million-funded/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2025-01-16weekly0.7 https://aibio.space/news/gain-therapeutics-regains-compliance-nasdaq-50-million-market-value/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2025-01-15weekly0.7 https://aibio.space/news/coherus-biosciences-now-coherus-oncology-seeks-vote-483-4-million/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2025-01-14weekly0.7 https://aibio.space/news/evaxion-biotech-now-evaxion-s-completes-ads-ratio-change-like-1-5/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2025-01-14weekly0.7 https://aibio.space/news/inhibrx-biosciences-gets-100-0-million-close-oxford-finance-term-loan/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2025-01-13weekly0.7 https://aibio.space/news/verastem-sells-75-0-million-notes-oberland-capital-repays-oxford-loan/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2025-01-13weekly0.7 https://aibio.space/news/ibio-sells-240-807-shares-officers-directors-655-000-private-placement/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2025-01-13weekly0.7 https://aibio.space/news/inhibrx-biosciences-closes-oxford-finance-loan-up-150-million-funds/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2025-01-13weekly0.7 https://aibio.space/news/opus-genetics-sets-up-40-000-000-market-program-leerink-partners/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2025-01-13weekly0.7 https://aibio.space/news/protara-therapeutics-puts-cash-runway-2027-counting-102-7-million/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2025-01-13weekly0.7 https://aibio.space/news/neogen-files-nt-10-q-late-filing-notice-expects-461-4-million-goodwill/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2025-01-10weekly0.7 https://aibio.space/news/matinas-biopharma-gets-nyse-american-deficiency-notice-missing-2024/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2025-01-10weekly0.7 https://aibio.space/news/incannex-gets-nasdaq-deficiency-notice-50-0-million-market-value/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2025-01-10weekly0.7 https://aibio.space/news/compass-pathways-prices-about-150-million-offering-adss-warrants/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2025-01-10weekly0.7 https://aibio.space/news/entera-bio-adds-up-30-000-000-shares-market-program/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2025-01-10weekly0.7 https://aibio.space/news/intellia-plans-about-27-percent-net-workforce-cut-drops-ntla-3001-ends/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2025-01-10weekly0.7 https://aibio.space/news/citrine-global-now-skytech-orion-global-converts-partnership-loans/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2025-01-10weekly0.7 https://aibio.space/news/sensei-biotherapeutics-inc-now-faeth-therapeutics-inc-gets-180-more/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2025-01-07weekly0.7 https://aibio.space/news/nasdaq-panel-keeps-revelation-biosciences-listed-condition-reverse/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2025-01-07weekly0.7 https://aibio.space/news/cassava-sciences-now-filana-therapeutics-cuts-33-percent-workforce/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2025-01-07weekly0.7 https://aibio.space/news/acurx-pharmaceuticals-prices-2-5-million-registered-direct-offering-1/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2025-01-07weekly0.7 https://aibio.space/news/cassava-sciences-now-filana-therapeutics-cuts-workforce-about-33/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2025-01-07weekly0.7 https://aibio.space/news/lifecore-biomedical-sells-unused-filling-equipment-17-million-7/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2025-01-07weekly0.7 https://aibio.space/news/renovaro-now-lunai-bioworks-signs-binding-letter-buy-predictive/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2025-01-07weekly0.7 https://aibio.space/news/maze-therapeutics-files-ipo-common-stock-seeks-nasdaq-listing-maze/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2025-01-07weekly0.7 https://aibio.space/news/abvc-biopharma-cuts-warrant-price-0-40-lind-agrees-exercise-1-029-167/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2025-01-06weekly0.7 https://aibio.space/news/aeon-biopharma-prices-20-0-million-offering-units-0-50-each/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2025-01-06weekly0.7 https://aibio.space/news/cyclacel-now-bio-green-med-solution-agrees-sell-3-1-million-preferred/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2025-01-06weekly0.7 https://aibio.space/news/cytomx-therapeutics-cut-about-40-percent-headcount-expects-5-million-6/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2025-01-06weekly0.7 https://aibio.space/news/citius-oncology-hires-jefferies-explore-strategic-alternatives/https://aibio.space/assets/img/a-stone-federal-courthouse-p007-1400.webp2025-01-06weekly0.7 https://aibio.space/news/ocugen-gets-nasdaq-minimum-bid-price-deficiency-notice-has-until-june/https://aibio.space/assets/img/an-aerial-view-of-the-capitol-and-its-grounds-p011-1400.webp2025-01-03weekly0.7 https://aibio.space/news/eton-pharmaceuticals-completes-acquisition-galzin-teva-7-0-million/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2025-01-03weekly0.7 https://aibio.space/news/veru-sells-fc2-female-condom-business-clear-future-18-0-million-cash/https://aibio.space/assets/img/the-capitol-dome-seen-from-below-p008-1400.webp2025-01-03weekly0.7 https://aibio.space/news/veru-closes-18-0-million-sale-fc2-female-condom-business/https://aibio.space/assets/img/the-capitol-in-autumn-p009-1400.webp2025-01-03weekly0.7 https://aibio.space/news/ibio-licenses-anti-myostatin-antibody-astralbio-paying-750-000-upfront/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2025-01-02weekly0.7 https://aibio.space/news/psyence-biomedical-agrees-2-0-million-private-placement-warrants/https://aibio.space/assets/img/the-capitol-dome-against-a-blue-sky-p012-1400.webp2024-12-31weekly0.7 https://aibio.space/news/kala-bio-agrees-10-750-000-private-placement-common-preferred-stock/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2024-12-30weekly0.7 https://aibio.space/news/precigen-agrees-79-0-million-private-placement-convertible-preferred/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2024-12-30weekly0.7 https://aibio.space/news/ascentage-pharma-files-u-s-ipo-adss-plans-nasdaq-listing-aapg/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2024-12-27weekly0.7 https://aibio.space/news/powerup-acquisition-now-aspire-lakewood-gets-loan-up-500-000-before/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2024-12-26weekly0.7 https://aibio.space/news/regen-biopharma-files-form-15-common-series-preferred-stock/https://aibio.space/assets/img/the-capitol-dome-and-spring-blossom-p017-1400.webp2024-12-26weekly0.7 https://aibio.space/news/serina-therapeutics-sells-univerxome-juvenescence-which-takes-11-2/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2024-12-26weekly0.7 https://aibio.space/news/tscan-therapeutics-agrees-sell-30-0-million-pre-funded-warrants-lynx1/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2024-12-26weekly0.7 https://aibio.space/news/cingulate-raises-5-million-net-through-5-480-000-unsecured-promissory/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2024-12-23weekly0.7 https://aibio.space/news/context-therapeutics-sells-14-705-882-shares-about-15-million-mpm/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2024-12-23weekly0.7 https://aibio.space/news/monopar-therapeutics-agrees-sell-798-655-shares-23-79-plus-pre-funded/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2024-12-23weekly0.7 https://aibio.space/news/quoin-pharmaceuticals-prices-6-8-million-offering-adss-warrants-0-45/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2024-12-23weekly0.7 https://aibio.space/news/bioatla-agrees-about-9-2-million-registered-direct-offering-0-9520/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2024-12-20weekly0.7 https://aibio.space/news/altamira-therapeutics-moves-nasdaq-otcqb-after-panel-decision/https://aibio.space/assets/img/the-white-house-and-its-lawn-p019-1400.webp2024-12-20weekly0.7 https://aibio.space/news/fennec-pharmaceuticals-repays-13-million-convertible-debt-early/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2024-12-20weekly0.7 https://aibio.space/news/marker-therapeutics-signs-16-1-million-private-placement/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2024-12-19weekly0.7 https://aibio.space/news/cara-therapeutics-now-tvardi-therapeutics-agrees-all-stock-merger/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2024-12-18weekly0.7 https://aibio.space/news/bionomics-now-neuphoria-therapeutics-wins-court-approval-us-move/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2024-12-16weekly0.7 https://aibio.space/news/salarius-pharmaceuticals-now-decoy-therapeutics-signs-equity-line-up/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2024-12-13weekly0.7 https://aibio.space/news/taysha-gene-therapies-files-300-000-000-shelf-100-000-000-atm/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2024-12-13weekly0.7 https://aibio.space/news/editas-medicine-ends-reni-cel-program-cuts-about-180-positions-65/https://aibio.space/assets/img/old-law-books-on-library-shelves-p033-1400.webp2024-12-12weekly0.7 https://aibio.space/news/eton-sells-583-334-shares-12-00-7-0-million-registered-direct-offering/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2024-12-12weekly0.7 https://aibio.space/news/inovio-pharmaceuticals-prices-30-million-offering-stock-warrants-3-00/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2024-12-12weekly0.7 https://aibio.space/news/neutra-corp-files-form-15-end-sec-reporting-duties/https://aibio.space/assets/img/the-washington-monument-and-the-city-beyond-p025-1400.webp2024-12-12weekly0.7 https://aibio.space/news/cardiff-oncology-prices-40-million-share-offering-2-60-above-last-sale/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2024-12-10weekly0.7 https://aibio.space/news/rocket-pharmaceuticals-launches-150-000-000-stock-offering-prices-12/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2024-12-10weekly0.7 https://aibio.space/news/celcuity-files-up-125-000-000-market-stock-sales/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2024-12-06weekly0.7 https://aibio.space/news/jupiter-neurosciences-prices-11-million-ipo-2-750-000-shares-4-00/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2024-12-02weekly0.7 https://aibio.space/news/korro-bio-files-400-000-000-shelf-100-000-000-stock-sales-program/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2024-12-02weekly0.7 https://aibio.space/news/nektar-completes-sale-huntsville-alabama-plant-ampersand-affiliate/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2024-12-02weekly0.7 https://aibio.space/news/olema-oncology-announces-250-0-million-private-placement-novartis/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2024-12-02weekly0.7 https://aibio.space/news/gyre-therapeutics-sets-up-50-000-000-market-stock-program-jefferies/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2024-11-27weekly0.7 https://aibio.space/news/tuhura-biosciences-signs-letter-intent-acquire-kinetas-kva12123/https://aibio.space/assets/img/ny-stock-exchange-traders-floor-lc-u9-1400.webp2024-11-25weekly0.7 https://aibio.space/news/scilex-noteholders-waive-defaults-tied-late-third-quarter-report/https://aibio.space/assets/img/a-city-skyline-seen-across-a-river-o53-1400.webp2024-11-22weekly0.7 https://aibio.space/news/iovance-moves-san-carlos-headquarters-smaller-space-cutting-monthly/https://aibio.space/assets/img/rows-of-law-reports-on-a-shelf-p034-1400.webp2024-11-21weekly0.7 https://aibio.space/news/chromadex-now-niagen-bioscience-adds-roth-capital-market-program/https://aibio.space/assets/img/a-distant-skyline-over-open-water-o54-1400.webp2024-11-21weekly0.7 https://aibio.space/news/pmv-pharmaceuticals-files-200-000-000-shelf-113-792-846-40-atm/https://aibio.space/assets/img/stock-prices-on-an-electronic-board-p128-1400.webp2024-11-20weekly0.7 https://aibio.space/news/verrica-pharmaceuticals-prices-42-007-776-stock-warrant-offering-0-89/https://aibio.space/assets/img/a-trading-board-being-updated-by-hand-p127-1400.webp2024-11-20weekly0.7 https://aibio.space/news/atossa-therapeutics-sets-up-100-000-000-market-stock-program-jefferies/https://aibio.space/assets/img/a-red-price-chart-on-a-screen-p129-1400.webp2024-11-19weekly0.7 https://aibio.space/news/aclaris-therapeutics-licenses-two-biosion-antibodies-ends-strategic/https://aibio.space/assets/img/trading-screens-with-price-charts-p130-1400.webp2024-11-18weekly0.7 https://aibio.space/news/aditxt-delays-quarterly-report-period-ended-september-30-2024/https://aibio.space/assets/img/the-facade-of-a-neoclassical-court-building-at-dusk-p001-1400.webp2024-11-15weekly0.7 https://aibio.space/news/neurogene-delays-quarterly-report-period-ended-september-30-2024/https://aibio.space/assets/img/the-stone-facade-of-a-federal-building-o63-1400.webp2024-11-14weekly0.7 https://aibio.space/news/scilex-holding-delays-third-quarter-10-q-notice-cites-ongoing-review/https://aibio.space/assets/img/stone-columns-of-a-government-building-o62-1400.webp2024-11-14weekly0.7 https://aibio.space/news/cellectar-biosciences-delays-quarterly-report-after-restating-past/https://aibio.space/assets/img/a-supreme-court-building-with-lit-columns-p003-1400.webp2024-11-13weekly0.7 https://aibio.space/news/oruka-reports-410-875-thousand-cash-september-30-2024/https://aibio.space/assets/img/a-columned-courthouse-p002-1400.webp2024-11-13weekly0.7 https://aibio.space/news/rockwell-medical-files-sell-up-25-000-000-stock-market/https://aibio.space/assets/img/glass-office-towers-seen-from-below-o55-1400.webp2024-11-13weekly0.7 https://aibio.space/news/mereo-biopharma-reports-80-5-million-cash-says-funds-operations-2027/https://aibio.space/assets/img/a-city-skyline-in-morning-haze-o56-1400.webp2024-11-12weekly0.7 https://aibio.space/news/akari-therapeutics-shareholders-approve-share-issuance-peak-bio-merger/https://aibio.space/assets/img/office-towers-against-a-dusk-sky-o57-1400.webp2024-11-08weekly0.7 https://aibio.space/news/assembly-biosciences-sets-up-75-000-000-market-program-jefferies/https://aibio.space/assets/img/the-lower-manhattan-skyline-o60-1400.webp2024-11-07weekly0.7 https://aibio.space/news/geron-completes-250-million-royalty-pharma-pharmakon-financings/https://aibio.space/assets/img/a-financial-district-skyline-and-bay-o59-1400.webp2024-11-07weekly0.7 https://aibio.space/news/pieris-now-palvella-therapeutics-files-merger-partners-phase-3-dosing/https://aibio.space/assets/img/a-downtown-skyline-with-a-highway-in-the-foreground-o58-1400.webp2024-11-07weekly0.7 https://aibio.space/news/scynexis-sets-up-market-program-up-50-000-000-stock-cantor/https://aibio.space/assets/img/midtown-manhattan-and-a-downtown-tower-in-haze-o61-1400.webp2024-11-06weekly0.7 https://aibio.space/news/anaptysbio-files-500-000-000-shelf-100-000-000-stock-sales-program/https://aibio.space/assets/img/planning-on-a-whiteboard-o65-1400.webp2024-11-05weekly0.7 https://aibio.space/news/relief-therapeutics-now-mindmaze-signs-non-binding-loi-renexxion/https://aibio.space/assets/img/an-executive-reading-charts-on-a-tablet-o64-1400.webp2024-11-05weekly0.7 https://aibio.space/news/neurogene-agrees-200-0-million-private-placement-50-00-share/https://aibio.space/assets/img/an-empty-boardroom-with-a-long-table-o70-1400.webp2024-11-04weekly0.7 https://aibio.space/news/lyell-immunopharma-completes-acquisition-immpact-bio/https://aibio.space/assets/img/a-boardroom-table-with-chairs-and-a-laptop-o72-1400.webp2024-10-31weekly0.7 https://aibio.space/news/eterna-now-ernexa-closes-1-1-million-placement-0-75-after-stockholder/https://aibio.space/assets/img/a-meeting-room-with-a-long-table-and-a-screen-o74-1400.webp2024-10-29weekly0.7 https://aibio.space/news/immunome-buys-licensed-zentalis-ror1-assets-1-805-502-shares/https://aibio.space/assets/img/a-conference-room-set-for-a-meeting-o73-1400.webp2024-10-29weekly0.7 https://aibio.space/news/nyse-american-files-remove-calidi-biotherapeutics-warrants-listing/https://aibio.space/assets/img/marble-steps-and-columns-of-a-supreme-court-building-p004-1400.webp2024-10-28weekly0.7 https://aibio.space/news/molecular-partners-prices-20-million-offering-3-642-988-adss-5-49/https://aibio.space/assets/img/two-people-shaking-hands-across-a-table-o75-1400.webp2024-10-28weekly0.7 https://aibio.space/news/bellevue-life-sciences-acquisition-now-osr-health-lends-300-000-osr/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2024-10-28weekly0.7 https://aibio.space/companies/intellia-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/intellia-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/vertex-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/vertex-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/regeneron-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/regeneron-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/alnylam-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/alnylam-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/crispr-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/crispr-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/beam-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/beam-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/moderna/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/moderna/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/eli-lilly/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/eli-lilly/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/novo-nordisk/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/novo-nordisk/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/amgen/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/amgen/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/gilead-sciences/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/gilead-sciences/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/argenx/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/argenx/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/insmed/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/insmed/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/sarepta-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/sarepta-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/recursion-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/recursion-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/absci/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/absci/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/bristol-myers-squibb/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/bristol-myers-squibb/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/pfizer-pfe/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/pfizer-pfe/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/gsk/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/gsk/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/silence-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/silence-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/eyepoint/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/eyepoint/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/fractyl-health/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/fractyl-health/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/biomarin-pharmaceutical/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/biomarin-pharmaceutical/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/madrigal-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/madrigal-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/viking-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/viking-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/abbvie/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/abbvie/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/johnson-johnson/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/johnson-johnson/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/astrazeneca/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/astrazeneca/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/roche/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/roche/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/biontech/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/biontech/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/ascendis-pharma/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/ascendis-pharma/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/exelixis/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/exelixis/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/neurocrine-biosciences/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/neurocrine-biosciences/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/united-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/united-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/bridgebio-pharma/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/bridgebio-pharma/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/summit-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/summit-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/acadia-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/acadia-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/ultragenyx-pharmaceutical/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/ultragenyx-pharmaceutical/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/arrowhead-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/arrowhead-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/legend-biotech/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/legend-biotech/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/revolution-medicines/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/revolution-medicines/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/krystal-biotech/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/krystal-biotech/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/dyne-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/dyne-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/vera-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/vera-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/xenon-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/xenon-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/incyte/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/incyte/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/jazz-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/jazz-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/alkermes/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/alkermes/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/halozyme-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/halozyme-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/roivant-sciences/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/roivant-sciences/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/chugai-pharmaceutical/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/chugai-pharmaceutical/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/novartis/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/novartis/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/sanofi/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/sanofi/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/takeda-pharmaceutical/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/takeda-pharmaceutical/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/daiichi-sankyo/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/daiichi-sankyo/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/astellas-pharma/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/astellas-pharma/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/beone-medicines/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/beone-medicines/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/zai-lab/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/zai-lab/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/genmab/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/genmab/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/ucb-s-a/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/ucb-s-a/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/teva-pharmaceutical-industries/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/teva-pharmaceutical-industries/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/csl/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/csl/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/axsome-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/axsome-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/scholar-rock/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/scholar-rock/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/mirum-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/mirum-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/arcus-biosciences/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/arcus-biosciences/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/celldex-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/celldex-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/immunovant/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/immunovant/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/disc-medicine/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/disc-medicine/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/praxis-precision-medicines/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/praxis-precision-medicines/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/kymera-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/kymera-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/ideaya-biosciences/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/ideaya-biosciences/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/vaxcyte/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/vaxcyte/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/corcept-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/corcept-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/biohaven/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/biohaven/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/akeso/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/akeso/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/innovent-biologics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/innovent-biologics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/tg-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/tg-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/rhythm-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/rhythm-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/travere-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/travere-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/biocryst-pharmaceuticals/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/biocryst-pharmaceuticals/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/protagonist-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/protagonist-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/viridian-therapeutics/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/viridian-therapeutics/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/ipsen/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/ipsen/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/companies/swedish-orphan-biovitrum/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31daily0.9 https://aibio.space/companies/swedish-orphan-biovitrum/desk-view/https://aibio.space/assets/img/armed-forces-dna-identification-laboratory-analysts-2018-1400.webp2026-10-31weekly0.8 https://aibio.space/privacy/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/terms/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/accessibility/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/membership/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/credits/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/disclosures/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/about/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/reputation/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/latest/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/financings/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/debt-financing/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/distress/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/legal/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/listings/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/mergers/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/medtech/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/pharma/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/company-channel/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/claim/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/weekly-deals/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/for-companies/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31monthly0.3 https://aibio.space/class-action-tracker/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-10-31daily0.7 https://aibio.space/reverse-split-tracker/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-10-31daily0.7 https://aibio.space/reverse-merger-tracker/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-10-31daily0.7 https://aibio.space/winners-losers/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-10-31daily0.7 https://aibio.space/trackers/https://aibio.space/assets/img/new-york-stock-exchange-trading-floor-on-1400.webp2026-10-31daily0.7 https://aibio.space/analysis/akari-cash-lasts-about-nine-months-latest-filing-flags/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/alx-oncology-has-about-23-months-cash-our-math-date-tight/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/alto-has-cash-now-but-burn-rising-runway-claim-thin/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/atossa-has-about-nine-months-cash-we-expect-another-raise/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/caribou-biosciences-cash-after-car-t-shutdown/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/genelux-has-about-9-months-cash-going-concern-warning-little/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/maplight-therapeutics-phase-3-cost/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/nuvectis-has-cash-now-but-trials-will-need-more-money/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/oncolytics-has-about-two-months-cash-average-burn/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/outlook-therapeutics-fda-approval-balance-sheet/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/protalix-has-about-year-cash-paper-second-year-less-clear/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/sutro-has-about-14-months-cash-average-burn-so-we-expect/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/protara-cash-covers-about-26-months-paper-but-own-plans/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-28monthly0.6 https://aibio.space/analysis/https://aibio.space/assets/img/a-group-of-scientists-working-in-a-1400.webp2026-10-31weekly0.6